Yaya tsawon lokacin da alamun suka kasance?
Kuma ya kamata a bi da dukan ciwon kirji ta wannan hanyar, musamman ma a shekarunmu.
Kuma idan kuna da zazzabi,
Kuma ya kamata a duba yawan cholesterol da kuma hawan jini.
Kuma yanzu kuna da zazzabi?
Kuma yanzu ƙirjinka yana ciwo?
Kuma kuna da matsala a numfashi?
Kuma za ku iya gaya mini ko akwai wasu alamun da kuke ji a lokacin?
Kuma yawan zafin jikinka ya yi yawa.
Kuma ina da tari.
Kuma ina da ɗan sanyi da tari.
Kuma a gaskiya, na ɗan ji ciwon kirji a yau.
Kuma shin lokaci ne da ya dace ka yi fure?
Kuma hakan na sa ni ciwon kirji.
Kuma ina ganin na ɗan samu zazzabi.
Kuma ina so in ji daga gare ku bayanin inda kirjinku yake ciwo.
Kuma suna da zazzabi.
Kuma da tarihin ciwon sukari.
Kuma ina jin kamar za a karya mini kirji.
Kuma mutane suna yin tari a gabana a kowane lokaci.
Kuma kana da ciwon kirji.
Kuma kun ce wannan shi ne matsin da ke cikin kirjinku.
Shin akwai wani a cikin iyalinku da ke da ciwon zuciya, ciwon zuciya, bugun zuciya, hawan cholesterol, hawan jini?
Shin kana da wasu alamun ko kuma matsaloli da suka shafi ciwon tsoka?
Shin akwai wani a cikin iyalinku da ke da irin wannan ciwo?
Shin kana da wasu alamu?
Kana jin tsoro?
Shin har yanzu kana jin ciwon kirji?
Wannan lokacin mura ne.
Amma bai kamata mu manta da ciwon zuciya ba.
Amma ciwon kirji ya zama babban matsala.
Amma ina da matsala na numfashi.
Amma na san cewa mutane da yawa sun yi tari a kaina.
Amma dole ne mu ɗauki kowane ciwon kirji da muhimmanci.
Amma shin kana numfashi yadda ya kamata?
Na yi baƙin ciki sosai a cikin ƙirjina, kuma na manta da kome.
Kuna jin kamar wani yana matsawa kirjinku?
Shin har yanzu kuna jin kamar kuna da tsoro?
Shin sun taɓa yin gunaguni game da ciwo da ya sa su ma suna da irin waɗannan alamun?
Shin kana da wata cuta mai tsanani kamar hawan jini ko kuma wata matsala da ta shafi wannan?
Shin kana da wasu matsaloli kamar ciwon sukari?
Shin kana jin zafi ne a lokacin da kake jin ciwon kirji?
Kana da hawan jini?
Shin kana jin tsoro ne?
Ka san alamun da take da su?
Kuna ganin wannan hoton?
Ka sha ruwa mai yawa a yau
Duk da haka, na yi gwajin ciwon sukari.
Amma tana da alamun da nake da su.
Yaya zafin zafin jikinka?
Menene hawan jini?
Idan kana da zazzabi sosai,
Idan kana da zazzabi mai yawan gaske ko sama da haka
Idan kana jin cewa kana bukatar ka mai da hankali ga yadda kake ji ko kuma yadda kake ji, ka yi tunani a kan wannan batun.
Ina da zazzabi jiya.
Ina da ɗan zazzabi.
Ina da zazzabi jiya.
Ina da ciwon zuciya a nan.
Ina da matsala a numfashi.
Zan aiko muku da hotuna.
Ina da ciwon kirji a yau.
Ina jin ciwon kai da kuma zazzabi a yau.
Ina ganin cewa akwai mura.
Ina ganin wannan ɗan mura ne.
Shin kana ganin kamar wani yana zaune a ƙirjinka da ya fi ƙarfin mutum?
Ya fara da ciwon kai da kuma zafin jiki.
Saboda haka, ina jin ciwo a tsakiya na kirji.
Wannan matsin yana kama da ciwon kirji.
Ina da shi a kirjina.
Yana tsakiyar kirjina.
Yana tsakiyar kirji.
Ina da ciwon kirji.
Ina matukar damuwa da ciwon kirji.
Ya kamata ka bayyana yadda kake jin ciwon kirji.
Wasu suna da ciwon sukari, wasu suna da ciwon jini, wasu suna da ciwon jini.
Kamar dai a tsakiyar kirji.
Za ku iya samun tachipirina a yanzu don zafin jiki.
Mary, ka san tsawon lokacin da kake da alamun cutar?
Yanzu kun ce kuna da ciwon kirji.
Wani lokaci ina jin ciwon kirji.
To, akwai wasu alamun da kuka lura da su ban da ciwo?
Ko kuwa wani yana zaune a kirjinka?
Haka yake da zazzabi da tari da ciwon kai da kuma ciwon tsoka.
Ina da 'yan sanda da yawa a cikin wannan.
Ka nuna mini inda kake jin zafi a cikin wannan hoton.
Domin kuna da zazzabi.
To, kana ganin wasu daga cikin waɗannan alamun suna da nasaba da ciki?
Shin yaranku suna da irin wannan alamar?
Ka gaya mini game da ciwon kirjinka.
Zafi yana ƙaruwa da dare.
Na yi zazzabi na kwana biyu.
Ya fara zafin jiki tun daren jiya.
Ni ne Dr. Porter daga cibiyar kula da gaggawa.
To, za ka iya gaya mini game da ciwon kirjinka?
Ina jin zafi a nan a gaban kirji.
Na yi kyau, amma na ji zafi sosai a kirji.
Ina jin zafi a kirji.
Wane irin ciwo ne kake ji a kirjinka?
Yaushe ne wannan ciwon kirji ya fara?
Ina kirjinka yake ciwo?
Idan ka ji ciwo a cikin kirjinka, za ka iya jin cewa yana ciwo.
Za ku ji cewa ƙirjinku yana da wuya.
Na yi fama da ciwon sukari da wasu matsaloli.
Ka ce kana da ciwon kirji.
Cutar cutar coronavirus (COVID-19) a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai da Burtaniya, suna ƙaruwa sosai tsakanin 1 ga Janairu zuwa 15 ga Maris, 2020.
Haɗakarwar cutar coronavirus (COVID-19) ta nuna kamanceceniya tsakanin EU/EEA da United Kingdom, yana tabbatar da cewa ko da yake matakan sun bambanta daga ƙasa zuwa ƙasa, cutar ta COVID-19 tana ƙaruwa cikin sauri a duk ƙasashe.
Dangane da kwarewar Italiya, ƙasashe, asibitoci da cibiyoyin kulawa da hankali dole ne su haɓaka shirye-shiryen su don karɓar yawan masu fama da COVID-19 waɗanda ke buƙatar kulawa da lafiya, musamman ma, kulawa mai ƙarfi.
A ranar 31 ga Disamba, 2019, an gano jerin cututtukan cutar sankarar bargo na kwayar cutar a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin China ta ba da shawarar sabon coronavirus a matsayin mai haifar da cutar, wanda yanzu ake kira da mummunan cutar numfashi mai saurin kamuwa da cuta 2 (SARS-CoV-2).
An sanya sunan cutar ta coronavirus (COVID-19) saboda cutar ta SARS-CoV-2 ce ta haifar da cutar.
Shaida ta nuna cewa kashi 80% na mutanen da ke fama da COVID-19 suna da cututtukan cututtukan numfashi, tare da ko ba tare da cutar huhu ba, kuma mafi yawansu sun warke.
A cikin kashi 14 cikin ɗari, COVID-19 yana da mummunan yanayi wanda ke buƙatar asibiti, yayin da sauran kashi 6 cikin ɗari ke da mummunan yanayi wanda ke buƙatar kulawa mai zurfi.
Kashi 4 na mutanen da suka mutu a asibiti saboda COVID-19.
A cikin wannan binciken, mun kimanta yanayin haɗakar COVID-19 a kowace ƙasa a cikin EU / EEA da United Kingdom (UK) kuma mun kwatanta su da lardin Hubei na China.
Mun kuma gwada adadin COVID-19 a cikin EU/EEA da UK tare da waɗanda ke cikin Italiya daga 31 ga Janairu - 15 ga Maris, 2020.
Al'amuran COVID-19 a ƙasashen EU/EEA da UK
Bayan China, COVID-19 ya sami ƙarin yaduwar ƙasa, kuma sauran ɓangarorin duniya na COVID-19 na yanzu suna bin yanayin a cikin wannan ƙasar.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar Maris 5, 2020, na EuroSurveillance 2020, Spiteri et al, ya ba da rahoton farkon yanayin COVID-19 a Turai, kamar yadda WHO ta bayyana.
A cikin EU/EEA, Faransa ta sanar da tabbataccen lamari na farko guda uku da suka dawo daga Wuhan, lardin Hubei na China, a ranar 24 ga Janairu, 2020.
Ya zuwa ranar 15 ga Maris, 2020, an sami rahoton COVID-19 a cikin dukkan ƙasashe 30 na EU/EEA da Burtaniya, tare da 39,768 da mutuwar 1,727 a ranar 31 ga Disamba, 2019, tare da 17,750 da mutuwar 1,441 a Italiya kadai.
Samun jimillar adadin COVID-19 da kuma abubuwan da suka faru
Cibiyar Kula da Cututtuka ta Turai (ECDC) tana yin rikodin COVID-19 na kowace ƙasa a duniya, wanda ake sabunta bayanai a kowace rana da ƙarfe 8:00 na safe ta amfani da tushen hukuma kamar ma'aikatun kiwon lafiya na ƙasashe, hukumomin kiwon lafiya na ƙasa da na yanki, da WHO.
Ana amfani da wannan bayanan don kimanta yanayin COVID-19 a cikin EU/EEA da UK da kuma kwatanta su da shari'o'in a Italiya.
A matsayin samfurin yaduwar COVID-19 masu aiki, mun ƙidaya adadin kwanaki 14 na COVID-19 masu haɗuwa, muna la'akari da yaduwar COVID-19 ta halitta a cikin kowace EU/EEA da Burtaniya daga 1 ga Janairu - 15 ga Maris, 2020.
Mun kuma gabatar da adadin adadin da aka ba da sanarwar a kowace ƙasa a ranar 15 ga Maris, 2020 da karfe 8:00 na safe, kuma mun gwada su da waɗanda ke Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a cikin EU/EEA da UK
Yanayin duka na 14 days na COVID-19 a cikin EU/EEA da UK ya yi kama da lardin Hubei (China) (Hoto 1).
A cikin EU/EEA da UK gaba ɗaya, haɗakar al'amuran COVID-19 sun fara ƙaruwa a kusa da 21 ga Fabrairu, sannan suka fara ƙaruwa sosai har zuwa 28 ga Fabrairu, 2020 (kayan aiki).
Wannan ya ƙunshi yawan adadin da aka ba da rahoton a Italiya, amma ya nuna cewa akwai karuwar adadin COVID-19 a duk sauran ƙasashen EU/EEA da kuma Burtaniya (abubuwan da ke ciki).
Shafi na 2 ya nuna adadin adadin COVID-19 a cikin EU/EEA da UK, idan aka kwatanta da waɗanda ke Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Ya nuna cewa an riga an sami adadin masu cutar a cikin sauran ƙasashen EU/EEA 15 da Burtaniya, makonni 3 kafin ko ƙasa da 8 na safiyar ranar 15 ga Maris, kamar yadda aka samu a Italiya.
Sakamakonmu ya nuna cewa COVID-19 yana ƙaruwa cikin sauri a cikin EU/EEA da UK.
Halin da aka lura a cikin abubuwan da suka faru na COVID-19 ya nuna cewa cutar ta ci gaba da ƙaruwa cikin sauri a duk ƙasashe.
Bugu da ƙari, yayin da ƙasashe daban-daban ke cikin matakai daban-daban, rata tsakanin halayen lafiyar jama'a na ƙasa da ma'anar yiwuwar yanayi daban-daban a cikin ƙasashe da kuma ƙa'idodin zaɓin marasa lafiya daban-daban waɗanda dole ne a bincika don tabbatar da COVID-19, gami da gwajin kamawa.
A farkon Maris 2020, likitoci a yankunan da ke fama da cutar a Italiya sun bayyana yanayin da ke buƙatar kulawa mai mahimmanci ga kashi 10% na marasa lafiya da ke fama da COVID-19, kuma kafofin watsa labarai sun nuna cewa asibitoci da cibiyoyin kulawa da hankali a cikin waɗannan yankuna sun riga sun kai iyakar ƙarfin su.
Bayanai game da shigar da marasa lafiya na COVID-19 a asibitoci da / ko cibiyoyin kulawa na ICU a halin yanzu suna samuwa ne kawai a cikin kashi 6% da 1% na shari'o'i a matakin EU/EEA (ba a nuna bayanan ba).
Amma suna buƙatar tattara bayanan sa ido na yanzu a cikin tsari mai ma'ana wanda ke mai da hankali kan adadin waɗanda aka ba da rahoton da kuma adadin mutuwar.
Wani bincike da aka yi a shekara ta 2010-11 ya nuna cewa akwai bambanci sosai tsakanin adadin gadajen asibiti na ICU da na matsakaici a Turai, wanda ya kai 29.2 a Jamus da 4.2 a Portugal.
Wannan yana nufin cewa sauran ƙasashe suna da ƙasa ko fiye da albarkatu fiye da Italiya (kwana 12.5 na asibiti da matsakaitan asibiti a kowace mutane 100,000 a cikin 2010-11).
Yawan COVID-19 da aka yi asibiti a kowace EU/EEA da UK, yanayin samfurin da ke da alaƙa da wadatar kiwon lafiya yana da alaƙa da haɗarin wucewa > 90% na ƙarfin asibiti, wanda aka bayar a cikin sabuntawa na shida na ECDC Rapid Risk Assessment na COVID-19.
Tun da yake har yanzu an iyakance shari'o'in zuwa wasu yankuna na EU/EEA da UK, kuma asibitoci da cibiyoyin ICU suna ba da magani ga wasu ƙididdigar yanki, ya kamata a samar da bayanan shari'o'i da bayanan ICU, a cikin ma'anar cibiyoyin yanki, a cikin matakin Figure 2 (NUTS-2).
Kwarewar Italiya da halin da ake ciki a wasu ƙasashe suna nuna cewa cutar COVID-19 tana yaduwa cikin sauri a cikin EU/EEA da UK.
Saboda haka, ƙasashe, asibitoci da cibiyoyin kulawa da gaggawa suna buƙatar shirya kansu don ci gaba da kamuwa da cutar SARS-CoV-2 a cikin al'umma da kuma karuwar adadin marasa lafiya da ke fama da COVID-19, waɗanda ke buƙatar kulawa da lafiya da kuma musamman kulawa da gaggawa, kamar yadda yanayin ya faru a yankunan da ke fama da cutar a Italiya.
A kwanan nan, ECDC ta yi saurin kimanta hadarin da ke nuna cewa, maimakon jinkirta hana yaduwar SARS-CoV-2, ana buƙatar hanzari, aiki da kuma cikakkiyar hanyar magance cutar, saboda idan ba a aiwatar da su ba da wuri, saurin da ake tsammani na irin waɗannan shari'o'in ba zai ba masu yanke shawara da asibitoci damar kimantawa, karɓa da daidaita martani ba.
An kuma lissafa matakan kiwon lafiya na jama'a a cikin saurin kimanta haɗarin don kawar da tasirin cutar.
Akwai ɗan lokaci na dama yayin da ƙasashe za su iya ƙara ƙoƙarin su don rage yaduwar SARS-CoV-2 da rage matsin lamba a kan kiwon lafiya.
Idan wannan ya gaza, akwai yiwuwar cewa tsarin kiwon lafiya na sauran ƙasashen EU/EEA zai fuskanci ɗumbin marasa lafiya waɗanda ke buƙatar kulawa mai mahimmanci a cikin kwanaki da makonni masu zuwa.
Cutar cutar coronavirus ta 2019 (COVID-19) ta barke ne sakamakon cutar sankara mai saurin kamuwa da cutar numfashi (SARS) Coronavirus 2 (SARS-CoV-2), wanda ya yi sanadiyar mutuwar mutane sama da 3,000 da kuma kamuwa da mutane sama da 80,000 a China da sauran kasashen duniya, kuma ya zama bala'i ga bil'adama.
Kamar SARS-CoV, wanda ya haifar da SARS a cikin dubban mutane a 2003, SARS-CoV-2 na iya zama mai cutar daga batutuwa kuma yana nuna alamun kama da juna ta hanyar irin wannan tsarin.
Koyaya, COVID-19 yana da ƙarancin ƙarfi da mutuwa fiye da SARS, amma yana da ƙarancin kamuwa da cuta, kuma yana faruwa a cikin tsofaffi fiye da matasa da maza fiye da mata.
A cikin amsa ga karuwar wallafe-wallafen game da cutar da ke tasowa, wannan labarin yana ƙoƙari ya samar da cikakken lokaci da kuma cikakken bita game da batun bincike mai tasowa.
Mun yi magana game da abubuwan da suka shafi cututtukan cututtuka, cututtukan cututtuka, cututtukan cututtuka, ganewar asali, magani, farfadowa da rigakafin cututtuka.
Ko da yake akwai tambayoyi da yawa da ba a amsa ba, muna fatan cewa wannan bita zai taimaka mana mu fahimci kuma mu kawar da wannan mummunar cuta.
Bikin bazara na 25 ga Janairu, 2020 ya kasance abin tunawa da ba a taɓa gani ba ga duk Sinawa waɗanda aka gaya musu su zauna a gida saboda barkewar sabuwar cuta mai yaduwa a duk lokacin hutu da makonni da yawa bayan haka.
Wannan kwayar cuta tana da alaƙa da kwayar cutar coronavirus (CoV) wacce ta haifar da barkewar cutar numfashi mai tsanani (SARS) a 2003, don haka a ranar 11 ga Fabrairu, 2020, WHO ta sanya sunan SARS-CoV-2 da kuma cutar da ke da alaƙa da shi a matsayin COV Disease 19 (COVID-19).
Cutar ta fara ne a birnin Wuhan na kasar Sin, kuma nan da nan ta bazu zuwa kasar da kuma wasu kasashe 50 a duniya.
Har zuwa 2 ga Maris, 2020, cutar ta haifar da tabbataccen shari'o'in COVID-19 80,000, tare da fitar da sama da marasa lafiya 40,000 da mutuwar marasa lafiya 3,000.
WHO ta yi gargadin cewa COVID-19 "magabcin jama'a ne lamba daya" kuma mai yiwuwa ya fi ta'addanci ƙarfi.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), sama da bincike 200 da aka buga akan COVID-19 a cikin watanni biyu, sun hada da ilimin kwayar cutar, cututtukan cututtuka, ilimin cututtukan cuta, ganewar asali da magani, wanda ya sanya jerin kwayoyin cutar a cikin marasa lafiya daban-daban tun lokacin da aka fara rahoton shari'ar farko a ranar 7 ga Janairu, 2020.
Wannan bita yana ƙoƙarin taƙaita ci gaban bincike a cikin sabon da kuma ci gaba da ci gaba da batun.
A duk lokacin da zai yiwu, za mu yi ƙoƙarin kwatanta COVID-19 da SARS da sauran cututtukan da ke haifar da CoV, da kuma cutar numfashi ta Gabas ta Tsakiya (MERS, barkewar cutar a shekarar 2012).
Za mu kuma tattauna abin da muka koya game da rigakafin cuta da kuma ci gabanta, da kuma wasu batutuwa na gaggawa da suka rage.
CoVs an saba da su a matsayin masu cutarwa da ba su da haɗari ga mutane, suna haifar da kusan kashi 15% na cututtukan sanyi.
Amma a wannan karni, mun fuskanci cututtuka biyu masu haɗari na CoVs na mutum, SARS-CoV da MERS-CoV, waɗanda suka fara fitowa a China a 2003 da Saudi Arabia a 2012, kuma nan da nan suka bazu zuwa wasu ƙasashe tare da mummunan lalacewa da mutuwa.
Saboda haka, COVID-19 na yanzu shine ɓarkewar CoV na uku a cikin tarihin ɗan adam na kwanan nan.
Kamar yadda aka nuna a Hoto 1.1, rukunin cutar pneumonia na asalin da ba a sani ba an fara lura da su a Wuhan a ranar 31 ga Disamba, 2019, ta Hukumar Lafiya ta Kasa ta China.
An ba da umarnin CoVs bayan kwana bakwai.
An sami mace-mace ta farko a Wuhan a ranar 15 ga Janairu, 2020.
A halin yanzu, annobar ta bazu cikin sauri zuwa garuruwa, larduna da ƙasashe makwabta.
A ranar 20 ga Janairu, an sami rahoton kamuwa da cuta a cikin masu ba da kiwon lafiya, wanda ya nuna cewa cutar za ta iya yaduwa daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, an fara kulle-kullen birnin Wuhan, kuma an dakatar da dukkan hanyoyin sufuri.
A ranar 24 ga Janairu, binciken farko na asibiti na cutar ya nuna cewa daga cikin tabbatattun shari'o'i 41 kawai 21 sun kasance cikin hulɗa kai tsaye da kasuwar abincin teku ta Wuhan, wanda aka ɗauka a matsayin cibiyar kamuwa da cutar ta farko daga asalin dabbobi da ba a sani ba.
A ranar 30 ga Janairu, WHO ta ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiya ta duniya.
A lokacin da aka wallafa wannan rahoto, cutar ta riga ta bazu ko'ina cikin China da kuma kasashe 50 a duniya (Figure 2.2).
Yanayin da ake ciki yana canzawa cikin sauri, kuma yanayin ƙarshe da kuma tsananin ɓarkewar har yanzu ba a tabbatar da su ba.
Nazarin da aka yi a wurare da yawa na marasa lafiya 8,866 da 4,021 da aka tabbatar da cutar COVID-19 a ranar 11 ga Fabrairu, 2020 ya ba da hoto na yau da kullun na cutar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da cutar a cikin mutane na kowane zamani, amma ya fi mayar da hankali ga mutanen da ke tsakanin shekaru 30-65.
Kusan rabin (47.7%) na waɗanda suka kamu da cutar sun kai shekaru 50, mafi ƙarancin shekarunsu ba su kai 20 ba, kuma 14 ne kawai ke da shekaru 10 ko ƙasa da haka.
SARS-CoV-2 ya kamu da maza (0.27/1,00,000) fiye da mata (0.31/1,00,000).
COVID-19 ya yadu a cikin Hubei da kewayen garuruwan birni.
Matsakaicin lokaci daga kamuwa da COVID-19 zuwa ganewar asali shine kwanaki 5 (2-9).
Matsakaicin lokacin riƙewa ya kasance kwanaki 4.8 (3.0-7.2).
Matsakaicin lokaci daga kamuwa da cutar zuwa mutuwa ya kasance kwanaki 9.5 (4.8-13).
Matsakaicin lambar sakewa (R0) 3.77 (95% CI: 3.51-4.05) kuma daidaitaccen R0 2.23-4.82.
An samu karuwar yawan mutanen da suka kamu da cutar kafin 23 ga Janairu, 2020, wanda ya yi daidai da barkewar cutar kafin bikin bazara a kasar Sin.
Rashin mutuwa na marasa lafiya tare da tabbataccen shari'o'i ya kasance 1.44% (95% CI: 1.10-1.86%) kuma daidaitaccen mutuwar marasa lafiya ya kasance 3.06% (95% CI: 2.02-4.59%).
Abubuwa uku na haɗari don COVID-19 sune jinsi (maza), shekaru (>60) da kuma ciwon huhu mai tsanani.
CoVs babban ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin ƙaramin
Ana iya raba su zuwa kwayoyin halittar hudu, wato alpha, beta, gamma da delta, wanda aka san cewa alpha da beta CoVs suna shafar mutane.
Wannan haɗin kai na (S) glycoprotein yana ɗaure da masu karɓar ƙwayar cuta na angiotensin-converting enzyme 2 (ACE2) da dipeptidyl peptides 4 (DPP4) don SARS-CoV da MERS-CoV, bi da bi, sannan kuma ya haifar da haɗuwa da fata.
Ana sakin kwayar cutar RNA zuwa cikin kwayar halitta; bayan kwayar cutar ta kwayar halitta ta kwayar halitta, RNA ta kwayar halitta tana samar da kwayar halitta mai dauke da virion tare da glycoprotein da kuma nucleocapsid protein, wanda daga baya ya hada da membrane na plasma don sakin kwayar cutar.
An fara samun jerin kwayoyin SARS-CoV-2 a ranar 10 ga Janairu, 2020.
SARS-CoV-2 an gano shi a matsayin sabon nau'in beta-CoV wanda aka gano 99.98% na asalin kwayoyin halittar a cikin jerin samfura 10 da aka ɗauka daga cibiyar asalin cutar, kasuwar abincin teku ta Huanan a Huanan.
SARS-CoV-2 ya fi kama da MERS-CoV a cikin kwayoyin halitta fiye da SARS-CoV.
Ta hanyar watsawar lantarki, an gano SARS-CoV-2 a cikin ƙananan ƙananan ƙananan ƙwayoyin cuta na ƙwayoyin cuta na mutum.
An gano ACE2 na ɗan adam a matsayin mai karɓar SARS-CoV-2 da SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana ɗaure ACE2 na ɗan adam da rauni fiye da furotin S na SARS-CoV, wanda ke haifar da ƙananan kamuwa da cuta daga SARS-CoV-2 fiye da SARS-CoV.
SARS-CoV-2 na iya samar da sabon ƙaramin furotin, wanda aka tsara ta hanyar orf3b, kuma furotin da aka yi amfani da shi wanda aka tsara ta hanyar orf8.
Wataƙila orf3b na SARS-CoV-2 na iya taka rawa a cikin kwayar cutar mai yaduwa da kuma hana bayyanar IFNß; duk da haka, orf8 ba shi da wani sanannen yanki ko manufa.
A ranar 18 ga Fabrairu, 2020, Zhou, et al. sun nuna cewa tsarin cryo-EM na tsawon tsawon mutum ACE2 a ƙuduri 2.9 Å ya haɗu da amino acid mai ɗaukar hoto B0AT1.
Sun gano cewa tsarin da aka rufe da kuma wanda aka buɗe ya haɗu a matsayin dimer, kuma cakuda ACE2-B0AT1 na iya ɗaure sunadarai biyu na S, wanda ke ba da tabbacin ganowa da kamuwa da cutar CoV.
B0AT1 na iya zama wata manufa ta warkewa don gwajin magani don shawo kan cutar SARS-CoV-2.
Mai watsa shiri na asali da na tsakiya
An san cewa SARS-CoV da MERS-CoV sun samo asali ne daga fararen hula kuma sun shiga mutane daga kuliyoyi da raƙuma, bi da bi.
Idan aka kwatanta SARS-CoV-2 da sauran CoVs, an gano cewa bat-CoV-2 na gida ne ga SARS-CoV-2 saboda sabon kwayar cutar tana da daidaito na 96% tare da bat-CoVZX45 da bat-CoVZX21 na SARS.
Koyaya, ba a san ko waɗanne matsakaita ne suka taimaka wa kwayar cutar ta ƙetare shingen nau'in don cutar da mutane ba, kuma hanyar watsawa har yanzu tana bayyana.
Ji, et al., sun ba da shawarar cewa macizai su zama masu jigilar abubuwa daga fararen hula zuwa ga mutane, wanda ya kamata a sami sake haɗuwa tsakanin jinsi a lokacin S furotin.
A cikin wani bincike, masu bincike a Guangzhou, China sun ba da shawarar cewa dogon hanci, mai cin naman alade, wanda ake amfani da shi sosai a cikin maganin gargajiya a China, na iya zama mai watsa shiri na SARS-CoV-2, wanda aka gano daidaiton kwayoyin halitta 99% tsakanin CoV da SARS-CoV-2 da aka gano a cikin naman alade.
Amma, bambancin kashi ɗaya cikin ɗari tsakanin kwayoyin halittar mutum biyu har ila yau babban bambanci ne, saboda haka ana jiran tabbaci mai ƙarfi don yanke shawara (Figure 33).
Ba a san halayen jiki na SARS-CoV-2 sosai ba.
SARS-CoV da MERS-CoV na iya rayuwa har tsawon awanni 48 a cikin bushewa da kuma tsawon kwanaki 5 a zafin jiki na digiri 20 da zafi na kashi 40 zuwa 50%.
SARS-CoV-2 yana da irin wannan halayen.
An nuna cewa SARS-CoV-2 ba zai iya jurewa ba bayan minti 30 a cikin hasken ultraviolet da kuma a zafin jiki na 56 ° C, yayin da ether, 75% ethanol, maganin kashe ƙwayoyin cuta mai chlorinated, paracetic acid, chloroform, da sauran magungunan ƙwayoyin cuta ba tare da chlorhexidine ba zasu iya kashe shi yadda ya kamata.
A cikin al'ada, dukkanin 'yan adam ba su da kariya ga SARS-CoV-2 kuma saboda haka suna da rauni ga wannan sabon kwayar cutar.
A halin yanzu, babu wani bincike mai zurfi game da amsawar rigakafi ga SARS-CoV-2.
Saboda haka, za mu iya komawa ga wasu nazarin CoVs, musamman SARS-CoV da MERS-CoV (Figure 4).
A yadda aka saba, lokacin da kwayar cutar ta kai hari ga mai masaukin, ana gano ta da farko ta hanyar masu karɓar tsarin ganewa (PRR), wanda ya haɗa da masu karɓar nau'in C-type lectin-like, mai karɓar mai kama da Toll (TLR), mai karɓar NOD-like (NLR), da RIG-I-like (RLR).
Ta hanyoyi daban-daban, kwayar cutar tana motsa bayyanar abubuwa masu kumburi, tsufa na kwayoyin dendritic, da kuma tsoma baki na nau'in I (INN), wanda ke iyakance yaduwar kwayar cutar da kuma hanzarta fashewar kwayar cutar ta kwayar cutar.
Amma, N-protein na SARS-CoV zai iya taimakawa cutar ta tsira daga amsawar rigakafi.
Ba da daɗewa ba, tsarin garkuwar jiki mai kyau zai shiga yaƙi da kwayar cutar.
T lymphocytes tare da CD4 + da CD8 + T kwayoyin suna taka muhimmiyar rawa a cikin kariya.
CD4+ T cells suna motsa B cells su samar da kwayar cutar ta musamman, kuma CD8+ T cells suna kashe kwayoyin cutar kai tsaye.
Kwayoyin T masu taimako suna samar da cytokines masu ba da taimako don taimakawa ƙwayoyin ceto.
Koyaya, COVID na iya hana T-cell aiki ta hanyar haɗa T-cell apoptosis.
Tsarin rigakafin jiki wanda ya ƙunshi abubuwa da kuma ƙwayoyin cuta kamar C3A da C5A, yana da muhimmanci wajen yaƙi da kamuwa da kwayar cutar.
Alal misali, ƙwayoyin cuta da aka samu daga marasa lafiya da suka warke sun kawar da cutar MERS-CoV.
A wani ɓangare kuma, ƙwayar cuta tana sa ƙwayoyin cuta su yi yawa a gida, kuma hakan yana iya sa a yi wa huhu da sauran gabobin jiki lahani mai tsanani, kuma a yanayi mai tsanani, zai iya sa a yi wa gabobin jiki lahani ko kuma mutuwa.
Cutar SARS-CoV-2 da ke farawa a cikin rukuni tana iya faruwa a cikin tsofaffi da mata masu juna biyu waɗanda ke da yiwuwar rikice-rikice.
Mutanen da suke da wasu cututtuka ko kuma waɗanda suke da tsarin rigakafi mai rauni suna da damar kamuwa da cutar fiye da sauran mutane.
An kiyasta matsakaicin lokacin warkewar SARS-CoV-2 na kwanaki 1-14, kwanaki 3-7 a mafi yawan lokuta kamar yadda aka gano a cikin farkon shari'o'i 425 a Wuhan.
Amma, binciken da aka yi a kan mutane 1,099 ya nuna cewa matsakaicin lokacin da ake warkewa kwanaki uku ne, kuma daga kwanaki 0 zuwa 24.
Kamar yadda aka bayyana a sama, wani binciken da aka yi kwanan nan ya nuna cewa a cikin mutane 8,866 da suka kamu da cutar, tsawon lokacin warkewa ya kai kwanaki 4.8 (3.0 - 7.2).
Yana da mahimmanci ga jami'an kiwon lafiya su daidaita lokacin keɓewa mai tasiri bisa ga mafi ƙarancin lokacin warkewa, wanda zai iya hana mutanen da ke da cutar amma ba su da alamun cutar daga yada cutar ga wasu.
A matsayin matsakaici, mutane da suka haɗu da cutar ko kuma waɗanda ke da cutar, galibi suna buƙatar keɓewa na kwanaki 14.
Shin dole ne a yi zaman keɓewa na kwanaki 24?
Zazzabi shine babban bayyanar COVID-19, wanda zai iya kasancewa tare da rashin bayyanar cututtuka ko wasu alamomi kamar tari mai bushe, rashin jin daɗi, ƙoshin tsoka, kumburi, ciwon kai, ɓacin hanci, rhinoria, ciwon kirji, zawo, amai da kuma amai.
Wasu marasa lafiya na iya samun dyspnea da/ ko hypoxemia bayan mako guda bayan kamuwa da cutar.
A cikin mawuyacin hali, marasa lafiya suna samun ciwon numfashi mai tsanani, ciwon daji, ciwon ciwon shan magani, da kuma coagulopathy.
Ana bukatar a fara gano cutar a cikin marasa lafiya da ke da zazzabi da kuma/ko alamun numfashi da kuma zazzabi mai tsanani, ko da kuwa akwai wani rashin daidaito na hoto na huhu.
Wani binciken alƙaluma da aka yi a ƙarshen Disamba na 2019 ya nuna cewa kashi 98 cikin ɗari na alamun cutar zazzabi ne, kashi 76 cikin ɗari na tari ne, kashi 55 cikin ɗari na dyspnea ne, kuma kashi 3 cikin ɗari na zawo ne; kashi 8 cikin ɗari na marasa lafiya suna buƙatar taimakon iska.
An kuma sami irin wannan sakamakon a cikin wasu bincike biyu da aka yi a baya-bayan nan, a kan mutanen da suka kamu da cutar daga danginsu da kuma mutanen da ba su da alamun cutar.
A kwatankwacin haka, binciken alƙaluma na 2012 ya nuna cewa masu fama da cutar MERS-CoV sun sami zazzabi (98%), tari mai bushe (47%), da dyspnea (55%) a matsayin manyan alamun.
Koyaya, kashi 80% daga cikinsu suna buƙatar taimakon iska, wanda ya fi na COVID-19 yawa kuma cutar MERS ta fi ta COVID-19 kisa.
An kuma samu zawo (26%) da kuma zawo (21%) a cikin marasa lafiyar MERS.
A cikin marasa lafiya na SARS, an ga cewa zazzabi (99-100%), busassun tari (29-75%), dyspnea (40-42%), diarrhea (20-25%) da kuma ciwon makogwaro (13-25%) sune manyan alamun cutar kuma kusan kashi 14-20% na marasa lafiya suna buƙatar tallafin iska.
A ranar 14 ga Fabrairu, lokacin da aka tabbatar da cewa adadin masu kamuwa da cutar ya kai 66,576, yawan mutuwar COVID-19 ya kai kashi biyu cikin dari.
A kwatankwacin haka, a watan Nuwamba na shekara ta 2002, mutuwar SARS ta kai kashi 10 cikin 100 na mutane 8,096 da aka tabbatar da cutar.
Don MERS, yawan mutuwar ya kai kashi 37% na 2494 da aka tabbatar da su, bisa ga binciken alƙaluma na Yuni 2012.
Binciken da aka yi a baya ya nuna cewa SARS-CoV-2 yana da RO na 6.47 da kashi 95% na lokacin amincewa (CI) na 5.71 - 7.23, yayin da SARS-CoV yana da RO na tsakanin 2 da 4.
Tabbacin 1.1 ya kwatanta SARS-CoV-2 da MERS-CoV da SARS-CoV dangane da bayyanar cututtuka, mutuwa da RO.
Bayanan da ke sama sun nuna cewa SARS-CoV-2 yana da damar yaduwa fiye da MERS-CoV da SARS-CoV, amma yana da ƙananan haɗari.
Saboda haka, sarrafa cutar SARS-CoV-2 ya fi kalubalen MERS-CoV da SARS-CoV.
A yawancin lokaci, ana fara taron ne a cikin iyali ɗaya ko kuma a kan jirgin ruwa ɗaya, kamar jirgin ruwa mai tafiya.
Marasa lafiya suna da tarihin tafiya ko zama a Wuhan ko wasu yankuna da ke fama da cutar ko kuma sun kasance tare da mutanen da ke da cutar a cikin makonni biyu da suka gabata kafin fara cutar.
Koyaya, an nuna cewa mutane na iya ɗaukar kwayar cutar ba tare da wata alama ba fiye da makonni biyu, kuma waɗanda suka warke daga asibiti na iya sake ɗaukar kwayar cutar, wanda ya ba da shawarar a ƙara tsawon lokacin keɓewa.
A farkon lokaci, marasa lafiya suna da ƙananan ƙananan ƙwayoyin jini (musamman lymphocytes).
Alal misali, an gano lymphopenia tare da ƙididdigar ƙwayoyin jini < 4×109/L tare da ƙididdigar lymphocyte < 1×109/L tare da matakan aminotransferase da viremia a cikin marasa lafiya 1,099 na COVID-19.
An samu ƙaruwar ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin.
A cikin marasa lafiya masu tsanani, an sami ƙaruwar matakan D-dimer na fibrin da ke ragewa a cikin jini kuma ƙididdigar lymphocyte ya ragu sosai.
Yawancin marasa lafiya na COVID-19 sun sami rashin daidaito a cikin radiography na kirji kuma an nuna su da bilateral patch shadows a cikin huhu ko kuma gilashin gilashi.
Yawancin lokaci marasa lafiya suna samun ciwon huhu, ciwon huhu mai tsanani, da kuma ciwon numfashi mai tsanani (ARDS).
Sa'ad da ARDS ta faru, kumburi marar kyau, ajiyar ruwa, da kuma ci gaba da zufa suna shafan yanayin iska.
Rashin daidaituwa a cikin nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
Saboda haka, sakamakon da ya fi muni a radiyo sau da yawa yana kama da wanda ya fi muni.
A ranar 18 ga Fabrairu, 2020, kimantawar farko ta COVID-19 ta nuna cewa desquamation na ƙwayoyin cuta, samar da membrane na maganin kashe cuta da kuma kutsawa cikin ƙwayoyin cuta na tsakiya da ƙwayoyin cuta masu yawa a cikin huhu na marasa lafiya da suka mutu sun dace da cutar kamuwa da cuta ta kwayar cuta da ARDS kuma sun yi kama da na SARS da MERS.
Gano SARS-CoV-2 RNA ta hanyar jujjuya-transcriptase polymerase chain reaction (RT-PCR) an yi amfani da shi azaman babban ma'auni don gano COVID-19.
Amma, saboda yawan ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙaran
Haka ma ya faru da cutar SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar asibiti, gwajin gwaji da sakamakon radiological suna da mahimmanci da mahimmanci don ingantaccen ganewar asali.
A ranar 14 ga Fabrairu, 2020, Feng Zhang Group ya bayyana yarjejeniya ta amfani da fasahar CRISPR-based SHERLOCK don gano SARS-CoV-2, wanda ke gano ƙwayoyin SARS-CoV-2 RNA na roba a cikin awa ɗaya daga 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (kowace 10-100 kwafi na microliter na shigarwa) ba tare da buƙatar kayan aiki masu yawa ba.
Ana fatan cewa idan an tabbatar da shi a cikin samfuran asibiti, sabon fasaha na iya haɓaka ƙwarewa da fa'ida sosai.
Saboda rashin ƙwarewa game da sabon CoV, likitoci na iya ba da kulawa ta tallafi ga marasa lafiya na COVID-19 kuma suna iya gwada hanyoyin da aka yi amfani da su ko kuma aka ba da shawarar a baya akan wasu CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan ƙwayoyin cuta (Table 2).
Wadannan hanyoyin sun hada da maganin da ake da su da kuma na gaba, wadanda suka hada da maganin rigakafi, maganin rigakafi, maganin steroids, maganin plasma, maganin kasar Sin, da kuma maganin tunani.
Ƙari ga haka, an ba da shawarar yin amfani da ƙwayoyin da suka warke don yin maganin.
Kamfanonin ƙwayoyi suna saurin yin ƙoƙari don samar da ƙwayoyin cuta da allurar rigakafi don cutar.
SARS-CoV-2 yana fara kai hari ga huhu, kuma yana iya kai hari ga wasu gabobin da ke bayyana ACE2, kamar tsarin gastrointestinal da koda.
Saboda haka, rashin aiki da kuma lalacewar numfashi na da matukar hadari ga marasa lafiya kuma shi ne babban dalilin mutuwa.
Saboda haka, don samun sauƙin bayyanar cututtuka da ceton rayuka, yana da mahimmanci a tallafawa tsarin numfashi, wanda ya haɗa da maganin oxygen na yau da kullun, oxygen mai gudana, iska mai iska mai iska, da iska mai iska mai iska, gwargwadon tsananin cutar.
Marasa lafiya da ke da cututtukan numfashi masu tsanani ya kamata su goyi bayan extracorporeal membrane oxygenation (ECMO), ingantaccen fasahar bugun zuciya da bugun jini wanda ake amfani da shi don cutar zuciya ko cutar numfashi.
Bugu da ƙari, kiyaye daidaiton lantarki, hana cututtukan na biyu da kuma cututtukan cututtukan cututtuka, da kuma kulawa da kulawa da ayyukan manyan gabobin jiki suna da mahimmanci ga marasa lafiya na SARS-CoV-2.
An gano cewa a cikin SARS da MERS, ƙarin amsawar tsarin rigakafi yana haifar da guguwar cytokine.
Cytokine Storm wani nau'i ne na amsawar mai ba da tsari wanda aka nuna ta hanyar sakin jerin cytokines wanda ya hada da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Waɗannan ƙwayoyin cuta suna sa ƙwayoyin cuta na rigakafi su saki ƙwayoyin cuta masu yawa waɗanda ke haifar da ARDS da kuma cututtukan gabobin jiki.
Immunosuppression yana da muhimmanci wajen magance matsalar cytokine, musamman ma marasa lafiya masu tsanani.
Ana amfani da maganin anti-IL6 monoclonal antibody corticosteroids da tosilizumab don magance matsalar cytokine.
Sauran magungunan rigakafin cututtukan cytokine sun hada da T-cell-directed immune response, hana IFN-Y, IL-1 da TNF, hana JAK, blintumomab, mai hana siginar cytokine 4, da kuma HDAC inhibitors.
Ana amfani da steroids a matsayin maganin rigakafi a cikin maganin SARS don rage lalacewar kumburi.
Koyaya, a cikin SARS da COVID-19, maganin steroid mai yawa bai kasance mai amfani ba don mummunan rauni na huhu.
Maimakon haka, suna iya haifar da sakamako masu illa, musamman: osteonecrosis na jijiyoyin jini, wanda zai iya shafar ganewar asali.
Koyaya, ana ba da shawarar yin amfani da ƙananan magungunan corticosteroids a cikin ƙananan magungunan matsakaici don masu cutar COVID-19 masu tsanani.
A lokacin da nake rubuta wannan, babu wani magani mai tasiri na rigakafin cutar da aka tabbatar.
Amma, an tabbatar da cewa maganin Remdesivir yana da tasiri a cikin jijiya ga wani mai cutar COVID-19 a Amurka.
Remdesivir, wani magani ne mai ban mamaki da GILID ta samar don magance cututtukan da suka fara da cutar Ebola da Marburg.
Daga baya, Remdesivir ya nuna yiwuwar toshewa ga wasu ƙwayoyin cuta na RNA guda ɗaya, ciki har da ƙwayoyin cuta na MERS da SARS.
Bisa ga wannan, Jilid ya ba da wannan kayan ga China don yin gwaji a kan marasa lafiya da ke dauke da SARS-CoV-2, kuma sakamakon ya kasance mai ban sha'awa.
Bugu da ƙari, baricytnb, interferon-α, lopinavir/ritonavir, da ribavirin an ba da shawarar su a matsayin yiwuwar magani ga marasa lafiya da ke fama da cututtukan numfashi.
Maganin haɗin Lopinvari/Ritonavir na iya haifar da zawo, amai, amai, raunin hanta da sauran halayen da ba su dace ba.
Ya kamata a lura da tasirin wannan magani a kan sauran magunguna da ake amfani da su a cikin marasa lafiya.
An yi amfani da maganin da ake kira plasma da kuma antibodies don ya warkar da marasa lafiya.
Akwai dogon tarihi na tattara jinin mutanen da suka warke daga cututtuka don a yi wa waɗanda suke da cututtuka magani ko kuma a hana mutane da suke da lafiya kamuwa da cututtuka.
Gaskiya ne cewa marasa lafiya da aka warkar suna da ƙwayoyin cuta da yawa a cikin jinin su fiye da waɗanda suke da cutar.
Kwayoyin rigakafi da ke yaƙi da ƙwayoyin cuta da sauran abubuwa na waje sune immunoglobulins (IGs) waɗanda ƙwayoyin cuta na B ke samarwa, kuma suna gano takamaiman kwayoyin a cikin ƙwayoyin cuta kuma suna kashe su kai tsaye.
A kan wannan, an tattara ƙwayoyin daga jinin waɗanda suka warke daga COVID-19 kuma an yi allurar rigakafi a cikin marasa lafiya 10.
Alamar cututtukansu sun inganta cikin awanni 24, tare da rage kumburi da matsin lamba, da kuma ingantawar iskar oxygen a cikin jini.
Amma, har sai an samar da takamaiman hanyoyin magani, ana bukatar tabbaci da bayani don amfani mai yawa.
Bugu da ƙari, wasu hasara da suka shafi ƙwayoyin halitta suna buƙatar la'akari da hankali don samun sakamako mai kyau.
Alal misali, ƙwayoyin cuta suna iya tayar da amsawar garkuwar jiki sosai kuma su haifar da ciwon cytokine, wanda zai iya zama mai guba a cikin nau'i.
Yawan ƙwayoyin cuta a cikin jini ba shi da yawa kuma ana bukatar ƙwayoyin cuta da yawa don magance marasa lafiya masu tsanani.
Yana da wuya a samu da kuma samar da takamaiman rigakafi da sauri don yaƙi da annobar duniya.
Saboda haka, yana da mahimmanci kuma mai amfani don ware ƙwayoyin B daga marasa lafiya da suka warke kuma gano lambobin ƙwayoyin cuta waɗanda ke yin kwafin kwayar cutar mai tasiri ko gwada kwayar cutar mai tasiri akan sunadarai masu mahimmanci na kwayar cutar.
Ta wannan hanyar, za mu iya ƙara yawan samar da ƙwayoyin cuta da sauri.
An yi amfani da TCM a cikin Sin don magance cututtuka daban-daban na shekaru dubbai.
Amma, tasirinsa ya dogara ne akan haɗuwa da abubuwa daban -daban a cikin ƙirar bisa ga ka'idar TCM don gano cutar.
Yawancin abubuwa masu tasiri ba a san su ba ko kuma ba su da tabbas saboda yana da wuya a cire da kuma tabbatar da irin waɗannan abubuwa ko kuma mafi kyawun haɗuwa.
Saboda rashin ingantaccen magani na COVID-19, TCM ya zama zaɓi na madadin magani ga marasa lafiya masu ƙarancin bayyanar cututtuka ko waɗanda suka warke daga mawuyacin yanayi.
Misali, Shu Feng Ji Du Capsules da Lian Hua King Wen Capsules an gano cewa suna da tasiri ga marasa lafiya na COVID-19.
A lardunan da ke amfani da TCM don maganin COVID-19 sun sami mafi yawan farfadowa a cikin kashi 87% na marasa lafiya, gami da Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da lardin Hubei, inda kawai kashi 30% na marasa lafiya na COVID-19 suka yi amfani da TCM, ya sami mafi ƙarancin farfadowa (13%).
Amma, wannan kwatancen bai dace ba domin akwai wasu abubuwan da za a iya gwadawa, kamar yawan marasa lafiya da kuma tsananin cutar.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aiki sun buga wani bincike da ke kwatanta maganin yammaci kawai (WM) tare da haɗin WM da TCM.
Sun gano cewa lokaci ya yi kadan a cikin WM + TCM don dawo da zafin jiki, kawar da alamun, da kuma shiga asibiti fiye da na WM kawai.
Mafi mahimmanci, yawan haɓakar bayyanar cututtuka (mai sauƙi zuwa mai tsanani) ya kasance ƙasa da WM + TCM fiye da ƙungiyar WM kawai (7.4% vs. 46.2%) kuma ƙarancin mutuwa a cikin ƙungiyar WM + TCM fiye da ƙungiyar WM kawai (8.8% vs. 39%).
Duk da haka, ana buƙatar yin gwaji mai yawa a cikin cibiyoyi da yawa don inganci da amincin TCM.
Zai zama da ɗan ban mamaki a bayyana tsarin aiki da kuma bayyana abubuwan da ke cikin maganin TCM ko kuma haɗuwa da su idan zai yiwu.
Marasa lafiya da ake zargi ko tabbatacce na COVID-19 galibi suna fuskantar cututtuka masu saurin yaduwa ko na mutuwa, kuma waɗanda ke keɓewa suna fuskantar rashin nishaɗi, kaɗaici da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar zazzabi, hypoxia da tari, da kuma cututtukan magani kamar rashin bacci da ke haifar da maganin corticosteroids na iya haifar da damuwa da baƙin ciki.
A farkon barkewar cutar SARS, an lura da rikicewar motsin rai kamar ci gaba da baƙin ciki, damuwa, tashin hankali, tashin hankali, alamun rashin hankali, ruɗani da tunanin kashe kansa.
Dole ne a bi sawun lamba da keɓewa a matsayin wani ɓangare na amsawar lafiyar jama'a ga ɓarkewar COVID-19, wanda zai iya ƙara damuwa game da kamuwa da cuta, keɓewa, da kuma laifuka tsakanin dangi da abokai.
Saboda haka, yana da mahimmanci a samar da kulawar lafiyar hankali ga marasa lafiya na COVID-19, waɗanda ake zargi da su, da waɗanda suka yi hulɗa da su, da kuma mutanen da ke da bukata.
Tallafi na hankali ya haɗa da kafa ƙungiyoyin kiwon lafiya na hankali, daidaitaccen bayani game da barkewar SARS-CoV-2 da kuma shirin magani, amfani da kayan aikin lantarki na kasuwanci da kuma amfani da aikace-aikacen hana kusanci.
Ana buƙatar ingantaccen rigakafi don karya sarkar watsawa daga tarin kwayar cutar a cikin dabbobi da kuma masu karɓar cutar daga mutane masu kamuwa da cutar, kuma ana iya amfani da rigakafin cutar sau da yawa don maganin cutar cutar don sarrafa annobar cutar ta hanyar cutar da ke tasowa.
Ana ƙoƙarin haɓaka allurar rigakafin S-protein don samar da madaidaicin lokaci da kuma ingantaccen maganin rigakafi da / ko rigakafin rigakafi a kan SARS-CoV.
An gwada rigakafin da aka kashe don SARS a kan samfurin dabba.
Koyaya, kafin fara gwajin asibiti, ba a gano abubuwan da ke haifar da rashin lafiyar jiki a cikin manya da kuma ƙalubalen ƙirar ƙwayoyin cuta da kuma rigakafin kamuwa da kwayar cutar ta hanyar dabbobi ba.
Wannan na iya kasancewa saboda SARS ya ƙare shekaru 17 da suka gabata kuma babu wani sabon shari'ar da aka ba da rahoton tun daga lokacin.
Akasin haka, wasu lokuta na MERS sun tashi a ƙasashen Gabas kuma suna ci gaba da yaduwa zuwa wasu yankuna, wanda ke nuna cewa akwai tushen watsa dabbobi a cikin yankin.
An tsara dabarun rigakafi don MERS ta amfani da ƙwayoyin cuta marasa tasiri, plasma na DNA, masu ɗaukar hoto na kwayar cuta, ƙwayoyin cuta, ƙwayoyin cuta kamar kwayar cuta da kuma ƙwayoyin cuta masu haɗuwa da wasu, kuma an kimanta wasu a kan samfuran dabbobi.
Samar da ingantacciyar rigakafin SARS-CoV-2 ga mutanen da ba su da rigakafi na da gaggawa da kuma muhimmancin gaske a cikin wannan annobar.
Duk da haka, shawo kan matsalar yana da ƙalubale saboda ana buƙatar lokaci mai tsawo (aƙalla watanni 18) don haɓaka allurar rigakafi da bambancin CoV.
A matsayin sabon cuta, COVID-19 ya fara nuna cikakkiyar hanyar warkarwa a cikin dubban marasa lafiya a yanzu.
A yawancin lokuta, mai haƙuri zai iya samun sauƙi ba tare da sakewa ba.
Koyaya, kamar SARS da MERS, COVID-19 yana da alaƙa da ƙaruwa da mutuwa a cikin manyan lamura.
Saboda haka, ya kamata cibiyoyin kiwon lafiya su kafa tsarin bincike na farko don fifita ayyukan su, musamman a yankunan da ba su da albarkatu.
Dangane da binciken asibiti da aka bayar a yanzu, waɗannan abubuwan na iya kasancewa suna da alaƙa ko tasiri ga cutar COVID-19 (Table 33):
Shekara: Shekara ita ce mafi mahimmancin abin da ke haifar da cutar SARS, wanda hakan ma ya shafi COVID-19.
A cikin nazarin shari'o'in 8,866 da aka bayyana a sama, 47.7% na waɗanda ke da COVID-19 waɗanda shekarunsu suka wuce 50 suna tsakanin shekaru 30-65.
Marasa lafiya da ke buƙatar kulawa mai zurfi sun fi saurin samun cututtuka da rikitarwa kuma sun fi tsofaffi fiye da waɗanda ba su da su (matsakaiciyar shekaru 51, da 66), wanda ke ba da shawarar cewa shekaru sune abubuwan ganewar asali ga marasa lafiya na COVID-19.
Jima'i: SARS-CoV-2 ya fi mata kamuwa da cutar (0.31/1,00,000 vs. 0.27/1,00,000) kamar yadda aka bayyana a sama.
Haɗuwa da Haɗuwa: Marasa lafiya da ke da COVID-19 da ke buƙatar kulawa mai ƙarfi suna iya fuskantar matsaloli na zuciya mai tsanani da rashin ƙarfi.
Cutar zuciya ma na daya daga cikin manyan sanadin mutuwar marasa lafiya da cutar SARS.
SARS-CoV-2 kuma an nuna cewa yana ɗaure zuwa ACE-2 mai inganci colangiocytes, wanda zai iya haifar da cutar hanta a cikin marasa lafiya na COVID-19.
Yana da muhimmanci a lura cewa dangantaka tsakanin shekaru da kuma ciwo na yanzu suna da muhimmanci kuma suna iya shafar juna.
Binciken Lab na Musamman: Matsakaicin C-reactive protein (CRP) a cikin jini yana nuna tsananin kumburi ko raunin nama kuma yana iya zama mai yiwuwa mai ba da shawara na dogon lokaci don rashin lafiya, amsawa ga magani da dawowa na ƙarshe.
An kuma nuna alaƙar CRP da tsananin COVID-19 da kuma cutar.
Bugu da ƙari, ƙaruwa na lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Ana bayyana waɗannan kwayoyin a wurare da yawa, musamman a cikin zuciya da hanta, kuma ana fitar da su a lalacewar nama.
Saboda haka, su ne masu lura da cututtukan zuciya ko na hanta.
Babban Alamomin Kiwon Lafiya: Radiography na kirji da kuma karuwa na alamun kiwon lafiya ya kamata a yi la'akari da su tare da sauran batutuwa don tantancewa da kuma ƙaddamar da COVID-19.
Amfani da steroids: Kamar yadda aka bayyana a sama, steroids sune maganin rigakafi wanda ake amfani dashi azaman magani na taimako don cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Amfani da magungunan corticosteroids a cikin marasa lafiya masu cutar SARS ya haifar da rashin ƙarfi da rashin ƙarfi, tare da nakasa da kuma rage rayuwar masu tsira.
Saboda haka, ana iya amfani da steroids a cikin ƙananan allurai da gajeren lokaci a cikin marasa lafiya na COVID-19 idan ya cancanta.
Matsin gwiwa: Kamar yadda aka bayyana a sama, yawancin marasa lafiya suna da ƙarin damuwa yayin barkewar COVID-19 saboda sun kasance cikin keɓewa da rashin tabbas na dogon lokaci kuma sun ga mutuwar danginsu da ƙaunatattun su.
Yana da muhimmanci a ba su shawara da kuma taimako na dogon lokaci domin su warke daga matsin kuma su koma rayuwarsu ta yau da kullum.
A cewar binciken alƙaluma na yanzu, yanayin COVID-19 ya bambanta da na SARS.
SARS-CoV-2 na iya sakewa cikin ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Saboda haka, marasa lafiya da ke kamuwa da cutar a farkon lokaci ko lokacin riƙewa na iya samar da ƙwayoyin cuta masu yawa a cikin ayyukan yau da kullun, wanda zai iya zama da wahala a sarrafa cutar.
Koyaya, ana tunanin cewa SARS-CoV yana yaduwa lokacin da marasa lafiya ke da rashin lafiya, yawancin kamuwa da cuta ba sa faruwa a farkon matakin.
Saboda haka, annobar COVID-19 ta yanzu ta fi ta SARS tsanani kuma tana da wuyar sarrafawa.
A halin yanzu ana yin wasu matakai masu yawa a kasar Sin, ciki har da kulle Wuhan da biranen da ke kewaye da shi da kuma sanya kusan dukkan al'umma cikin keɓewa, don dakatar da yaduwar SARS-CoV-2.
Duk da cewa wadannan ayyukan suna haifar da mummunan illa ga tattalin arziki da sauran sassan kasar, adadin sabbin masu kamuwa da cutar yana raguwa kuma hakan yana nuna cewa cutar ta ragu.
Mafi kyawun hasashen shine cewa barkewar cutar zata ƙare a watan Maris kuma za ta ragu har tsawon watanni 3-4.
Amma wasu masana ba su da bege.
Paul Hunter, ya yi hasashen cewa COVID-19, wanda ya fi SARS kamuwa da cuta, ba zai ƙare ba a shekarar 2020.
Ira Langini ya kafa wani tsari don hango sakamakon cutar, kuma ya ba da shawarar cewa SARS-CoV-2 na iya cutar da kashi biyu bisa uku na yawan mutanen duniya.
Wata ƙungiyar Kanada ta ba da shawarar cewa SARS-CoV-2 ya bayyana a cikin mid-terbine da kuma throat swabs na mai haƙuri wanda ya warke daga rashin lafiya kuma ya bar asibiti makonni 2 da suka gabata, yana nuna cewa sabon kamuwa da cutar na iya zama a cikin jerin zagaye kamar na mura.
Duk da haka, ana ganin alamun fata daga China dangane da raguwar sabbin lamura, wanda ke nuna cewa manufofin yanzu suna da tasiri mai kyau.
An yi hasashen cewa cutar za ta kai miliyan daya kuma ta kashe mutane miliyan biyar.
Amma, an sami nasarar shawo kan cutar ta hanyar tsauraran matakan killacewa.
Wataƙila SARS-CoV-2 kamar SARS-CoV zai iya zama mai rauni har ya zama mara tasiri kuma a ƙarshe ya mutu ko kuma ya zama ƙarancin kwayar cuta mai haɗuwa da ɗan adam.
An kwatanta annobar COVID-19 da annobar SARS da MERS a ƙasa (Figure 55).
SARS-CoV-2 yana da yaduwa ta hanyar tari ko tari kuma yana iya faruwa ta hanyar hulɗa kai tsaye da kayan da cutar ta gurɓata.
An kuma gano kwayar cutar a cikin fitsari, wanda ke haifar da sabon yiwuwar kamuwa da cutar daga fitsari zuwa baki.
Wani binciken da aka yi kwanan nan a kan mutane 138 ya nuna cewa kashi 41% na masu cutar na iya zama kamuwa da cuta a asibiti, tare da marasa lafiya 17 da ke da wasu cututtuka na baya da kuma masu ba da lafiya 40.
Saboda haka, ya zama dole a yi taka tsantsan wajen kare mutane, musamman: masu ba da kiwon lafiya, ma'aikatan zamantakewa, danginmu, abokan aiki, da kuma mutanen da ke da alaƙa da marasa lafiya ko kuma waɗanda ke da cutar.
Mataki na farko na kariya don rage haɗarin kamuwa da cuta shine amfani da abin rufe fuska; masks na tiyata da N95 respirator masks (jerin #1860s) duka suna taimakawa wajen hana yaduwar kwayar cutar.
Takunkumin rufe fuska na tiyata yana hana ruwa daga mutane masu cutar daga iska zuwa saman kayan, don haka ba za su iya cutar da wasu ba.
Koyaya, kawai N95 (jerin # 1860) abin rufe fuska na iya dakatar da numfashi na ƙwayoyin cuta daga 10 zuwa 80 nm, wanda kawai kashi 5% na ƙwayoyin cuta zasu iya shiga gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV a girma, kuma duka suna da girman kusan 85 nm.
Tun da ƙwayoyin cuta na iya shiga ta hanyar takaddun rufe fuska guda biyar, masu ba da lafiya waɗanda ke hulɗa kai tsaye da marasa lafiya suna buƙatar sanya N95 (jerin # 1860) ba tare da yin amfani da abin rufe fuska ba.
Baya ga abin rufe fuska, masu ba da lafiya suna buƙatar sanya rigar keɓewa don guje wa hulɗa da kwayar cutar.
Ƙwayoyin cuta na iya kaiwa mutum ta idanu.
A ranar 20 ga Janairu, 2020, wani likita ya kamu da cutar SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska na N95; mai yiwuwa kwayar cutar ta shiga jikinsa ta hanyar idanunsa masu ƙonewa.
Saboda haka, masu ba da kiwon lafiya suna buƙatar yin amfani da abin rufe fuska mai haske ko tabarau yayin aiki tare da marasa lafiya.
Ana ba da shawarar cewa jama'a a yankunan da ke fama da cutar ko kuma waɗanda za su iya kamuwa da cutar su wanke hannayensu da sabulu mai kashe ƙwayoyin cuta fiye da yadda ya kamata, su keɓe kansu a gida, kuma su rage hulɗa da mutanen da ke da cutar.
An yi la'akari da cewa nesa da mutum ya kamata ya kasance daga mai cutar ya kai kafa uku.
An gano cewa waɗannan ayyuka suna da tasiri wajen rage haɗarin kamuwa da cutar da kuma hana yaduwar cutar.
Kodayake SARS-CoV-2 ya zo duniya a matsayin sabon kwayar cuta, ya kamata a yi gargadi sosai a China saboda abubuwan da suka faru na barkewar SARS a 2003 saboda yana da alaƙa da SARS-CoV, kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020.
Amma har zuwa ranar 19 ga Janairu, 2020, daraktan cibiyar kula da cutar ta Wuhan ya gaya wa mutane cewa sabon kwayar cutar ba ta da saurin yaduwa, kuma ba ta da saurin haifuwa daga mutum zuwa mutum, kuma ba shi da wahala a hana cutar da kuma sarrafa ta.
Wannan sakon ya rage yawan hankalin jama'a, musamman a lokacin da duk kasar ke shirin bikin bazara, kuma Wuhan ta rasa lokaci mai mahimmanci don rage cutar zuwa mafi ƙarancin matakin.
Hukumar kula da cututtuka a China na iya koyon darasi daga wannan mummunan yanayin kuma suyi canje-canje masu mahimmanci a nan gaba.
Alal misali, waɗannan cibiyoyin suna bukatar su yi waɗannan matakan: (1) su kasance masu hankali wajen sanar da jama'a, domin kowane kalma da aka faɗa yana da muhimmanci kuma yana iya canza ra'ayi da yanke shawara; (2) su kasance masu saukin kai da kuma amsawa ga bayanai masu ban mamaki a asibitoci ba tare da jiran rahotanni na likita ko ma'aikatan jinya ba; (3) su sanya ƙarin takunkumi don hana yiwuwar annoba a farkon matakai maimakon ƙarfafa jama'a; da kuma (4) su gabatar da gwaje-gwaje masu tasiri da kuma lokaci don inganta wayar da kan jama'a game da annobar, da kuma gwada da inganta tsarin mayar da martani na al'umma.
Cutar COVID-19 ta samo asali ne daga sabon kwayar cutar SARS-CoV-2 wanda ya fara a ƙarshen Disamba 2019.
A cikin watanni biyu da rubuta wannan labarin, ya yaɗu a duk ƙasar Sin da kuma ƙasashe 50 a duniya.
Tun da yake kwayar cutar ta yi kama da SARS-CoV kuma alamun cutar sun yi kama da na COVID-19 da SARS, barkewar COVID-19 ta haifar da jin kamar SARS ya dawo.
Duk da haka, akwai wasu manyan gibin da ke tsakanin COVID-19 da SARS, wanda ke da mahimmanci wajen sarrafa cutar da kuma kula da marasa lafiya.
COVID-19 na shafar tsofaffi fiye da matasa, maza fiye da mata, kuma yana da yawan tsufa da mutuwa fiye da matasa.
Yawan mutuwar SARS ya fi na COVID-19 girma (10.91% vs. 1.44%).
Masu cutar COVID-19 suna kamuwa da cutar ba tare da bayyanar cututtuka ba, yayin da masu cutar SARS ke kamuwa da cutar lokacin da suka kamu da cutar, wanda ya sa ya fi wahalar hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana dalilin da yasa SARS-CoV-2 ke yaduwa da sauri fiye da SARS-CoV.
A cikin wasu marasa lafiya na COVID-19, kimantawa na RNA na yau da kullun na SARS-CoV-2 na iya zama mara kyau.
A wani bangare kuma, marasa lafiya da suka warke za su iya sake kamuwa da kwayar cutar.
Wadannan binciken sun kara hadarin yaduwar kwayar cutar sosai.
Wannan saurin ci gaba a binciken COVID-19 bai magance wasu mahimman batutuwa ba, kamar:
Daga ina SARS-CoV-2 ya fito?
Ko da yake an gano daidaiton kwayoyin halittar kashi 96% tsakanin SARS-CoV-2 da SARS-like COV guda biyu, ba za mu iya yanke shawarar cewa SARS-CoV-2 ya fito ne daga bat.
Wanne dabba ce ta yi amfani da ita wajen kamuwa da kwayar cutar daga mahaifarta, kunkuru ko mutum?
Idan ba mu san amsoshin 1 da 2 ba, ba za mu iya hana kamuwa da cutar ba kuma za ta iya sake dawowa.
Kodayake samfurin kwayoyin halitta da kimantawar kwayoyin sun nuna cewa SARS-CoV-2 yana ɗaure zuwa ACE2, ta yaya kwayar cutar ta shiga cikin ƙwayoyin cuta na pneumonia kuma ta canza yanayin cutar?
Shin kwayar cutar tana ɗaure da ƙwayoyin bayyana ACE-2 a wasu gaɓoɓin jiki?
Idan ba mu sami amsoshi masu gamsarwa ga waɗannan tambayoyin ba, ba za mu iya samun saurin ganewar asali da kuma magani mai inganci ba.
Yaya tsawon lokacin da annobar za ta ci gaba?
Ta yaya ne kwayar cutar take samun ci gaba a cikin kwayoyin halittar mutum?
Zai zama annoba ta duniya, kamar SARS, ko kuma za ta ci gaba da zuwa kamar mura?
Tambayoyin da ke sama da kuma wasu da yawa suna bukatar amsa amma zai ɗauki lokaci.
Amma duk da haka, ba mu da wani zaɓi sai dai mu shawo kan cutar da wuri-wuri kuma mu koma ga rayuwarmu ta yau da kullun.
Tushen cutar coronavirus na mutum daga dabbobi
A cikin dubban shekaru, kwayar cutar corona (CoV) da kuma zuriyarta tare da mutane sun sami ci gaba ta hanyar juyawa da daidaitawa.
Kafin 2003, an san cewa kwayar cutar korona guda biyu (HCoVs) na haifar da cututtukan sanyi.
Cutar cututtukan numfashi mai tsanani (SARS) da cututtukan numfashi na Gabas ta Tsakiya (MERS) sun nuna yadda cutar HCoV take da haɗari da kuma mutuwa.
An sake gano kwayar cutar SARS-CoV-2 a tsakiyar China a ƙarshen 2019, kuma mun yi mamakin yadda take da yaduwar cuta amma ba ta da cutarwa kamar yadda ta yi daidai da SARS-CoV.
Cutar HCoV cuta ce ta dabbobi, saboda haka yana da kyau mu fahimci asalin cutar HCoV.
Yawancin HCoVs sun samo asali ne daga batutuwan da ba su da cutar.
An kuma san wasu ƙwayoyin cuta masu tsaka -tsaki na HCoV.
Gano ƙwayoyin cuta na dabbobi na iya samun tasiri kai tsaye kan rigakafin cututtukan ɗan adam.
Binciken hulɗar COVID-possidic a cikin dabbobi na iya ba da haske game da mahimman bayanai game da kwayar cutar COVID a cikin mutane.
A cikin wannan bita, muna gabatar da bita game da bayanan da muke da su game da HCoVs bakwai, tare da mai da hankali kan tarihin gano su da kuma asalin cutar da ke haifar da su da kuma kamuwa da cuta ta cikin jiki.
Abin da ya fi muhimmanci shi ne, muna gwada HCoVs daban-daban daga tsarin ci gaban ƙwayoyin cuta da kuma tsarin ƙwayoyin halitta.
An tattauna game da cutar COVID-19 na yanzu.
Bugu da ƙari, an kuma nuna bukatar sauya fashewar da ya dace da kuma tasirin juyin halittar kwayar cutar akan tsananin cutar.
Coronavirus (CoV) yana cikin dangin Coronavirusidae, wanda ya ƙunshi rukunin ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta guda ɗaya.
Ana kiran wadannan ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta da suke da babban kwayar halitta mai girma daga kilobase 26 zuwa 32 COV domin suna kama da kambi a ƙarƙashin allon lantarki.
A tsarin halitta, C.O.V. suna da kwayoyin halittar da ba su rabu ba da suke da tsari iri ɗaya.
Kusan kashi biyu bisa uku na kwayoyin halitta suna dauke da manyan manyan open reading frames (ORF1a da ORF1b), wanda aka canza zuwa pp1a da pp1ab replicase polyproteins.
Ana sarrafa polyproteins don samar da wasu sunadarai 16 da ba su da tsari, waɗanda aka tsara su a matsayin NSP1-16
Sauran ɓangaren kwayoyin sun ƙunshi ORFs don sunadaran tsari, ciki har da spike (S), envelope (E), membrane (M), da nucleoproteins (N).
Hakanan, ƙwayoyin cuta masu yawa na musamman na CoV suna ƙunshe da ƙwayoyin cuta daban-daban.
Ana rarraba COVs zuwa tsararraki huɗu (alpha-CoV, beta-CoV, gamma-CoV, da delta-CoV) bisa ga jerin sunayen sunadarai daban-daban, waɗanda ke da mafi yawan HCoVs a cikin ƙarni na beta-CoVs kuma an raba su zuwa tsararraki huɗu (A, B, C, da D).
Shaidar ilimin halittu ta nuna cewa damisa da beraye suna aiki ne a matsayin tushen kwayoyin halitta don alpha-CoV da beta-CoV, yayin da tsuntsaye su ne tushen tushen kwayoyin halitta don gamma-CoV da Delta-CoV.
COVs sun ci gaba da ƙetare shingen nau'in a cikin dubban shekaru, kuma sun fito a matsayin wasu muhimman cututtukan ɗan adam.
A yanzu, an san mutane bakwai da ke dauke da cutar COV.
Daga cikinsu akwai HCoV-229E da HCoV-NL63, waɗanda sune Alpha-CoVs.
Sauran beta-CoVs guda biyar sun hada da HCoV-OC43, HCoV-HKU1, cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk da cututtukkan cututtukkan cututtukan cututtuk
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 suna haifar da rashin jin daɗi kamar sanyi da/ko zawo.
A gefe guda, SARS-CoV, MERS-CoV, da sabon SARS-CoV-2 suna da cututtuka masu yawa, suna haifar da cututtukan ƙananan cututtukan ƙananan cututtuka a cikin marasa lafiya da ke da haɗarin haɗarin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut
An ware kwayar cutar HCoV-229E ta farko, B814, daga hanci na marasa lafiya da ke fama da mura a shekara ta 1960.
Tun daga wannan lokacin, an sami ƙarin ilimi ta hanyar nazarin HCoV-229E da HCoV-OC43 waɗanda ke haifar da alamun iyakance kansu.
Amma, kafin barkewar cutar SARS, an yi imani cewa cutar HCoV ba ta da lahani.
Cutar SARS ta 2003 tana ɗaya daga cikin cututtuka mafi muni a tarihin zamani, ta kashe mutane fiye da 8,000, tare da kimanin kashi 10 cikin 100 na mutuwar.
Shekaru goma bayan haka, annobar cutar MERS ta Gabas ta Tsakiya ta haifar da ci gaba da barkewar annobar a yankin Larabawa, wadda ta bazu zuwa sauran duniya.
Sabuwar HCoV na 2019 (2019-nCoV) wanda daga baya aka sake masa suna SARS-CoV-2, shine wanda ya haifar da cutar ta Coronavirus Disease 2019 (COVID-19), wanda ya yi sanadiyar mutuwar sama da 3,120 da kuma kamuwa da mutane sama da 91,000 a ranar 3 ga Maris, 2020.
Ana ta faɗakar da ƙararrawa, kuma duniya tana bukatar ta shirya don zuwan SARS-CoV-2.
Dukkanin cututtukan ACOV guda bakwai sun samo asali ne daga dabbobi masu shayarwa, da beraye, da kuma dabbobi masu gida.
Shaida da yawa sun ba da tabbacin cewa batirin ne ya samo asali, wanda ya nuna cewa ƙwayoyin cuta sun sami matsayi kuma ba su da cutar amma suna nuna bambancin kwayoyin halitta.
Cutar COVID-19 ta gabatar da manyan kalubale na likita, kimiyya, zamantakewa da ɗabi'a ga China da duniya.
Binciken asalin cutar ta ACOV a cikin dabbobi ya nuna tarihin halitta, abubuwan motsawa, da kuma tsarin abubuwan da ke hanawa.
Hakanan zai jagoranci ko sauƙaƙe gano wuraren zama, matsakaici da kuma haɓaka kwayar cutar SARS-CoV-2 (V) Poshinda, wanda zai iya zama mai mahimmanci don hana yaduwar cutar a nan gaba.
A cikin wannan bita, muna ba da bita game da asalin cutar ta dabbobi, yaduwar jinsuna, da kuma cutar HCoV.
Musamman: Mun mai da hankali kan waɗannan batutuwa na yau da kullun kuma mun tattauna cewa kwayar cutar HCoV mai iyaye ba ta da cutar a cikin asalin kwayar cutar ta halitta amma tana haifar da cutar yayin da ta kamu da sabon kwayar cutar.
Mun kuma bincika fasahar juyin HCoV, inda idan kamuwa da cuta ta ƙaru, cutar ta ragu.
An kuma tattauna game da tasirin cutar SARS-CoV-2 da ke gudana.
An san game da cutar COV a cikin dabbobi tun daga ƙarshen 1930s.
Kafin a fara gano HCoV-229E deformity B814 daga nasal secretions na marasa lafiya masu sanyi, an gano nau'ikan COVs daban-daban daga nau'ikan dabbobin da suka kamu da cutar, gami da turkey, beraye, shanu, aladu, kuliyoyi da karnuka.
An gano HCOVs bakwai a cikin shekaru goma da suka gabata.
Takaitaccen taƙaitaccen binciken HCoVs (Table 1) a cikin jerin lokaci zai zama mai faɗakarwa da bayani.
An ware kwayar HCoV-229E ta farko daga marasa lafiya da ke fama da cutar numfashi a shekara ta 1966, kuma ta haifar da ci gaban WI-38 na ƙwayoyin ƙwayoyin huhu.
Masu cutar HCoV-229E sun nuna alamun sanyi da suka hada da ciwon kai, tari, kumburi da kuma ciwon makogwaro, da zazzabi da tari a kashi 10-20 cikin dari.
Daga baya, a shekara ta 1967, an ware HCoV-OC43 daga al'adun gabobin ƙananan beraye da kuma daga jerin hanyoyin kwakwalwa.
Halitta na asibiti na kamuwa da cutar HCoV-OC43 sun yi kama da kamuwa da cutar HCoV-229E, wanda ba za a iya rarrabe shi ta hanyar bayyanar cututtuka daga kamuwa da wasu cututtukan numfashi kamar su cutar Influenza A da rhinoviruses ba.
HCoV-229E da HCoV-OC43 duk sun yadu a duniya kuma suna yaduwa a cikin yanayin sanyi a yanayin zafi.
A al'ada, wannan kwayar cutar tana da tsawon warkewa kasa da sati daya, sannan kuma makonni biyu na rashin lafiya.
Binciken da aka yi a kan masu sa kai na ɗan adam ya nuna cewa mutane masu lafiya da ke dauke da cutar HCoV-229E sun sami ciwon sanyi.
Wasu marasa lafiya da suke da ƙarancin garkuwar jiki ne kawai suke samun kamuwa da cutar numfashi mai tsanani.
SARS wanda ake kira "atypical pneumonia" shine farkon HCoV da aka rubuta a cikin tarihin ɗan adam kuma mai haifar da cutar SARS-CoV, shine HCoV na uku da aka gano.
An gano farkon cutar SARS a ƙarshen 2002 a lardin Guangdong na kasar Sin.
Cutar SARS ta yi sanadiyar mutuwar mutane 774 da kuma kamuwa da cutar a kasashe da nahiyoyi da dama.
Ba tare da masu watsawa ba, an kiyasta cewa kowane yanayi na iya haifar da kusan kashi biyu na sakandare, tare da lokacin dawowa na kwanaki 4 zuwa 7, kuma ana iya ganin saman tasirin kwayar cutar a rana ta 10 na cutar.
Masu kamuwa da SARS-CoV suna iya fara da ciwon tsoka, ciwon kai, zazzabi, kumburi, da kuma sanyi, sannan kuma suna iya yin numfashi, yin tari, da kuma numfashi.
Rashin kumburi, rashin aikin hanta da kuma ƙaruwar ƙwayoyin halitta su ne abubuwan da aka saba gani a cikin lab na SARS.
An kuma ga lalacewar diffuse alvelar, da ƙaruwar ƙwayoyin halittar da kuma ƙaruwa a cikin macrophages a cikin marasa lafiya da SARS.
Kusan kashi 20 zuwa 30 na marasa lafiya suna bukatar kulawa mai zurfi da kuma na'ura mai kwantar da iska.
Ƙarƙashin numfashi, hanta da kuma ƙwayoyin cuta na iya kamuwa da wannan mummunar cuta, sau da yawa ta hanyar tsananin cututtukan cytokine, wanda zai iya zama mai haɗari musamman ga marasa lafiya da ke da rashin lafiyar jiki.
An fara gano kwayar cutar ne daga wani dan uwan wani mai cutar da ya zo daga Guangzhou zuwa Hong Kong.
Tun daga wannan lokacin, an yi ƙoƙari sosai don binciken HCoV.
An ware HCoV-NL63 daga jariri mai wata bakwai a Netherlands a ƙarshen 2004.
An fara gano shi a cikin yara, tsofaffi, da kuma marasa lafiya da ke fama da cutar numfashi da ke da rashin garkuwar jiki.
Cutar da ke haifar da HCoV-NL63 tana haifar da sanyi, ciwon ido, zazzabi da kuma kumburi.
Wani bincike kuma ya nuna cewa an gano wannan kwayar cutar a hancin wani jariri mai wata takwas da ke fama da cutar huhu a Netherlands.
Ko da yake an samo shi ne a Netherlands, ya yaɗu a dukan duniya.
An kiyasta cewa HCoV-NL63 yana da alhakin kashi 4.7% na cututtukan numfashi na yau da kullun, kuma ya fi yawa a lokacin bazara, bazara da farkon hunturu.
HCoV-NL63 yana da alaƙa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
A wannan shekarar, an ware HCoV-HKU1 daga wani mutum mai shekaru 71 da aka kwantar da shi a asibiti saboda ciwon huhu da kuma ciwon huhu a Hong Kong.
HCoV-HKU1 yana da alaƙa da ci gaban asma mai tsanani, gami da cutar sankarar zuciya da kuma cutar numfashi da ke faruwa a cikin al'umma.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, HCoV-HKU1 na faruwa a duk duniya wanda ke haifar da cututtukan numfashi.
Dukkanin wadannan nau'o'in cutar HCoV guda hudu sun sami karbuwa sosai a cikin mutane kuma ba su da wata hanyar canzawa zuwa cututtuka masu saurin kamuwa da cuta, duk da haka, saboda wasu dalilai da ba a sani ba, ana iya samun haɗari kamar yadda ya faru a cikin ƙarin nau'ikan cutar HCoV-NL63, wanda kwanan nan aka ba da rahoton cewa ya haifar da kamuwa da cuta mai saurin kamuwa da cuta a cikin ƙananan hanyoyin numfashi a China.
A al'ada, idan HCoVs suka samu damar yaduwa cikin gaggawa kuma suka ci gaba da zama a cikin mutane, su ma za su zama masu guba ko masu cutarwa.
An fara ware MERS-CoV a shekarar 2012 a Saudi Arabia daga huhu na wani mutum mai shekara 60 wanda ke fama da ciwon huhu mai tsanani da kuma rashin aikin koda.
Kodayake yawancin waɗanda aka tabbatar da su sun samo asali ne daga Gabas ta Tsakiya, an sami wasu lokuta a cikin ƙasashen Turai da Tunisia, waɗanda ke da alaƙa da keɓaɓɓun hanyoyin watsawa.
Cutar ta biyu ta barke ne a Koriya ta Kudu a shekarar 2015 inda aka samu mutum 186 da suka kamu da cutar.
Alamar cutar MERS tana kama da SARS, wanda ke nuna ci gaba da ciwon huhu mai tsanani.
Ba kamar SARS ba, yawancin marasa lafiya da ke fama da cutar MERS suna fuskantar mummunan lalacewar koda, wanda ba shi da yawa a cikin cututtukan HCoVs.
Yawan marasa lafiya da suka kamu da cututtukan narkewa kamar zawo da kuma amai sun kai kashi 30 cikin dari.
Ya zuwa 14 ga Fabrairu, 2020, an sami fiye da 2,500 da aka tabbatar da su tare da kashi 34.4% na mutuwar, wanda ya sanya MERS-CoV ɗayan cututtukan cututtukan da aka sani ga ɗan adam.
A tsakiyar zuwa ƙarshen Disamba 2019, an fara ganin gungun masu cutar ciwon huhu da ke da alaƙa da sanannen kamuwa da cutar SARS-CoV-2 a Wuhan, lardin Hubei na kasar Sin.
Hukumar Lafiya ta Duniya (WHO) ta ayyana barkewar cutar SARS-CoV-2 a matsayin gaggawa ta lafiyar jama'a mai damuwa ta duniya, kuma ta sanya sunan cutar a matsayin COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da kamuwa da cutar 90,053 a duniya, wanda ya kai kashi 3.4 cikin dari na mutuwar.
Abin lura, yawan mutanen da suka kamu da cutar a Hubei na kasar Sin ya kai kashi 4.2 cikin dari, idan aka kwatanta da na kasashen waje da suka kamu da cutar da kashi 1.2 cikin dari.
SARS-CoV-2 na haifar da cututtukan numfashi masu tsanani kamar SARS-CoV da MERS-CoV, wanda ke nuna zazzabi, tari da kuma kumburi.
Wasu marasa lafiya ma sun kamu da cutar.
Cutar huhu na ɗaya daga cikin munanan alamun cutar kuma yana iya ƙara saurin ciwon numfashi mai tsanani.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda babban daidaiton nucleotide, suna cikin rassa daban-daban a cikin tsarin phylogenetic.
SARS-CoV-2 ba shi da cutar amma yana da kamuwa da cuta fiye da SARS-CoV da MERS-CoV.
An sami rahoton marasa cutar SARS-CoV-2 da ke da alamun cutar, kuma suna iya taimakawa wajen saurin yaduwar cutar a duniya.
Idan aka kwatanta SARS-CoV-2 da sauran HCoVs guda shida, za a ga cewa akwai kamance da bambance-bambance masu yawa.
Da farko, tsawon lokacin kamuwa da cutar da kuma na cutar HCoV suna da kamanceceniya sosai.
A wannan ma'anar, SARS-CoV-2 ya bi al'ada na sauran HCoVs shida.
Na biyu, tsananin bayyanar COVID-19 ya kasance tsakanin SARS-CoV da HCoVs masu tushe daga al'ummomi huɗu (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana nuna halaye da aka saba gani yayin kamuwa da cutar HCoV, gami da rashin takamaiman, mai sauƙi ko rashin bayyanar cututtuka.
A gefe guda, ko da yake akwai ƙananan ƙididdiga, ana samun ƙananan ƙananan ƙididdigar COVID-19 a cikin SARS-CoV.
Na uku, kamuwa da SARS-CoV-2 yana nuna halaye masu ban sha'awa na HCoV da SARS-CoV da ke faruwa a cikin al'umma.
A gefe guda, SARS-CoV-2 yana da yaduwar cutar kamar HCoVs da ke gudana daga cikin al'umma.
A gefe guda, kamar yadda SARS-CoV da MERS-CoV suka rage yaduwar cutar zuwa mutane, ana bukatar a tabbatar ko SARS-CoV-2 ya rage yaduwar cutar.
A ƙarshe, kamar sauran HCoVs, SARS-CoV-2 na iya bayyana a cikin samfurin fitsari.
Nazarin da za a yi nan gaba zai bayyana ko kwayar cutar SARS-CoV-2 ta hanyar baki tana taka muhimmiyar rawa kamar SARS-CoV, aƙalla a wasu yanayi.
Zai zama mai ban sha'awa a ga ko SARS-CoV-2 yana nuna yanayi kamar yadda yake a cikin al'ummomin da ke da cutar HCoV.
Duk da haka, bayan yaduwar ɗan adam, fasalin SARS-CoV-2, gami da fasalin kamuwa da cuta, cutar, da kuma ci gaba da yaduwar ɗan adam, zai iya tasiri ga ƙarshen ƙarshen barkewar COVID-19.
HCoVs daga dukkan al'ummomin da ke haifar da rashin ciwo sun daidaita da kyau ga mutane.
A wani bangare kuma, yana iya zama gaskiya cewa mutane sun daidaita da wadannan HCOVs guda huɗu.
A wasu kalmomi, za su iya tsira daga cutar HCoV na farko.
HCoVs masu haifar da cututtuka masu tsanani a cikin mutane da kuma cututtukan HCoVs masu tsanani da aka haifar da mutum.
Don a yi haka, dole ne a bar HCoVs su yi kwafi a cikin mutane har sai sun sami isasshen kwayar halittar da za ta iya hana masu hana cutar.
A wannan ma'anar, da zarar barkewar SARS-CoV-2 ta daɗe kuma ta cutar da mutane da yawa, da alama za ta daidaita da ɗan adam.
Idan ya daidaita sosai, zai yi wuya a dakatar da yaduwar cutar tsakanin mutane ta hanyar keɓewa ko wasu matakan sarrafa kamuwa da cuta.
An yi shekaru ana yaduwar kwayar cutar COVID 4 a cikin al'umma, wadda ke haifar da kamuwa da cutar sanyi a cikin mutane masu ƙarancin garkuwar jiki.
Wadannan ƙwayoyin cuta ba sa bukatar wurin da dabbobi suke zama.
Akasin haka, cututtukan SARS-CoV da MERS-CoV ba su daidaita da kyau ga mutane ba kuma ba za su iya ci gaba da yaduwa tsakanin mutane ba.
Dole ne a kiyaye su kuma a yada su a cikin wuraren da suke da dabbobi kuma a iya yada su ta hanyar daya ko fiye da matsakaici da kuma masu haɓaka.
Halayen SARS-CoV-2 iri ɗaya ne tsakanin SARS-CoV/MERS-CoV da kuma HCoVs huɗu da ke cikin al'umma.
A yanzu, yana da saurin yaduwa kamar yadda cutar HCoV take a cikin al'umma.
Duk da haka, yana da cutar fiye da HCoVs da ke cikin al'umma kuma ba shi da cutar fiye da SARS-CoVs ko MERS-CoVs.
Za su zama cikakke tare da mutane ba tare da mafaka ko matsakaici ba, kuma za a ci gaba da lura da ko za su iya yaduwa a cikin mutane.
Kafin mu tattauna asalin dabbobi na HCoV, zai dace mu tattauna ma'anar da kuma halaye na HCoV mai juyin halitta, na halitta, mafaka, matsakaici da kuma mai haɓaka Poshinda.
Dabba zai iya zama mai ɗaukar hoto na HCoV idan ya sami babban magaji wanda ke da alaƙa da juna a matakin jerin nucleotides.
A cikin wannan kwayar cutar, kwayar cutar ta saba da kuma sau da yawa ba ta haifar da cuta.
Hakazalika, ƙwayoyin cuta suna ba da gidaje ga HCoVs na dogon lokaci.
A duka biyun, kwayar cutar tana kamuwa da cutar ta halitta kuma ita ce kwayar cutar HCoV ko kuma mahaifanta.
Akasin haka, idan aka saka HCoV a cikin mai watsawa na tsaka-tsaki kafin ko lokacin da aka gabatar da shi ga mutane, ba zai iya daidaitawa da sabon kwayar cutar ba kuma yana iya zama mai cutarwa.
Wadannan kwayoyin masu matsakaici na iya zama masu watsa kwayar cutar ta dabba zuwa ga mutane, kuma suna iya zama masu watsa kwayar cutar ta hanyar ba da damar kwayar cutar ta ɗan lokaci don yin kwayar cutar, sannan kuma su iya watsawa zuwa ga mutane don faɗaɗa yaduwar kamuwa da cutar.
Cutar HCoV za ta iya ƙare idan ba ta iya riƙe kamuwa da ita a cikin kwayar halittar ba.
A gefe guda, HCoVs na iya ɗaukar matsakaitan ƙwayoyin cuta kuma ba wai kawai ba, amma kuma suna iya kafa yanayin rashin lafiya na dogon lokaci.
A wannan yanayin, matsakaiciyar kwayar halitta ta zama kwayar halitta.
Bayanan cutar sun nuna cewa farkon cutar SARS ta samo asali ne daga dabbobi masu fara'a.
Binciken da aka yi na ci gaba da bincike ya nuna cewa, ana samun karin maganin SARS-CoV-IGG a cikin kasuwancin dabbobi fiye da sauran mutane.
A cikin kasuwar rayayyun dabbobi, an gano masks na dabbobi masu kama da dabbobi (Paguuma larvata) da karnuka masu kama da raccoon suna ɗaukar kwayar cutar SARS-CoV-like, wanda yayi kama da SARS-CoV.
Wannan ya sami karfafawa ta hanyar cewa ba a sake samun SARS ba bayan an kashe duk wani ciyawa a kasuwa.
Duk da haka, an kuma lura cewa masks na dabbobi masu rai da ba a yi wa kasuwa ba, da kuma masks na dabbobi masu rai da ba a yi wa kasuwa ba, sun kasance masu rinjaye ga SARS-CoV, wanda ya nuna cewa masks na dabbobi masu rai na iya zama masu watsawa amma ba su da sararin samaniya na SARS-CoV.
Abin lura, kashi 80% na dabbobi daban-daban a kasuwar Guangzhou suna da rigakafin SARS-CoV, don haka ba za a iya yin watsi da yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa suna aiki a matsayin matsakaici na SARS-CoV.
Dukkanin waɗannan suna nuna alamun ƙarshen SARS-CoV.
Binciken da aka yi na binciken SARS-CoV a cikin dabbobi na halitta ya gano wani nau'in COVID mai alaƙa da SARS-related Rhinolopus bat COVID HKU3 (SARS R-RH-BATCOV-HKU3), wanda ke cikin bat Horseshoe na kasar Sin.
Waɗannan kunkuru suna da kyau don anti-SARS-CoV antibodies da kuma jerin kwayoyin SARS-RH-BATCOV-HKU3.
Wannan da sauran kunkuru suna da kashi 88 zuwa 92% na daidaiton tsarin nucleotide tare da SARS-CoV.
Waɗannan binciken sun kafa tushen sabon ra'ayi cewa kunkuru suna ciyar da ƙwayoyin cuta na ɗan adam da ke tasowa.
An gano wasu SARS-like COVs (SL-CoVs) daga batsa, amma babu wanda aka gano a matsayin mai rai, ban da WIV1.
An gano cewa kwayar cutar SARS-CoV-2 tana karɓar kwayar halittar nan ta mutum (ACE2).
An samo WIV1 daga samfurin fitsari na bat wanda aka nuna don amfani da bat, civet da ACE2 na mutum azaman mai karɓa don shigar da ƙwayoyin cuta.
Abin sha'awa, jini na mutanen da suka warke daga cutar SARS ya iya kawar da cutar WIV1.
Saboda haka, WIV1 ya wakilci kakannin SARS-CoV a cikin kunama wanda ya fi kusa da juna wanda ya raba kashi 95% na daidaiton tsarin nucleotide.
Kodayake akwai babban kamanceceniya tsakanin waɗannan ƙwayoyin cuta guda biyu, ana fahimtar cewa WIV1 ba shine mai kula da SARS-CoV ba kuma cewa batutuwa ba su da alaƙar cututtukan SARS-CoV.
Binciken genealogical ya haɗa MERS-CoVs a cikin rukuni ɗaya kamar COVID-HKU4 da Bat COVID-HKU5.
COVID-HKU4 na kwari da MERS-CoV na Poshinda Grahi suna amfani da dipeptidyl peptidase 4 (DPP4) don shigar da kwayar cutar.
Tsarin RNA mai dogara da RNA polymers na MERS-CoVs yana da kusanci da tsarin tarihi da aka samo a cikin bat beta-CoVs a Turai da Afirka.
Ya zuwa yanzu, ba a gano wani kwayar cutar MERS-CoV a cikin daji ba.
An gano daidaiton tsari na nucleotide kashi 87% tsakanin MERS-CoV da bat-CoV-HKU25, wanda ke da alaƙa da shi.
Saboda haka, akwai yiwuwar cewa kunkuru ba su zama masu saurin kamuwa da cutar MERS-CoV ba.
A gefe guda kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuman ruwa suna da kwayar cutar MERS-CoV, irin ta raƙuman ruwa na Gabas ta Tsakiya da ake samu a ƙasashen Afirka da dama.
Kwayar cutar MERS-CoV mai rai tana kama da kwayar cutar da aka gano a cikin mutum daga swabs a hancin raƙuman ruwa, wanda ya nuna cewa raƙuman suna aiki a matsayin masu cin zarafin parasitic na MERS-CoV.
Abin lura shi ne cewa an gano cewa yawancin ƙwayoyin cuta masu saurin nuna alamun cutar sun shiga cikin raƙuman da ke dauke da cutar MERS-CoV.
Abin lura, raƙuman da ke kamuwa da cutar ba kawai suna ɗaukar kwayar cutar ta hanyar numfashi ba amma kuma ta hanyar shayarwa, wanda kuma shine babban hanyar ɗaukar kwayar cutar daga farji.
Amma, batun ya kasance cewa yawancin waɗanda aka tabbatar da su na MERS ba su da tarihin haɗuwa da raƙuma kafin bayyanar cututtuka, hanyoyin kamuwa da mutum-zuwa-mutum, ko hanyoyin kamuwa da cuta da ba a sani ba waɗanda ke da yiwuwar haifar da nau'in dabbobi da ba a sani ba waɗanda ke ɗaukar MERS-CoV.
SARS-CoV-2 yana da kashi 96.2 cikin ɗari na kwayar cutar nucleotide tare da bat COVID RATG13 da aka ware daga rhinolophus.
Kamar yadda yake a cikin shari'ar SARS-CoV da MERS-CoV, bambancin tsari tsakanin SARS-CoV-2 da RATG-13 yana da kyau wajen tantance alaƙar iyaye.
Wannan yana nufin cewa ba za a iya ganin cewa bat-CoV-2 ba zai iya zama mai ɗaukar hoto ba, sai dai idan an gano irin wannan bat-CoV a nan gaba.
Wataƙila, mai watsa SARS-CoV-2 shine dabba mai kama da dabba mai kama da dabba da aka sayar da kashe a kasuwar sayar da abincin teku ta Hunan, tare da wasu daga cikin farkon shari'o'in da suka shafi COVID-19, wanda ke nuna yiwuwar yaduwar cutar daga dabba zuwa mutum.
Yawancin binciken kwanan nan da suka dogara da jerin metagenomic sun nuna cewa ƙananan ƙananan dabbobi masu shayarwa da aka sani da pangolins (Manis javanica - cats da aka ci) na iya zama wurin da ke da alaƙa da SARS-CoV-2.
Waɗannan sababbin pangolins sun nuna cewa sun yi daidai da SARS-CoV-2 a cikin kashi 85 zuwa 92 cikin ɗari na jerin nucleotides.
Duk da haka, suna da dangantaka da RATG13 a kusan kashi 90 cikin dari na daidaituwa a matakin jerin nucleotides.
Sun rarraba ƙwayoyin cuta kamar SARS-CoV-2 zuwa ƙananan rassa biyu a cikin bishiyar zuriya, ɗayan wanda ke da babban yanki mai ɗaure (RBD), kashi 97.4% na amino acid, wanda ya fi SARS-CoV-2 kama.
A cikin rikicewar gaskiyar, RBDs na SARS-CoV-2 da RATG13 sun fi bambanta, duk da haka, suna da babban adadin jerin daidaito na genomic.
Binciken kwanan nan a kan pangolins marasa lafiya sun kuma ba da rahoton gano kwayar cutar a kan samfurin huhu, wanda aka gano yana da alaƙa da SARS-CoV-2.
Wannan bincike ya yi amfani da tsarin taro daban da kuma gyaran jiki don samar da jerin kwayoyin cuta na kashi 86.3 cikin dari na cikakken jinsin kwayar cutar.
Ba za mu iya yin watsi da yiwuwar cewa daya daga cikin kwayoyin da ke kawo SARS-CoV-2 shi ne pangolins.
Koyaya, saboda bambancin tsari tsakanin SARS-CoV-2 da pangolins SARS-CoV-2 masu alaƙa da beta-CoVs, babu wata hujja a halin yanzu don tallafawa asalin SARS-CoV-2 kai tsaye.
Bugu da ƙari, bambanci tsakanin SARS-CoV-2 da RATG13 ya fi bambanci tsakanin SARS-CoV-2 da pangolins SARS-CoV-2 masu alaƙa da beta-CoVs.
Har yanzu, akwai sauran hanyoyin da za a bi don tabbatar da juyin halittar SARS-CoV-2 a cikin damisa, pangolins da sauran dabbobi masu shayarwa.
RBDs sun sami mafi yawan daidaiton tsari tsakanin SARS-CoV-2 da pangolins, tare da SARS-CoV-2 da ke da alaƙa da beta-CoVs, SARS-CoV-2 da RATG13 suna da mafi yawan daidaiton tsari na genomic.
Akwai hasashe da yawa cewa akwai babban daidaituwa tsakanin RBD na pangolins SARS-CoV-2 da SARS-CoV-2 wanda ke ɗaukar maganin magani mai zaɓi wanda ke ɗaukar juyin halitta.
Wani zaɓi na sake fasalin tsakanin pangolins SARS-CoV-2 da beta-CoVs da RATG13 a cikin nau'in daji na uku shine a cikin shawarwari.
A matsayin abin motsawa a cikin juyin halitta, sake haɗawa ya zama ruwan dare a cikin beta-CoVs.
Har yanzu, masu shari'a suna binciken asalin SARS-CoV-2 na dabbobi.
Duk da cewa akwai manyan cututtukan HCoV, an kuma bincika asalin dabbobi na HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar asalin halitta ta nuna cewa HCoV-NL63 da HCoV-229E sun samo asali ne daga COVID na bat, yayin da HCoV-OC43 HCoV-HKU1 wanda ya zama mahaifa ya samo asali ne daga dabbobi masu shayarwa.
An ba da rahoton cewa COVID-19 na garkuwa da mutane, ARCOV.2 (Appalachian Ridge COVID-19), wanda aka gano a cikin garkuwa da mutane na Arewacin Amurka, ya nuna dangantaka ta kusa da HCoV-NL63.
A gefe guda, HCoV-229E yana da alaƙa da chromosomal a cikin wani COVID na bat, wanda aka sanya wa suna Hipposideros/Ghanaquam/19/2008, wanda aka gano a Ghana, lokacin da aka yi zargin cewa raƙuma ne matsakaitan masu watsawa.
Don ƙarin haske, Figures 1 da Table 2 sun ba da taƙaitaccen ilimin yanzu game da asalin dabbobi na HCoVs da aka sani.
Tarihi ya nuna cewa akwai tabbacin kamuwa da cutar HCoV tsakanin jinsuna ta hanyar nazarin tarihin.
A shekara ta 1890, sa'ad da cutar HCoV-OC43 ta fara yaduwa daga dabbobi zuwa mutane, an yi wani annoba na kamuwa da cuta ta numfashi.
Tarihin watsawa tsakanin nau'in HCoV-229E ba shi da tabbas.
An gano bat alpha-CoV wanda ke da alaƙa da HCoV-229E.
Akwai wani abu a cikinsu mai suna Alpha-CoV.
Akwai wasu matakan shaida da ke tallafawa kai tsaye na kwayar cutar daga bat zuwa mutum.
Na farko, mutane ne suka fara saduwa da kunama a cikin yanayin da suke da shi, ba Alpacas ba.
Maimakon haka, mutane suna da dangantaka ta kusa da 'yan tsiraru.
Na biyu, HCoV-229E-da ke da alaƙa da batirin alpha-CoVs sun bambanta kuma ba su da cutar, yayin da Alpacas alpha-CoVs suka haifar da barkewar cutar numfashi a cikin dabbobin da suka kamu da cutar.
A ƙarshe, ba a taɓa samun Alpha-CoV a cikin daji ba.
Saboda haka, ba za a iya ware yiwuwar cewa alpacas sun sami HCoV-229E-da ke da alaƙa da alpha-CoV daga ɗan adam ba.
A gaskiya ma, damisa sune tushen cututtukan cututtukan mutum, ciki har da kwayar cutar rabi, Ebola, Nipah, da kuma Hendra.
Saboda haka, ba abin mamaki ba ne cewa kunkuru na iya kaiwa mutane cutar HCoV-229E kai tsaye.
A madadin haka, bat alpha-CoV shine asalin HCoV-229E, alpacas da dromedary raƙuma na iya zama matsakaiciyar hanyar da za ta iya watsa kwayar cutar ga mutane, kamar yadda ya faru a cikin yanayin MERS-CoV.
MERS-CoV ya zama misali mafi kyau na watsawa tsakanin jinsuna daga raƙuman ruwa zuwa raƙuman ruwa da kuma daga raƙuman ruwa zuwa ɗan adam.
An san asalin juyin halittar MERS-CoV daga kunkuru saboda farkon gano shi kuma binciken da aka yi daga baya ya ƙarfafa shi.
A bayyane yake cewa, kunkuru suna samar da wadataccen nau'in kwayar cutar don musayar nau'ikan nau'ikan kwayoyin halitta da kuma watsawa tsakanin jinsuna.
Tsawon rayuwa, ƙauyuka masu yawa, hulɗa da zamantakewa, da kuma iyawar tashi, duk sun sa batutuwan su zama 'masu watsa kwayar cuta'.
A gefe guda, MERS-CoV ya shiga cikin raƙuman raƙuman ruwa na shekaru da yawa.
Waɗannan raƙuman sun karɓi su sosai wanda ya sa suka zama matsakaiciyar abinci mai ƙarfi da kuma abincin da ke haifar da parasites.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙarancin canji a cikin waɗannan dabbobi.
Cutar da ta kai ga mutane kaɗan ba zato ba tsammani ce, kuma mutane suna iya kamuwa da cutar MERS-CoV saboda ba su da tabbacin cewa za su iya kamuwa da ita.
Matsayin raƙumi a cikin yaduwar cutar MERS-CoV ya bambanta da na pangolins, idan akwai, a cikin cutar SARS-CoV-2.
Musamman, kwayar cutar ta pangolin beta-CoV tana da yawa a cikin kwayar cutar ta pangolin.
Suna iya zama masu saurin kamuwa da cutar SARS-CoV-2 da ke da nasaba da beta-CoVs, kamar yadda ake samu a cikin SARS-CoV.
Binciken da za a yi nan gaba ya kamata ya yi la'akari ko kuma ya ƙi da yiwuwar cewa SARS-CoV-2 zai iya yaduwa daga dabbobi zuwa mutane.
Na farko, damisa na iya zama mai daukar kwayar cutar SARS-CoV-2 mai kama da SARS-CoV-2.
Mutane za su iya raba wannan yanayin tare da kunama ta hanyar kashe su ko kuma ta hanyar hakar kwal.
Na biyu, pangolins, wataƙila ɗaya daga cikin masu haɓaka matsakaici waɗanda aka gano kwanan nan don cutar SARS-CoV-2.
Mutane suna samun kwayar cutar ne ta hanyar kashe kifi da cin kifin da aka yi musu kisa.
Wataƙila dabbobi masu shayarwa da dama, ciki har da dabbobin gida, suna da saukin kamuwa da cutar SARS-CoV-2.
Dole ne a yi binciken dabbobi da namun daji don samun rigakafi.
Na uku, kamar yadda aka ambata a sama, ana iya samun sake haɗuwa da karɓar SARS-CoV-2 a cikin nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Ana ci gaba da bincike kan asalin SARS-CoV-2.
Baya ga bambancin nau'ikan dabbobi, akwai manyan abubuwa guda uku a cikin cutar ta COVID wanda ke taimakawa wajen sauƙaƙe ƙetare shingen nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau
Na farko, suna da yawan canji a cikin kwafin RNA.
Idan aka kwatanta da sauran ƙwayoyin cuta na RNA guda ɗaya, ƙimar canjin COV ya dogara da matakin karɓar COV ta sabon mai maye gurbin, tare da matsakaicin sauyawa na "lafiya" zuwa "babba" tare da sauyawa sau 10-4 a kowace shekara a kowane wuri 2.
COVs suna da hujja-karin exoribonuclease, wanda cire shi yana haifar da ƙarancin canji da lalacewa ko ma rayuwa.
Abin mamaki, an san cewa nucleotide analogue Remdesivir yana yin kwafin COV don rage hanawa na waɗannan exoribonucleases da RNA masu dogara da RNA polymers.
Remdesivir yana daya daga cikin magungunan SARS-CoV-2 da aka gwada a asibiti.
Duk da haka, yawan canjin da ke faruwa a cikin C.O.V. ya ninka na 'yan'uwansu sau miliyan.
Bugu da ƙari, idan ba a karɓi COVID da kyau ta hanyar ƙwayoyin cuta ba, yawan canjin canjin yana da yawa.
Idan aka kwatanta da SARS-CoV, wanda ke da yawan canji, SARS-CoV-2 yana da ƙarancin canji, yana nuna babban matakin yarda ga ɗan adam.
Wataƙila an riga an riga an ɗauke shi a wani halittar da ke kusa da ɗan adam.
Wannan kuma ya shafi MERS-CoV, wanda ya sami karbuwa sosai a cikin Dronadery Camel, a matsayin ƙari ga SARS-CoV-2.
A ka'ida, ba zai yiwu ba cewa kwayar halitta ta yi tasiri a kan SARS-CoV-2 ta hanyar yin rigakafi da sauri da kuma sanya shi ya zama mai cutarwa.
Na biyu, babban RNA din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din din
Wannan yana da goyon baya ta hanyar wasu abubuwa masu budewa da za a iya karantawa da kuma ayyukan sunadarai da aka rubuta a ƙarshen 3' na kwayoyin.
Na uku, COVs suna canza samfuri tsakanin kwafin RNA ta hanyar "kwafin-zaɓi" na yau da kullun da kuma na yau da kullun.
A cikin ƙwayoyin cuta suna aiki a matsayin tukwane na haɗuwa, sauyawa na tsiri yana faruwa sau da yawa yayin fassarar RNA na COV.
Ana iya sake haɗa babban adadin DNA mai tsawon tsawon lokaci da kuma RNA mai ƙarancin jini don samar da sabon COVID.
An sami shaidar asalin halitta ta hanyar HCoV-HKU1 da HCoV-OC43 da kuma wasu nau'ikan C.O.V. na dabbobi kamar su Batwagel SL-CoV da Batwagel C.O.V. -HKU9.
Hadin kan kwayar cutar da kwayar cutar a cikin hanyar yaduwar cutar.
Baya ga abubuwan da aka ambata a sama guda uku, hulɗar kwayar cuta tare da mai karɓa mai ƙwayar cuta wani muhimmin abu ne wanda ke da tasiri a cikin yaduwar nau'in.
A nan, an ɗauki sake haɗuwa da SARS-CoV a matsayin misali na misali, wanda kuma ya nuna hujja na zaɓi mai kyau tsakanin abubuwan da ke faruwa na watsawa tsakanin jinsuna.
Bisa ga kwatancen bincike tsakanin mutane da masu rarrabe SARS-CoV na al'umma, SARS-CoV ya nuna cewa an karɓa da sauri a cikin kwayoyin daban-daban, musamman tare da canji a cikin RBD na S protein.
A cikin RBD na S, COV yana hulɗa da mai karɓar kwayar halitta kuma ana zaɓar shi ta hanyar amsawar kwayar cutar mai haɗari.
A SARS-CoV, RBDs suna cikin kashi 318 zuwa 510 na amino acid a cikin S1, wanda ke ɗaure da ACE2 na ɗan adam da masu karɓa don shigar da kwayar cutar.
RBD na SARS-CoV yana ba da damar watsa kwayar cutar tsakanin jinsuna, wanda ke iya gano masu karɓar ACE2 na dabbobi daban-daban, gami da damisa, wadatattun dabbobi, berayen da karnukan raccoon.
A zahiri, RBDs a cikin kwayar cutar ta mutum da kwayar cutar ta Civet sun gano cewa ragowar amino acid guda 6 ne kawai suka bambanta, kuma huɗu daga cikinsu suna cikin tsarin mai karɓar mai karɓar don hulɗa tare da mai karɓar ACE2.
CIVT SARS-CoV yana da masu canji K489N da S487T a cikin RBD ɗinsa, wanda zai iya ƙarfafa sha'awar hulɗar protein na spike tare da masu karɓar ACE2 na ɗan adam.
A wasu kalmomi, maye gurbin wadannan amino acid guda biyu na iya zama muhimmiyar hanyar kamuwa da kwayar cutar a cikin mutane.
Yana da mahimmanci a lura cewa SARS-CoV-2 yana da mai karɓar ƙwayar cuta iri ɗaya da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV-2 a cikin S1 na S2 sun nuna cewa haɗin S2 ɗin su na iya canzawa tare da ACE2 na ɗan adam.
Hakika, wani bincike na Cryogenic-EM ya nuna cewa wannan son son son son son son ne ya fi na mutane sau 10 zuwa 20 fiye da na ACE2 da SARS-CoVS.
Hakanan zai zama da sha'awa don tantance ko ana buƙatar wasu masu haɗin gwiwa don watsa SARS-CoV-2.
HCoV-NL63 ma yana iya ɗaure zuwa ACE2, amma tare da wani sashi na S.
Akwai wasu masu karɓar HCoV masu yawa kamar su amino peptides N don HCoV-229E, da 9-O-acetylated sialic acid don HCoV-OC43.
Hakanan suna iya zama alhakin nasarar ɗaukar wannan COVID a cikin ɗan adam bayan yaduwar nau'in daga abincin dabbobi.
A matsayin ƙari a cikin ƙwayoyin cuta, tasirin HCoV zuwa nau'in watsawa yana sarrafawa ta hanyar dogaro da sauran abubuwan gina jiki da abubuwan hanawa.
Ruwa tsakanin mutane da masu tarin HCoVs kamar su fararen hula, raƙuman ruwa, da beraye na iya hana yaduwar kwayar cutar tsakanin jinsuna.
HCoVs suna buƙatar ƙarfafa abubuwan dogaro da abinci mai gina jiki da kuma kawar da abubuwan hana abinci mai gina jiki don samun nasarar yaduwar nau'in.
A wannan yanayin, har yanzu ana ganowa da kuma ƙayyade ƙayyadaddun ƙwayoyin cuta a cikin wannan muhimmin ɓangaren hulɗar ƙwayar cuta da ƙwayar cuta.
Yin amfani da fasahar CRISPR ta zamani don SARS-CoV-2, bincike mai zurfi na ƙwayoyin cuta da abubuwan hanawa na iya zama da amfani.
Sabbin cututtukan HCoV: koma baya zuwa sifili
Bambancin COVID na batirin yana ba da dama ga fitowar sabbin HCoVs.
Saboda haka, cutar COVID ta kunkuru tana aiki a matsayin taskar kwayoyin HCoV.
Bugu da ƙari, saurin canji da kuma sake fasalin kwayoyin suna haifar da HCoVs kuma suna aiki a matsayin matakai biyu masu muhimmanci a wannan tsari.
Alal misali, saye ko kuma lalacewar sababbin kwayoyin da ke sa sunadarai na iya canja yanayin ƙwayar cutar gaba ɗaya.
A cikin sunadarai masu taimakawa SARS-CoV, ORF8 ana ganin yana da mahimmanci don karɓa a cikin ɗan adam, saboda SARS-CoV-da ke da alaƙa da cutar batirin da aka gano yayin da aka ware shi, amma an sami ɓarna a cikin encoding na ORF8 sunadarai.
An gano SARS-CoV a cikin kwayar halitta da aka ware a farkon cutar a cikin mutane, tare da fasalin 29-nucleotide deletion.
Bayan an cire shi, ORF8 ya rabu zuwa ORF8a da ORAP8b kuma ana ɗaukarsa mai karɓaɓɓen canji, wanda ke inganta ƙaurawar abinci.
Bugu da ƙari, SARS-CoV yana da tarihin yiwuwar sake haɗawa tare da zuriyar alpha- da gamma-CoVs, wanda ke nuna yawancin ƙananan sassan sake haɗawa a cikin RNA.
An kuma gano wuraren sake tsarawa a cikin NSP 9, da yawa a cikin NSP10, da kuma wasu sassan NSP 14.
Hakazalika, an nuna cewa cutar MERS-CoV ta sami ci gaba a cikin wasu nau'ikan da aka gano a cikin raƙuman ruwa a Saudi Arabiya.
Baya ga SARS-CoV da MERS-CoV, an kuma gano abubuwan sake haɗawa a cikin HCoVs, waɗanda HCoVs suka sake haɗawa da COVs na wasu dabbobi a cikin ƙwayoyin halittar su.
Zaɓin wucin gadi na iya ba da gudummawa ga sauyawar kwayar cutar da ba a so, wanda sau da yawa yakan haifar da sauƙin zaɓin ƙwayar cuta ta hanyar tsarin rigakafin ƙwayar cuta.
Wani misali na wannan sakamako shine asarar cikakken tsawon ORF4 a cikin kwayar HCoV-229E wanda ke haifar da cire nucleotides biyu.
Ana iya samun ORF4 guda ɗaya a cikin kwayar cutar HCOC-229E da kwayar cutar raƙuman ruwa, Alpaca alfa-CoV yana nuna haɗuwa da nucleotide guda ɗaya, wanda ke haifar da sauyawa.
A ƙarshe, amma ba ƙarshe ba, canjin sabon HCoVs kuma yana yiwuwa ne ta hanyar matsin zaɓin da ke cikin mahaɗan da ke cutar.
An sami alamun gaggawa ko kuma marasa tsanani lokacin da batutuwan suka kamu da cutar ta COVID, wanda ke nuna yarda tsakanin COVID da batutuwan.
Kamar dai batirin ya shawo kan cutar COVID sosai a zahiri da kuma ta jiki.
Misali, lahani a kunnawar amsawar pre-infection a cikin farji yana rage ingancin maganin cututtukan da COV ke aiwatarwa.
Bugu da ƙari, aikin kwayar halitta na halitta a cikin farji yana da ƙarancin ƙarancin ƙarancin ƙwayoyin halitta na halitta na halitta na halitta na halitta na NKG2/CD94 da kuma ƙananan ƙarancin ƙwayoyin halitta na nau'in I.
Bugu da ƙari, yawancin nau'in oxygen mai haɗari (ROS) wanda ya samo asali daga babban metabolism na bat da ke hana aikin kwafin COV da kuma haifar da tabbatarwa ta hanyar exoribonuclease, ta yadda lokacin da aka shigar da sabon abinci, asalin asalin kwayar cutar yana ba da zaɓi don zama mai cutarwa sosai.
Ƙarin kwayar cutar COV tana iya juyawa ta hanyar sake haɗuwa, wanda ke haifar da sabon furotin ko kuma fasalin furotin don karɓar abinci.
Saboda haka, ba a samu sababbin ƙwayoyin cutar HCoV guda uku ba da gangan a cikin shekaru ashirin da suka gabata.
COVs suna haifar da rashin lafiya ko kuma rashin jin daɗi a cikin kwayar cutar su, kamar su batsa ko raƙuma.
Waɗannan ƙwayoyin cuta masu ƙarfi suna yin kwafi da kyau ba tare da kashe amsawar rigakafi ba.
Wannan yana ɓoye asirin dalilin da yasa masu ɗaukar hoto suka bayyana da kuma abin da ke haifar da babbar matsala a cikin kamuwa da mutane.
Alamun cutar suna da yawa saboda yawan aikin da ake yi na maganin rigakafi da kuma tashin sitokin, yayin da inda maganin rigakafi ya fi karfi, ana ganin ana samun mummunar lalacewar huhu.
Akasin haka, a cikin mai ɗaukar cutar, an tsara amsawar rigakafi daga kwafin COVID.
Wannan na iya zama wata dabara mai fa'ida don karya amsawar rigakafi a cikin maganin SARS-CoV-2.
Amsar Interferon tana da ƙarfi musamman a cikin ƙwayoyin cuta.
Saboda haka, gudanar da Interferon Type-I ya kamata ya zama mai amfani a farkon kamuwa da SARS-CoV-2 a cikin mutane.
Bugu da ƙari, kunnawa na mai ba da NLRP3 a cikin batsa ba daidai ba ne.
Saboda haka, MCC950 na mai ba da NLRP3 na iya zama mai amfani a cikin maganin COVID-19.
An gano cewa SARS-CoV-2 yana bin tsarin da ya haifar da SARS-CoV da MERS-CoV.
A gefe guda, an gano cewa beta-CoVs na bat sun raba kashi 95% na nucleotide tare da SARS-CoVs, yayin da kuma kashi 96% na nucleotide na bat sun kasance tare da SARS-CoV-2.
Amma duk da cewa an gano wasu dabbobi da ke kasuwa a matsayin masu daukar nauyin SARS-CoV, ba a gano masu saurin shiga tsakanin SARS-CoV-2 ba.
An gano daidaiton SARS-CoV-2 a cikin pangolins beta-CoV, wanda ke nuna cewa pangolins na iya zama ɗaya daga cikin matsakaitan matsakaici, ko kuma pangolins beta-CoV na iya ba da gudummawa ga rarraba kwayar halitta a cikin sigar ƙarshe ta SARS-CoV-2.
Amma, babu tabbacin cewa SARS-CoV-2 na mutum ne da gangan ko kuma ba zato ba tsammani.
C.O.V.s sun sake dawowa cikin farfajiyar jama'a saboda barkewar cutar SARS-CoV-2.
Nazarin da aka yi a kan damisa da sauran dabbobi ya sauya fahimtarmu game da asalinmu na dabba da kuma muhimmancin kwayar cutar HCoV a cikin kamuwa da mutane.
Bayanan yaduwar sun nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga bat, kuma ya sami yaduwar su ga mutane ta hanyar matsakaiciyar kwayar cuta.
Cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da cats a kasuwa, rufe kasuwar abincin teku da kashe cats a can, kuma cutar ta ƙare SARS-CoV.
Saboda wannan dalili, ya kamata a cire pangolins daga kasuwar abincin teku don hana yaduwar cutar daga dabbobi, saboda gano cewa bambancin dangin pangolins beta-CoV suna da alaƙa da SARS-CoV-2.
Koyaya, binciken gaba ya rage don bayyana ko kuma yadda SARS-CoV-2 ya kamuwa da mutane daga pangolins da sauran dabbobi masu shayarwa.
A gefe guda, MERS-CoV ya daɗe yana cikin raƙuman ruwa.
Ta zama hanya mai mahimmanci na sufuri, kuma ta kasance babbar hanyar samar da nama, madara, fata da kayan saƙa ga mazauna yankin.
An yada su a Gabas ta Tsakiya da Afirka.
Kamar yadda aka yi a kasuwar namun daji ta kasar Sin don hana yaduwar SARS-CoV da SARS-CoV-2, ba zai yiwu a yi hadaya da dukkan raƙuma don sarrafa MERS ba.
Don dakatar da sake fashewar MERS, dole ne a bi da cikakkiyar hanyar samar da ingantaccen rigakafi a kan MERS-CoV a kan raƙuma, tare da haɗa sauran matakan sarrafa kamuwa da cuta.
Saboda ba za mu iya kawar da wannan kwayar cutar ba, za mu iya haifar da sabon nau'in cutar da zai haifar da barkewar cutar.
Akwai dabbobi da yawa da suke da irin wannan halittar.
Musamman, bat-CoVs suna da bambanci sosai tare da yiwuwar dabbobi.
Akwai damar da yawa na juyin halitta da sake haɗawa a cikin wannan kwayar cutar ta COV ta dabba, wanda zai haifar da sabon kwayar cutar ta COV mai saurin yaduwa da / ko mai sa mutuwa a cikin mutane a nan gaba.
Don rage hulɗa mara amfani tsakanin mutane da dabbobi, ya kamata a daina al'adun cin naman daji a wasu yankuna na kasar Sin.
A cikin jerin SARS, MERS da COVID-19, ya kamata a samar da kyakkyawan shiri da shirin amsawa.
A gaskiya, akwai ƙwayoyin cuta da yawa a duniya da suka daɗe suna wanzuwa.
Suna zama a cikin nasu mazaunin har sai sun sami damar yaduwa.
Ko da yake akwai abubuwa da yawa da ke haifar da yaduwar ƙwayoyin cuta a cikin bat, koyon mutane su guji bat da sauran nau'in namun daji na iya rage hulɗar su da mutane.
Ana buƙatar sa ido kan dabbobi masu shayarwa don fahimtar rayuwar COV da kuma yanayin da suke ciki, wanda zai iya taimakawa wajen hana yaduwar cutar daga dabbobi zuwa mutane da kuma hana barkewar cutar nan gaba.
A ƙarshe, mafi kyawun hanyar da za a iya hana kwayar cutar daga dabbobi ita ce a nisanta mutane daga yanayin yanayin da kwayar cutar ta halitta take.
Akwai abubuwa da yawa da ba a gano ba game da asalin SARS-CoV-2 daga dabbobi.
Da farko, idan kunkuru ya kamu da cutar SARS-CoV-2 zuwa pangolins, zai zama mai ban sha'awa a ga yanayin da kunkuru da pangolins suke raba yanayin muhalli.
Na biyu, idan akwai wani abu da ke nuna cewa batutuwan sun fi saurin kamuwa da cutar zuwa ga mutane, dole ne mu yi la'akari da yadda mutane suka shiga cikin batutuwan.
Na uku, idan dabbobi masu shayarwa na uku sun yi aiki a matsayin matsakaici, ya kamata a bayyana yadda suka yi hulɗa da wasu nau'o'i, har da mutane, da damisa, da pangolins.
A ƙarshe, ya kamata a bincika da kuma gwada wasu dabbobi masu shayarwa, ciki har da dabbobin gida, da ke da yiwuwar kamuwa da SARS-CoV-2.
Idan kun kasance kunkuru, ko pangolin ko wasu dabbobi masu shayarwa, a nan gaba za a iya gano irin wannan SARS-CoV-2 ko kuma kwayar cutar kakanninsu a cikin yanayin da suke ciki.
Ci gaba da bincike a cikin wannan fannin zai bayyana mahimman ma'anoni a cikin rigakafin COVID-19 da sarrafawa a cikin mutane, a cikin hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi.
Yana da mahimmanci a sabunta ƙa'idodin bincike na "matsalolin" da "haɓaka" na COVID-19.
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga Jagororin Shawarwari na Saurin Magani don Magungunan Kwayoyin Cutar Kwayar cuta don Gano cutar Novel Coronavirus (2019-nCoV) na 2019, kuma waɗannan jagororin sun zama kyakkyawan tunani ga ƙungiyarmu da kuma duniya don yaƙar cutar.
Koyaya, cutar Coronavirus 2019 (COVID-19) sabuwar cuta ce. Saninmu da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da ke gudana da kuma kwarewar asibiti, don haka, ana sabunta dabarun ganewar asali da magani akai-akai.
A cikin wannan wasikar, mun yi tsokaci kan ka'idodinmu da kuma sabbin ka'idojin bincike na COVID-19 (Sashe na 7) "Masu shakku" da "Tabbatar da Lamuran" bisa ga sabon bincike da magani da kwamitin kiwon lafiya na Jamhuriyar Jama'ar Sin ya bayar.
A watan Disamba na 2019, cutar coronavirus (2019-nCoV) ta fashe, wanda aka sanya masa suna Coronavirus Disease 2019 (COVID-19) kuma an sanya wa cutar sunan Severe Acute Syndrome Coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta bayyana COVID-19 a matsayin annoba.
Don magance cutar SARS-CoV-2, ƙungiyarmu ta haɓaka jagororin shawarwari na gaggawa kuma an buga su ta yanar gizo a cikin Military Medical Research a ranar 06 ga Fabrairu, 2020.
Tun bayan da aka buga shi, ya jawo hankalin mutane da yawa.
Lura cewa duk da cewa COVID-19 sabuwar cuta ce, iliminmu da wayewarmu yana ƙaruwa a hankali bisa binciken bincike da ke gudana da kuma aikin asibiti; don haka dabarun ganewar asali da magani suna ci gaba da sabuntawa.
Misali, jimillar juzu'i bakwai na jagororin bincike da magani don COVID-19 da aka buga tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, ta Kwamitin Lafiya na Jamhuriyar Jama'ar Sin (NHC) an buga su tare da wasu gyare-gyare na mahallin.
Yanzu da aka samu bayani game da jagororinmu daga Zhou et al., sun gabatar da shawarwari masu sauki bisa ga kwarewarsu a asibiti.
Aikinsa ya ba da sabon tabbaci ga ƙa'idodinmu kuma ya ba da mahimmin bayani game da wannan annoba ta duniya.
Muna godiya da kuma girmama aikinsa mai ban mamaki.
Koyaya, aikinsa ma yana buƙatar sabuntawa bisa ga sabbin hanyoyin bincike da magani na COVID-19 (Gwaji na bakwai) da kuma binciken kwanan nan.
Bisa ga na bakwai (3 Maris 2020), tabbatar da wata cuta na bukatar hada kowane abu na tarihin asibiti tare da abubuwa biyu na binciken asibiti, ko kuma kammala abubuwa uku na binciken asibiti idan babu bayyanannen tarihin asibiti.
Tarihin cuta: (1) Tarihin tafiya ko zama a cikin garin Wuhan da ke kewaye, ko kuma a yankin da aka samu rahoton cutar COVID-19 a cikin kwanaki 14 kafin bayyanar cututtuka; (2) Tarihin hulɗa da masu kamuwa da cutar SARS-CoV-2 (ciki har da gwajin nucleic acid mai kyau); (3) Tarihin hulɗa da marasa lafiya da ke da zazzabi ko cututtukan numfashi daga garin Wuhan da ke kewaye, ko kuma wasu al'ummomin da ke da cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) Tarihin haɗuwa da yankin da aka samu rahoton cutar (kamar gida, ofis, makaranta, aji, da sauransu) tare da ƙananan cututtukan numfashi da zazzabi a cikin makonni 2.
Binciken asibiti: (1) bayyanar zazzabi da/ko alamun numfashi; (2) tare da fasalin kamuwa da cutar COVID-19; (3) nuna yawan adadin ƙwayoyin farar fata da suka ragu zuwa na al'ada, ko kuma ƙarancin ƙwayoyin lymphocyte a farkon farkon farawa.
Ganowar tabbatar da shari'ar ya kamata ya kasance bisa ga zargin da ake yi na cutar ko kuma tare da ɗayan ɗayan abubuwan da ke cikin hujjojin serological kamar yadda aka bayar: (1) gwajin PCR na lokaci na gaske don SARS-CoV-2 ya zama tabbatacce; (2) cikakkiyar kwayar halitta ta kwayar cutar da ke nuna haɓakar haɓakar kwayar cutar; (3) tabbatacce ga SARS-CoV-2 a cikin gwajin magani don takamaiman IgM da IgG antibodies; ko sauyawa daga mummunan zuwa tabbatacce na SARS-CoV-2-specific IgG antibodies, ko kuma a cikin matakan warkewa a cikin matsanancin yanayi ≥4 sau.
Za mu iya ganin cewa gwajin PCR na ainihi don kwayar cutar nucleic acid a cikin hanyar numfashi ko samfurin jini an ƙara shi a cikin na biyu (Janairu 18, 2020) da na uku (Janairu 22, 2020).
An ƙara ganowar cututtukan jini a cikin juzu'i na huɗu (Janairu 27, 2020) da na biyar (Fabrairu 8, 2020); kuma an ƙara hujjojin serological a cikin juzu'i na bakwai.
Waɗannan gyare-gyare sun dogara ne akan aikin yau da kullun na masu bincike, gami da bincika mafi kyawun gano nucleic acid don saurin ganewar asali, da kuma haɗawa da samfurin jini daga hanyar numfashi, waɗanda suka haɓaka wadatar samfuran daban-daban, kuma suna tallafawa tabbataccen sakamako na takamaiman antibody a cikin ma'aunin da aka tabbatar.
Bugu da ƙari, akwai ƙarin tabbaci da ke tunatar da mu mu yi taka tsantsan da marasa lafiya da ke da alamun rashin lafiya da kuma rashin lafiya.
Saboda haka, Zhou et al. ya kamata su sabunta taswirarsu, domin suna rarraba mutum ba tare da alamun asibiti ba a matsayin "mai ƙarancin haɗari".
Hakanan akwai buƙatar tabbatar da tsarin ƙididdiga a cikin aikin asibiti da karatu.
A ƙarshe, muna fatan ƙarin tabbaci kai tsaye zai zo don masu karatu su yi sharhi.
Don gano yanayin da ake zargi da kuma wanda aka tabbatar, dole ne mu bi kuma mu bi sabbin ka'idojin ƙasarsu.
Ƙungiyarmu za ta kuma sabunta jagororinmu a kan lokaci don taimakawa.
Bangladesh ta ba da rahoton sabbin mutuwar COVID-19, mafi girma a rana guda
A jiya, Bangladesh ta tabbatar da sabbin mutuwar COVID-19 guda biyar a rana ɗaya.
Wannan shi ne adadin mutuwar da cutar ta yi a kowace rana.
Kamar yadda na jiya, Cibiyar Kula da Cututtuka, Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton cewa, daga cikin waɗanda suka kamu da cutar, akwai masu aiki 114, da kuma masu warkewa 33 da ke zaune a gida.
An samu mutuwar mutane 17 a duk faɗin ƙasar.
A wani jawabi da ta yi a kan layi, Daraktan IEDCR, Dr. Mirzade Sabrina Flora, ta ce, wadanda suka mutu sun hada da maza hudu da mace daya.
A cewar Dr. Mirzade, mutum biyu sun kai shekara 60, biyu sun kai shekara 51 zuwa 60, kuma guda ya kai shekara 41 zuwa 50.
Ta kuma ce biyu daga cikin wadanda aka kashe sun kasance daga Dhaka.
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba.
Jami'an asibitin sun shaida wa kamfanin dillancin labarai na Adolu cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, daraktan hukumar yaki da cin hanci da rashawa ta Bengal, wanda ke jinya a asibitin Mitrai na Kuwait.
A wani sanarwar bidiyo ta yanar gizo a ranar Asabar, Ministan Sufuri da Gidajen Ruwa na Bangladesh, Obedul Quadar, ya ce za a dakatar da sufuri na jama'a na tsawon lokaci fiye da yadda aka tsara, har zuwa wannan Asabar.
An shirya wannan dakatarwar ta fara ne a ranar 26 ga Maris kuma za ta ƙare a ranar Asabar, 4 ga Afrilu.
Har ila yau, ana yarda da jigilar kayayyakin rayuwa - magani, man fetur, da abinci.
An fara samun rahoton cutar COVID-19 a Bangladesh a ranar 8 ga Maris, wanda ya hada da mutane biyu da suka dawo daga Italiya, da matar daya daga cikinsu.
A ranar 19 ga Maris, dukansu uku sun riga sun warke.
SARS-CoV-2 ya kai miliyan ɗaya a duniya
A ranar Alhamis, adadin masu kamuwa da cutar SARS-CoV-2 a duniya ya zarce miliyan, kamar yadda bayanan Jami'ar Johns Hopkins suka nuna.
An danganta mutuwar mutane 52,000 ga COVID-19, cutar da coronavirus ke haifarwa.
Wannan muhimmin abu ya zo ne a ranar da Malawi ta tabbatar da kamuwa da cutar korona ta farko da Zambia ta tabbatar da mutuwar da ta shafi cutar.
Koriya ta Arewa, a ranar Alhamis, ta yi ikirarin cewa tana cikin wasu ƙasashe kaɗan da suka kasance ba tare da kamuwa da cutar coronavirus ba.
Har zuwa jiya, WHO ta tabbatar da 1,051,635 na cutar, gami da 79,332 a cikin awanni 24 da suka gabata, a ranar 4 ga Afrilu, da karfe 10.00 na safe na tsakiyar Turai (0800 UTC).
A Amurka, an samu sama da mutane 244,000 da suka kamu da cutar, tare da mutuwar mutane 5,900.
CBS News, tana ambaton bayanan Jami'ar Johns Hopkins, ta ruwaito cewa cutar coronavirus ta yi sanadiyar mutuwar mutane sama da 1,000 a Amurka a ranar Laraba.
A duk duniya, an sanar da tsauraran matakai don hana yaduwar cutar.
A ranar Alhamis, Magajin garin Moscow, Sergei Sobyanin, ya dage dokar kulle har zuwa ranar 1 ga Mayu.
A matakin kasa, Shugaba Vladimir Putin ya sanar da cewa, har zuwa 30 ga Afrilu, 'yan Rasha za su ci gaba da samun albashi ba tare da sun tafi aiki ba.
Majalisar dokokin Portugal ta dage dokar ta kasa har tsawon kwanaki 15, inda aka amince da kudurin da kuri'u 215, 10 suka ki, kuma 1 ya ki.
Saudi Arabiya ta kafa dokar hana fita ta yini a cikin biranen mai tsarki na Makka da Madina: A baya, dokar hana fita ta kasance daga karfe 3 na yamma zuwa 6 na safe.
Thailand na shirin aiwatar da dokar hana fita daga karfe 10 na dare zuwa 4 na safe.
Gwamnan Ohio, Mike DeWine ya tsawaita dokar zama a gida har zuwa ranar 1 ga Mayu.
Shaguna a Australia sun rage iyakar takardar bayan gida da ake sayarwa.
A ranar Lahadi da Asabar da yamma, manyan kantunan Australiya Woolworths da Coles sun rage takunkumin sayen takardar bayan gida zuwa biyu da kuma kunshin daya a kowace ma'amala.
ALDI ma, ya fara iyakar fakiti ɗaya a ranar Litinin.
An sanya waɗannan iyakokin a matsayin saƙo a wurin biya da kuma shafin Facebook na sarkar.
Masu siye suna adana su don tsoron COVID-19 idan mutane suna buƙatar keɓewa.
A ranar Laraba, Woolworths ya ƙayyade kowane sayayya zuwa fakiti ɗaya don bayarwa zuwa gida.
Waɗannan canje-canjen sun biyo bayan ƙuntatawa na kwantena huɗu da aka gabatar a ranar 4 da 5 ga Maris, bi da bi, da Woolworths da Coles suka gabatar.
Coles, a cikin bayyanarsa na 8 ga Maris, ya ba da rahoton cewa za a hana fakitin hudu, "yawancin shagunan suna siyarwa cikin sa'a guda na isarwa", kuma ya ce buƙatar "ba ta da tabbas", yayin da ALDI, a cikin shafin Facebook ɗin su a ranar Talata, ya kira shi "ba zato ba tsammani".
Wani mai magana da yawun Woolworths ya ce, "an samu karuwar tallace-tallace a makon da ya gabata.
Costco's store a Canberra ma ya rage adadin zuwa fakiti biyu a makon da ya gabata.
Don rage ƙarancin, Coles ya ba da umarni ga manyan fakiti daga masu samarwa kuma ya haɓaka yawan isar da su. Woolworths ya ba da umarnin ƙarin kaya, yayin da ALDI ya ba da damar samun wuri don ranar Laraba da aka tsara.
Russell Zimmerman, babban daraktan kungiyar 'yan kasuwar Australiya, ya ce 'yan kasuwar sun yi kokarin kara yawan kayayyaki, amma an hana su saboda dokar da majalisar ke kafawa kan lokacin da ake sayen motocin.
Suna tsammanin farashin zai ƙaru, domin masu samarwa suna bukatar su biya bukatar, kuma suna bukatar su biya na musamman a ƙarancin.
A ranar Talata, ADLI ta sanar da cewa saboda saurin jigilar kaya, wasu shagunan ba za su iya gudanar da na musamman na Laraba ba.
A cikin rahoton News.com.au, Dr. Gary Mortimer, masanin sayar da kayayyaki a Jami'ar Fasaha ta Queensland, ya ce shagunan suna cike kayayyaki a kowane dare.
Ya yi tsokaci cewa takardar bayan gida abu ne mai girma, wanda ke haifar da karancin adanawa, kuma, idan aka sayar, yana kwashe ɗakunan ajiya da yawa.
Coles da Woolworths sun nuna cewa idan akwai abubuwa da yawa a kan shelf, kamar su kayan wanka da masu tsabtace jiki, kuma suna da yawa a can, za ku rage yiwuwar tashin hankali, in ji Russell Zimmerman a ABC News.
Kamfanin da ke yin takardar wanki mai sake amfani da ita mai suna Who Gives a Crap ya ce ya gama kayayyakin.
Kamar yadda News.com.au ta ruwaito, Kimberly-Clark, wanda ke kera Kleenex Toilet Tissue, da Solaris Paper, wanda ke kera Sorbent, sun jaddada cewa suna aiki 24/7 don kiyaye wadatar.
Domain.com, wani shafin sayar da kayayyaki, ya ruwaito cewa wasu 'yan kasuwa a Melbourne suna ba da takardar wanka kyauta ga mai neman farko a kan gwaninta, yayin da aka yi wasu gwaninta saboda masu sayen suna da lokaci a lokacin babban ranar ma'aikata.
A cikin labarin da aka buga a ranar Alhamis na NT News, an saka takardun ruwa guda takwas a cikin takarda da ake amfani da ita a matsayin takarda ta wanka, wanda ake bugawa a kowace rana a Darwin.
A cewar rahoton ABC Australia na 3 ga Maris, kantin sayar da kayayyaki ya saba adawa da sanya takunkumi, yana mai cewa ba su da wani shiri na sanya takunkumi kan sayayya.
Russell Zimmerman ya ce akwai bukatar wasu kayayyaki da yawa, kamar masks, masu tsabtace jiki, bushe-bushe, wanke hannu da kuma gari.
Hakazalika, a waje da Ostiraliya, a ranar Lahadi da yamma, kantin sayar da kayayyaki na kan layi na Ocado na Burtaniya ya ƙuntata sayen takardar bayan gida ta Andres zuwa fakiti biyu na 12 -rol.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba ta duniya
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana barkewar cutar COVID-19 a matsayin annoba ta duniya da ke haifar da cutar SARS-CoV-2.
Ko da yake kalmar nan "tazarar duniya" ba ta nufin yadda wasu abubuwa suke da haɗari ba, amma ta shafi yadda cutar take yaɗuwa, WHO ta ce gwamnati na bukatar ta ɗauki mataki mai tsanani.
Dukkanin kasashe na iya magance wannan annoba ta duniya.
Darakta Janar na WHO Tedros Adhanom Ghebreyesus ya ce, idan al'ummai suka gane da amsa, za su iya yin gwaji, magani, warewa, ganowa da kuma haɗa kan jama'arsu a wannan gwagwarmayar.
Muna matukar damuwa da yadda ake yaduwar cutar da kuma yadda ake ta'azantar da ita da kuma yadda ake rashin aikin yi.
Tsohon shugaban Cibiyoyin Kula da Cututtuka na Amurka, Dr. Tom Friedman, ya ce wannan "ba a taɓa ganin irinsa ba" a duniya.
A cikin wani bayani da aka wallafa a kan CNN a watan Fabrairu, ya ce, "Babu wani kwayar cutar numfashi da aka gano daga farkonta zuwa yaduwar duniya, sai dai cutar mura".
Gebreyesus ya bayyana wannan ra'ayi, "Ba mu taɓa ganin irin wannan rikici na duniya ba".
Ya ci gaba da cewa, "kuma ba mu taɓa ganin irin wannan yanayin duniya da za a iya sarrafawa a lokaci ɗaya ba".
Yanayin annobar na duniya ya biyo bayan shawarar da WHO ta yanke a watan Janairu na ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiya na duniya.
"Babu shakka, yanayin zai ci gaba da taɓarɓarewa", in ji Dokta Anthony Fosse, shugaban Cibiyar Kula da Cututtuka da Keɓaɓɓun Cututtuka ta Amirka.
Har zuwa ranar Alhamis, Kamfanin dillancin labarai na Associated Press ya ruwaito cewa akwai aƙalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, wanda ya haifar da mutuwar sama da 4,600.
Cutar cutar korona ta 2019-20 ita ce cutar korona ta 2019 (COVID-19), wadda ke haifar da cutar korona ta 2 (SARS-CoV-2), wadda ke haifar da cututtuka masu tsanani na numfashi.
An gano wannan annobar a watan Disamba na 2019 a Wuhan, China, an ayyana ta a matsayin gaggawa ta lafiyar jama'a ta damuwa ta duniya a ranar 30 ga Janairu, 2020, kuma an sanya ta a matsayin gaggawa ta duniya daga 11 ga Maris, 2020.
A ranar 10 ga Afrilu, 2020, an sami kusan 1.61 miliyan na COVID-19 a cikin ƙasashe da yankuna 210 kuma kusan mutuwar 97,000 ta haifar.
Kusan mutane 3,64,000 sun warke.
An kiyasta cewa China tana da kashi 4 cikin 100 na yawan mutuwar mutane, inda a duniya ta kai 13.04% a Aljeriya da 0.08% a New Zealand.
Alamun da suka fi kowa sun haɗa da zazzabi, tari, da kuma rashin jin daɗi.
Idan akwai matsaloli, za a iya samun ciwon huhu da kuma wahalar numfashi.
Lokaci daga kamuwa da cutar zuwa bayyanar cututtuka yawanci yana da kwanaki biyar, amma yana iya zama daga kwana biyu zuwa goma sha huɗu.
Babu maganin rigakafi ko kuma takamaiman maganin rigakafi.
Maganin farko shine maganin cututtuka da kuma na asali. Matakan rigakafi da aka ba da shawarar sun haɗa da wanke hannu, rufe fuska lokacin tari, nisantar mutane, saka idanu, da kuma keɓewa daga waɗanda ake zargin suna da cutar.
Hukumomi a duniya sun amsa ta hanyar hana tafiye-tafiye, keɓewa, keɓewa, sarrafa haɗarin aiki da rufe ayyuka.
Cutar ta haifar da tsananin rashin zaman lafiya da rashin zaman lafiya a duniya, inda aka dage ko soke wasanni, al'adu, siyasa da al'adu, da kuma karancin kayayyaki da aka yi ta hanyar sayayya.
A ƙasashe 193, makarantu da jami'o'i suna rufewa ko dai a ƙasa ko a gida, kuma hakan ya shafi kusan kashi 99.4% na ɗaliban duniya.
Rashin gaskiya game da kwayar cutar ya yadu a yanar gizo kuma akwai wasu al'amuran tsoro ko ƙiyayya da nuna bambanci ga Sinawa, sauran mutanen Gabas ta Tsakiya da Kudu maso Gabas, da kuma mutanen da suke kama da su a yankunan da ke da manyan lamuran cutar.
Rage tafiye-tafiye da rufe manyan masana'antu sun rage gurɓataccen iska da fitar da iskar carbon.
Jami'an kiwon lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton cutar cutar sankarar huhu da ba a san dalilin ta ba a ranar 31 ga Disamba, 2019, kuma an fara binciken a farkon Janairu, 2020.
Yawancin waɗannan lamuran sun shafi kasuwar cin abincin teku ta Hunan, saboda haka ana ganin cewa cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ta haifar da wannan barkewar cutar, wanda aka sani da SARS-CoV-2, sabon ƙwayar cuta ce da ke da alaƙa da kwayar cutar coronavirus na fararen hula, kwayar cutar coronavirus da ke da alaƙa da cats da SARS-CoV. An gano farkon wanda aka gano yana da alamun cutar a ranar 1 ga Disamba, 2019, kuma mutumin ba shi da alaƙa kai tsaye da rukunin kasuwar dabbobi na baya.
Kashi biyu bisa uku na farkon rukunin da aka ruwaito a cikin 2019 sun kasance tare da market.
Rahoton da ba a tabbatar da shi ba daga South China Morning Post a ranar 13 ga Maris, 2020 ya nuna cewa mutum mai shekaru 55 a lardin Hubei wanda aka gano a ranar 17 ga Nuwamba, 2019 na iya zama farkon wanda aka gano. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa yayin da sabbin cututtukan da aka samu a China suka ragu amma ba zato ba tsammani suka ƙaru a Italiya da Koriya ta Kudu, wannan shine karo na farko da sabon adadin lambobin da aka samu a wajen China ya zarce na kasar Sin.
Ana iya samun rahotanni masu yawa a ƙasa, musamman ma waɗanda ke nuna alamun rashin lafiya.
A ranar 26 ga Fabrairu, an sami ƙananan lamura a cikin matasa, tare da shari'o'in da ke da shekaru 19 ko ƙasa da haka sun kai kashi 2.4% na shari'o'in duniya. Babban mai ba da shawara kan likitancin Burtaniya Patrick Valens ya yi hasashen cewa kashi 60% na yawan mutanen Burtaniya suna buƙatar kamuwa da cutar kafin su sami ƙarfin ƙwayar cuta.
Lamuran suna nuni ne ga yawan mutanen da suka gwada COVID-19 kuma waɗanda suka tabbatar da tabbatacce a cikin ƙa'idodin hukuma.
Babu wata ƙasa da ta gwada sama da kashi 3 cikin ɗari na yawan jama'arta har zuwa 23 ga Maris, kuma yawancin ƙasashe kamar Italiya, Netherlands, Spain da Switzerland suna da manufofin hukuma na ƙin gwada waɗanda ke da alamun rashin lafiya.
Wani bincike da aka fitar a ranar 16 ga watan Maris ya nuna cewa, a cikin kasar Sin, kimanin kashi 86% na mutanen da ke dauke da cutar COVID-19 ba a gano su ba a ranar 23 ga watan Janairu, kuma kashi 79% na wadanda ba a rubuta sun kamu da cutar ba.
Wani bincike na kididdiga da aka fitar a ranar 30 ga Maris ya kiyasta cewa adadin masu kamuwa da cutar a Italiya ya fi adadin da aka samu.
Hasashen farko na R0 na COVID-19 ya kasance daga 1.4 zuwa 2.4.
Wani bincike da Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka suka fitar ya nuna cewa zai iya zama 5.7.
Yawancin mutanen da ke da COVID-19 suna warkewa.
Kuma a cikin waɗanda ba su da shi, tsawon lokacin da ake ɗauka daga bayyanar cututtuka zuwa mutuwa ya kai kwanaki 6 zuwa 41, kuma yawanci kwanaki 14 ne.
Kusan mutane 97,000 sun mutu sakamakon COVID-19 har zuwa 10 ga Afrilu, 2020.
A cikin China, kashi 80% na waɗanda suka mutu a ranar 5 ga Fabrairu sun kasance sama da shekaru 60, kuma kashi 75% suna da cututtukan zuciya da suka haɗa da ciwon sukari tare da matsalolin kiwon lafiya na baya. Bayanan hukuma na mutuwar COVID-19 yawanci suna da alaƙa da waɗanda suka sami sakamako mai kyau na gwajin COVID bisa ga ƙa'idodin hukuma.
Gaskiya, mutuwar COVID-19 na iya zama da yawa, saboda ba za a iya haɗa da mutanen da ke mutuwa ba tare da gwaji ba, misali, a gida, a cikin gidajen wanka, da sauransu.
Wani ɗan bayani daga Italiya ya nuna cewa yawan mutuwar da aka yi a lokacin annobar ya ninka na COVID sau 4-5 fiye da adadin da aka ba da izini.
"Mun san cewa [yawan mutuwar da aka samu] ƙididdiga ce", in ji wata mai magana da yawun Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC), "wannan sanarwa ce da ba a kammala ba game da raguwar ƙididdiga a cikin Amurka. Irin wannan raguwar yawanci yakan faru ne a cikin annobar, kamar yadda ya faru a lokacin cutar H1N1 na 2009 na aladu.
Mutuwa ta farko a waje da babban yankin China ta faru ne a Philippines a ranar 1 ga Fabrairu, kuma ta farko a wajen Asiya a Faransa a ranar 14 ga Fabrairu.
A ranar 28 ga Fabrairu, fiye da mutane goma sha biyu sun mutu a waje da babban yankin China, a Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga Maris, an samu mutuwar mutane fiye da 40 a ƙasashe da yankuna a duk nahiyoyi, sai dai Antarctica.
Wannan adadi ya bambanta da yanki da lokaci, kuma ya shafi yawan gwaje -gwaje da aka yi, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokacin da cutar ta ɓarke, da kuma abubuwan da ke tattare da alƙaluma, kamar su shekaru, jinsi, da kuma lafiyar jama'a.
A cewar bayanan Jami'ar Johns Hopkins, yawan mutuwar mutane a duniya ya kai kashi 6.0 (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Wannan adadi ya bambanta daga yanki zuwa yanki.
Rashin mutuwar mutane a China ya ragu daga kashi 17.3% (ga waɗanda ke da alamun cutar a ranar 1 zuwa 10 ga Janairu 2020) zuwa 0.7% (ga waɗanda ke da alamun cutar bayan Fabrairu 2020). Sauran hanyoyin sun haɗa da Rashin Mutuwar Mutuwa (CFR), wanda ke nuna yawan mutanen da suka kamu da cutar (waɗanda ba a gano su ba) da suka mutu daga cutar.
Wannan bayanan ba shi da wani lokaci kuma yana bin wani takamaiman adadi na mutane daga lokacin da cutar ta fara zuwa lokacin da aka warware matsalar.
Yawancin cibiyoyin ilimi sun yi ƙoƙarin yin lissafin wannan adadi na yawan jama'a.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan kamuwa da cutar a duniya ya kai tsakanin 0.1% da 0.39%.
Hasashen da ke saman wannan zangon ya yi daidai da gwajin COVID-19 na farko da aka yi a cikin Jamus da kuma nazarin ƙididdiga wanda ke nazarin tasirin gwajin akan CFR.
WHO ta tabbata cewa za a iya shawo kan wannan matsalar ta duniya.
Ba a san ainihin lokacin da za a iya samun wannan annobar ba kuma za ta iya canjawa a wurare dabam dabam.
Maciej Bonnie na Penn State University ya lura cewa, "Idan ba a bincika ba, cutar za ta iya tsayawa a wani wuri kuma ta ragu yayin da ake samun ƙananan runduna.
Amma a yanzu, ba shi yiwuwa a yi hasashen lokacin da hakan zai faru".
Zhong Nan Shan, babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin kasar Sin, ya yi jayayya cewa idan dukkan kasashe suka fara bin shawarar WHO kan matakan hana yaduwar cutar, "zai kare a watan Yuni".
A ranar 17 ga Maris, Adam Kucharsky na Makarantar Kula da Lafiya da Magunguna ta London ya ba da shawarar cewa SARS-CoV2 na iya yaduwa cikin shekara daya zuwa biyu.
Binciken da Neil Ferguson na Kwalejin Imperial ya jagoranci ya nuna cewa kiyaye nesa da sauran matakan "za su zama dole (wataƙila watanni 18 ko fiye) har sai an sami allurar rigakafi".
William Schaffner na Jami'ar Vanderbilt ya lura cewa "ba zai yiwu a kawar da wannan cuta ba domin tana yaduwa cikin hanzari", saboda haka "za ta zama cuta ta yanayi kuma za ta iya sake dawowa kowace shekara".
Yanayin cutar ko kuma tsananin cutar ya dangana ne akan garkuwar jiki da kuma yawan sauyin halittar.
Alamun COVID-19 ba su da bambanci kuma ba za a iya samun alamun a cikin mutanen da ke kamuwa da cutar ba.
Alamun biyu da suka fi kowa su ne zazzabi (88%) da kuma tari mai bushe (68%).
Alamun da ba sa yawan faruwa sun haɗa da gajiya, ƙanshin numfashi, rashin jin ƙanshi, rashin jin ƙanshi, ciwon tsoka da ciwon haɗin gwiwa, ciwon makogwaro, ciwon kai, sanyi, amai, zub da jini, zawo, ko kuma fata mai launin shuɗi saboda rashin isashshen iskar oxygen. WHO ta ce kusan mutum ɗaya cikin shida yana fama da rashin lafiya mai tsanani kuma yana fama da matsalar numfashi.
Cibiyoyin Kula da Cututtuka da Rigakafin Amurka (CDC) sun lissafa alamun gaggawa; misali, wahalar numfashi, ciwon kirji mai tsawo ko matsi, rikicewar kwatsam, tashin hankali da fuska ko lebe; yana ba da shawarar neman magani nan da nan idan akwai alamun. Idan cutar ta ci gaba, za a iya haifar da ciwon huhu mai tsanani, ciwon numfashi mai tsanani, rauni, haɗarin haɗari, da mutuwa.
Wasu daga cikin waɗanda suka kamu da cutar ba su da alamun bayyanar cututtuka, ba su da alamun asibiti, amma sakamakon gwajin zai tabbatar da kamuwa da cutar, don haka masu bincike sun ba da shawarar cewa duk waɗanda suka yi hulɗa da mutanen da suka kamu da cutar za a kula da su sosai kuma a bincika su don kawar da yiwuwar kamuwa da cuta.
A kasar Sin, an kiyasta cewa yawan mutanen da ba su da alamun cutar zai kai kashi 44 cikin dari.
A cikin yanayi, lokacin farawa na ainihi (lokacin kamuwa da cutar daga bayyanar cututtuka) yana daga kwana 1 zuwa 14, yawanci kwanaki 5. Misali na rashin tabbas shine, yawan mutanen da ke da cutar COVID-19 da suka rasa ƙanshin ƙanshi ya fara daga kashi 30 cikin dari zuwa kashi 15 cikin dari.
Har yanzu ana neman wasu bayanai game da yadda cutar ta yadu.
An yi imanin cewa cutar tana yaduwa ne ta hanyar kusanci da kuma ƙananan raɗaɗɗen da aka samu ta hanyar tari, hancin ko magana, tare da kusanci tsakanin mita 1 zuwa 2 (daga 3 zuwa 6 feet).
A lokacin binciken, an gano cewa saukad da za su iya tafiya daga mita 4.5 (mita 15) zuwa mita 8.2 (mita 27), saboda tari ba tare da rufe bakinsu ba.
Wasu sun yi hasashen cewa za a iya kamuwa da kwayar cutar ta hanyar ƙananan ɗigon da ke fitowa daga bakinsu yayin magana, wanda zai iya zama a cikin iska na dogon lokaci. Ko da yake ba a samar da kwayar cutar a cikin iska ba, amma za a iya samar da ɗigon numfashi yayin numfashi, magana.
Za a iya shigar da waɗannan raƙuman a bakin mutane ko a hanci ko kuma a cikin huhu tare da numfashi.
Aikin likita kamar su intubation ko cardiopulmonary resuscitation na iya sa a yayyafa abubuwa masu yawa daga cikin numfashi kuma a yi amfani da iska.
Idan mutum ya taɓa wani abu mai gurɓataccen abu, har da fata, sannan ya taɓa idanunsa, hanci, ko baki, zai iya yaɗuwa.
Ko da yake akwai damuwa cewa ana iya yada shi ta hanyar fitsari, ana ganin cewa wannan yana da ƙananan hadari.
Gwamnatin kasar Sin ta yi watsi da yiwuwar kamuwa da cutar SARS-CoV-2 ta hanyar fitsari ko ta baki. Ko da yake ana iya yada cutar kafin bayyanar cututtuka da kuma a cikin wani lokaci na gaba, cutar ta fi dacewa a cikin kwanaki uku na farko bayan bayyanar cututtuka.
An samu mutane da suka yi gwajin da suka nuna cewa suna da cutar kwanaki uku kafin bayyanar cututtuka, kuma hakan na nuna cewa ana iya kamuwa da cutar kafin bayyanar cututtuka.
Akwai rahotanni kaɗan na lab da aka tabbatar da marasa cutar, amma binciken da aka yi game da hulɗa da wasu ƙasashe ya gano cewa akwai kamuwa da cutar ba tare da bayyanar cututtuka ba.
Cibiyar hana yaduwar cututtuka ta Turai ta ce ko da yake ba a san yadda cutar take yaduwa ba, amma mutum ɗaya yana iya cutar da mutane biyu ko uku, kuma yana iya tsira daga sa'o'i zuwa kwanaki a kan farfajiyar.
Musamman, an gano cewa za a iya gano kwayar cutar a kan filastik (polypropylene) da bakin karfe 304 har tsawon kwanaki uku, a kan kwali kwana ɗaya, da kuma a kan jan ƙarfe har tsawon awanni huɗu.
Amma, wannan na iya canzawa dangane da zafi da zafin jiki.
Kodayake jami'an Burtaniya sun ba da shawarar wanke hannu bayan hulɗa da wasu wurare kamar waɗanda mutane masu kamuwa da cutar suka taɓa, da kuma bayan hulɗa da dabbobi, babu wata hujja da ke nuna cewa dabbobi na iya yada kwayar cutar zuwa ga mutane.
Kwayar cutar coronavirus mai saurin numfashi mai saurin kamuwa da cuta 2 (SARS-CoV-2) wani sabon abu ne wanda aka fara warewa a Wuhan daga mutane uku da ke da cutar sankarar huhu da ke da alaƙa da rukunin masu cutar cutar numfashi mai saurin kamuwa da cuta.
Dukkanin halayen SARS-CoV-2 suna cikin duk wasu coronaviruses masu alaƙa da ke wanzu a cikin yanayi. A waje da jikin mutum, cutar ta mutu saboda sabulu na gida ya narkar da murfin kariya. SARS-CoV-2 yana da alaƙa da SARS CoV.
An yi imani cewa asalinsa dabba ne.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar ta Corona ta haɗu da nau'ikan da suka samo asali daga nau'ikan biyu, ciki har da nau'ikan betacoronavirus da subgenus serbicovirus (Lineage B).
Yana da daidaito na 96% tare da samfuran coronaviruses (BatCov RaTG13) na sauran masu rarrafe a matakin genomic.
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa bambancin amino acid guda daya ne kawai a wasu sassan jerin kwayoyin halittar da ke tsakanin kwayar cutar mai cin nama da kwayar cutar mutum.
A yau, an gano kashi 92% na kayan kwayar halitta a cikin kwayar cutar cuckoo da SARS-CoV-2 a cikin kwatancen kwayar halitta, wanda bai isa ya tabbatar da cewa cuckoo shine mai watsa shiri na tsakiya ba.
Ana iya gano cutar ta hanyar bayyanar cututtuka, amma ana iya tabbatar da cutar ta hanyar jujjuyawar jujjuyawar polymerase chain reaction (rRT-PCR) ko CT.
Nazarin kwatancen PCR da CT da aka yi a Wuhan ya nuna cewa CT, kodayake ba shi da daidaito, yana da ƙwarewa fiye da PCR, kuma yawancin halayen sa na hoto sun yi daidai da sauran cututtukan huhu da hanyoyin cuta.
A watan Maris na 2020, Kwalejin Kula da Radiyo ta Amurka ta ba da shawarar cewa kada a yi amfani da CT don gano COVID-19, ko kuma a yi amfani da shi azaman gwajin farko.
WHO ta fitar da dokoki da yawa na gwajin RNA game da SARS-CoV-2, na farko a ranar 17 ga Janairu.
Wannan gwajin yana amfani da halayen sarkar polymerase chain reaction (rRT-PCR) na lokaci na ainihi.
Ana iya yin gwajin ne ta hanyar yin amfani da jini ko kuma ta hanyar numfashi.
Sakamakon yana zuwa cikin sa'o'i da yawa zuwa kwanaki.
Ana yin wannan gwajin ne ta hanyar yin amfani da samfurin jini daga cikin hanci, amma ana iya yin amfani da samfurin jini daga cikin hanci.
Har zuwa 6 ga Afrilu, 2020, babu ɗayan waɗannan gwajin da ya tabbatar da daidaito don amincewa da amfani da yawa.
Wani gwajin jini da aka samar da kamfanin Cellax a Amurka an amince da shi ne kawai ta hanyar ingantattun dakunan gwaje-gwaje don amfani da gaggawa.
A cikin mutanen da ba su da alamun bayyanar cututtuka, ƙayyadaddun hotuna a kan radiographs da ƙirar ƙirar ƙira (CT) suna nuna rashin daidaitattun gilashin gilashin ƙasa da kuma rashin haɗin gwiwar.
Ana tattara bayanan kan layi na duniya game da sakamakon hoton da aka tabbatar da shi ta hanyar Radiological Society na Italiya.
Yin amfani da imaging don gano COVID-19 ba tare da tabbacin PCR ba saboda haɗuwa da kamuwa da cuta kamar adenovirus ba shi da tabbaci.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da PCR, kuma ya nuna cewa, ko da yake ba daidai ba ne, amma ya fi sauri da kuma saukin ganewa don gano kamuwa da cuta, kuma ya ba da shawarar yin la'akari da amfani da shi azaman kayan aikin bincike a yankunan da cutar ta yadu.
An haɓaka hanyoyin sadarwa na juyayi tare da radiographs da CTs bisa ga ƙwarewar kere kere don gano halaye na hoto na kwayar cutar.
Shirye-shiryen rigakafin cutar sun haɗa da kiyaye lafiyar mutum gaba ɗaya, wanke hannu, guje wa taɓa idanu, hanci, ko baki ba tare da wanke hannu ba, amfani da nama lokacin tari ko tari, da kuma zubar da nama kai tsaye.
An shawarci waɗanda suka riga sun kamu da cutar su sanya abin rufe fuska a wuraren jama'a.
An kuma bada shawarar kiyaye nesa ta jiki don hana yaduwar cutar. Gwamnatoci da yawa sun iyakance ko ba da shawarar balaguro daga wuraren da cutar ta bulla.
Amma, cutar ta kai matakin yaduwar jama'a a yankuna da dama na duniya.
Wannan yana nufin cewa kwayar cutar ta fara yaduwa a cikin al'umma kuma wasu ɓangarorin al'umma ba su san lokacin da suka kamu da cutar ba. Masu ba da kiwon lafiya waɗanda ke kula da wanda ke da cutar an ba da shawarar su kula da daidaitattun ƙa'idodi, kula da hulɗa da kula da idanu. Binciken mutanen da suka sadu da su shine hanya mai mahimmanci ga jami'an kiwon lafiya don gano asalin kamuwa da cutar da hana ƙarin kamuwa da cuta.
Amfani da bayanai na wurin da aka yi amfani da su ta wayar salula ta gwamnati don wannan dalili ya haifar da damuwa game da sirrin mutum, kuma Amnesty International da wasu kungiyoyi 100 sun ba da sanarwar hana irin wannan sa ido.
An aiwatar da aikace-aikacen hannu da yawa ko kuma an ba da shawarar yin amfani da su, kuma har zuwa 7 ga Afrilu, 2020, fiye da gungun masana dozin suna aiki akan zaɓuɓɓuka kamar amfani da Bluetooth don yin rajistar kusanci da mai amfani da ke riƙe da sirrinsa tare da sauran wayoyin salula.
Sa'an nan kuma masu amfani suna samun saƙo idan sun kasance kusa da mutumin da ya gwada tabbatacce na COVID-19. Rashin fahimta game da rigakafin kamuwa da cuta, misali, wanke hanci da goge hanci ba su da tasiri.
Babu allurar rigakafin COVID-19, kungiyoyi da yawa suna ƙoƙarin haɓaka allurar rigakafi.
Ana ba da shawarar wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu akai-akai da sabulu da ruwa na akalla sakan 20, musamman bayan sun je bayan gida ko idan hannayensu suna da datti, kafin cin abinci da kuma bayan hanci, tari, ko tari.
Dalilin shi ne, a waje da jikin mutum, kwayar cutar tana mutuwa ne ta hanyar sabulu na gida, domin sabulu na gida yana karya garkuwar kariya.
Idan ba a samun ruwa da sabulu, CDC ta ƙara ba da shawarar yin amfani da kayan aikin tsabtace hannu na barasa wanda ya ƙunshi aƙalla kashi 60% na giya.
WHO ta ba da shawarar kada a taɓa idanu, hanci, ko baki ba tare da wanke hannu ba.
Yawancin magunguna kamar su 62-71% ethanol, 50-100% isopropenol, 0.1% sodium hydrochlorite, 0.5% hydrogen peroxide, da 0.2-7.5% powidone-iodine na iya kawar da gurɓataccen farfajiya (za'a iya kashe farfajiyar bakin karfe ta amfani da maganin kashe cuta na minti daya kawai.)
Wasu magunguna kamar benzalkonium da crohexidine ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan akwai wanda ake zargi ko wanda aka tabbatar da cutar COVID-19 a cikin wani wuri kamar asibiti ko ɗakin kwana, to a kashe duk wasu na'urori kamar su Allunan, allon taɓawa, na'urorin sarrafawa na nesa da na'urorin ATM da ke amfani da marasa lafiya a cikin irin wannan yankin.
Ƙungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hancinsu da wani abu da ya yi kauri ko kuma wani abu da ya yi kauri sa'ad da suke yin tari ko kuma hancin su, kuma su zubar da abin nan da nan.
An ba da shawarar sanya abin rufe fuska na tiyata ga waɗanda ke da yiwuwar kamuwa da cutar, saboda sanya abin rufe fuska na iya iyakance adadin da kuma nisan tafiya daga raunin da ke gudana ta hanyar numfashi yayin magana, sneezing, ko tari.
Hukumar ta WHO ta ba da shawarwari kan lokacin da kuma yadda ake amfani da abin rufe fuska.
"Mask din zai iya rage yawan mutane da ke taɓa fuska, wanda shine babban tushen kamuwa da cuta idan ba a kula da lafiyar hannu ba", in ji Stephen Griffin, masanin ilimin cututtukan cuta na Jami'ar Leeds. "An kuma bada shawarar sanya abin rufe fuska ga masu kula da waɗanda ke da cutar".
WHO ta ba da shawarar cewa masu lafiya su sanya abin rufe fuska kawai idan suna cikin haɗari, misali waɗanda ke kula da waɗanda ke da cutar COVID-19, kuma sun yarda cewa sanya abin rufe fuska na iya taimakawa mutane su guji taɓa fuskokinsu.
Kasashe da dama sun fara karfafawa talakawa gwiwa su sanya abin rufe fuska.
CDC ta ba da shawarar yin amfani da abin rufe fuska na masana'anta a Amurka. China ta ba da shawarar yin amfani da abin rufe fuska na likita wanda za a iya zubar da shi a cikin jama'a, musamman ma a lokacin hulɗa da wasu mutane (1 mita (3 feet) ko ƙasa da haka).
Hong Kong ta ba da shawarar yin amfani da abin rufe fuska yayin amfani da sufuri na jama'a ko a wuraren da jama'a ke taruwa.
Jami'an kiwon lafiya na Thailand suna ƙarfafa mutane su yi takunkumin fuska a gida kuma su wanke su kowace rana.
Jamhuriyar Czech da Slovakia sun hana fita waje ba tare da sanya abin rufe fuska ba ko rufe hanci da baki.
A ranar 16 ga Maris, Vietnam ta nemi mutane su sanya abin rufe fuska a wuraren jama'a don kare kansu da sauran mutane.
Gwamnatin Austria ta sanya sanya abin rufe fuska a matsayin tilas a kantin sayar da kayan masarufi.
Isra'ila ta bukaci dukkan mazauna yankin da su sanya abin rufe fuska a wuraren taruwar jama'a.
Taiwan tana kera abin rufe fuska miliyan 10 a kowace rana tun tsakiyar watan Maris, kuma daga ranar 1 ga Afrilu, dole ne matafiya su sanya abin rufe fuska a jiragen kasa da bas na birni.
Panama ta sanya sanya abin rufe fuska a waje ya zama tilas kuma an ba da shawarar ga waɗanda ba za su iya sayan abin rufe fuska ba su yi a gida.
Ana amfani da abin rufe fuska a Japan, Koriya ta Kudu, Malaysia da Singapore.
Nisa nesa (wanda ake kira ma nisantar jiki) ya ƙunshi ayyukan sarrafa kamuwa da cuta waɗanda ke da nufin rage yaduwar cuta ta hanyar rage kusanci tsakanin mutane.
Hanyoyin sun hada da keɓewa, ƙuntatawa kan tafiye-tafiye da rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo ko cibiyoyin kasuwanci.
Mutane na iya aiwatar da wannan hanyar ta hanyar zama a gida, rage tafiye tafiye, guje wa wuraren taruwa, ba tare da taɓawa ba yayin gaisuwa, da kuma nisantar jiki daga wasu.
Gwamnatoci da dama sun ba da umarni ko kuma ba da shawarar nisantar zamantakewa a yankunan da cutar ta bulla.
Hukumomin gwamnatin Amurka da Ma'aikatar Lafiya sun rage adadin mutane da za su taru daga mutane 250 (idan ba a san yaduwar COVID-19 a yankin ba) zuwa mutane 50 sannan zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta hana mutane fiye da biyu taruwa a wuraren jama'a. CDC tana ba da shawarar cewa tsofaffi da waɗanda ke da takunkumin likita, watau cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Amfani da kalmar "rabuwa da jama'a" ya haifar da mutane su ware kansu gaba ɗaya daga juna ta wasu hanyoyi maimakon ƙarfafa su su kasance tare da juna. Wasu jami'ai sun ba da jagororin kiwon lafiya na jima'i a lokacin wannan annoba ta duniya.
Wannan ya haɗa da shawarwari game da yin jima'i da wanda kuke zama tare da shi wanda ba shi da cutar ko kuma wanda ba shi da alamun cutar.
An ba da shawarar cewa duk waɗanda aka gano suna da COVID-19 kuma waɗanda ake zargin suna da cutar su keɓe kansu a gida.
Hukumomin kiwon lafiya sun ba da shawarwari masu kyau game da yadda za a keɓe kai. Gwamnatoci da yawa sun ba da umarni ko kuma sun ba da shawarar keɓe dukan mutanen da ke zaune a yankunan da cutar ta bulla.
An ba da umarnin tsauraran matakan keɓewa ga waɗanda ke cikin rukunin haɗari.
An shawarci duk waɗanda suka iya kasancewa tare da mai cutar COVID-19 kuma waɗanda suka yi tafiya zuwa ƙasar da ke da cutar a kwanan nan ko yankin da ke da cutar ta ƙarshe su keɓe kansu na kwanaki 14 daga lokacin da suka kasance tare da su.
Maganin da za a iya bi wajen shawo kan cutar shi ne a hana ko kuma a hana yaduwar cutar.
Ana yin rigakafin yaduwa a farkon ɓarkewar cutar kuma ana nufin bin diddigin waɗanda ke da cutar, ware su, da kuma tsara matakan sarrafawa da allurar rigakafi don hana yaduwar cutar a cikin sauran jama'a.
Lokacin da ba za a iya hana yaduwar cutar ba, ana ɗaukar matakai don rage cutar: ana ɗaukar matakan rage saurin yaduwar cutar da kuma rage tasirinsa ga tsarin kiwon lafiya da al'umma.
Za a iya haɗa hanyoyin hana yaduwa da rage yaduwar cutar.
Don hana yaduwar, ana buƙatar ƙarin matakan kai tsaye kamar rage yawan maimaitawa na asali zuwa ƙasa da 1 ta hanyar jujjuya cutar ta duniya. Ana ƙoƙarin rage girman yaduwar cutar a matsayin ɓangare na tsarin cuta mai yaduwa wanda ake kira flattening the spread graph.
Wannan zai rage wahalar da ke tattare da kula da lafiya kuma zai ba da lokaci don samar da allurar rigakafi da magani.
Abubuwan da ba na likita ba waɗanda za su iya sarrafa ɓarkewar sun haɗa da hanawa da kuma ƙarfafa al'umma su yarda da abubuwan da ake yi kamar tsabtace hannu, sanya abin rufe fuska da keɓewa, rufe makarantu, hana taron jama'a, da kuma matakan kariya na mutum kamar tsabtace yanayin da ke kewaye da su. Don shawo kan ɓarkewar, China ta ɗauki matakai masu tsauri kamar keɓewar birni gaba ɗaya da tsauraran ƙa'idodi kan tafiye -tafiye.
Sauran ƙasashe ma sun ɗauki matakai don hana yaduwar cutar.
Koriya ta Kudu ta fara yin gwaji da keɓewa a gida kuma ta yi gargadin cewa za a kasance mai hankali game da motsin mutanen da ke da cutar.
Singapore ta ba da tallafin kuɗi ga waɗanda suka keɓe kansu kuma ta hukunta waɗanda ba su iya yin hakan ba.
Taiwan ta kara samar da takunkumin rufe fuska da kuma hukunta tarin kayan kiwon lafiya. Yin koyi da Burtaniya da Majalisar Dinkin Duniya, akwai manyan kalubale wajen rage yaduwar cutar (rage saurin yaduwar cutar, ba tsayawa ba) da kuma hana (juya yaduwar cutar).
Shirye-shiryen da suka dace don rage yaduwar cutar na iya rage yawan buƙatun kiwon lafiya da kashi biyu bisa uku, kuma rage mutuwar, amma har yanzu dubban mutane za su mutu, kuma hakan na iya haifar da matsin lamba ga tsarin kiwon lafiya.
Dakatar da yaduwar cutar ko hana ta na iya zama fifiko amma ya kamata a ci gaba da kiyaye shi har sai cutar ta yaɗu a cikin al'ummomin mutane (ko kuma har sai an sami allurar rigakafi, idan ta faru da farko), in ba haka ba, cutar za ta sake yaduwa bayan an sassauta matakan.
Tsawon lokaci na shiga tsakani don hana ko hana yaduwar annoba yana haifar da lalacewar tattalin arziki da zamantakewa.
Babu takamaiman maganin rigakafin cutar COVID-19 amma ana ci gaba da ƙoƙarin haɓaka shi wanda ya haɗa da gwajin magungunan da ake da su.
Shan magungunan sanyi da ake samu a kantin magani, shan ruwa, da kuma hutawa na iya taimaka wajen rage alamun.
Bukatar yin maganin oxygen, da kuma taimakon numfashi zai iya zama da tsanani.
Yin amfani da kwayoyin steroid zai iya sa sakamakon ya yi muni.
Ana gudanar da bincike kan wasu magunguna da aka riga aka amince da su don magance wasu cututtukan kwayar cuta na COVID-19.
WHO ta kuma ce "magungunan gargajiya da na gida" na iya sauƙaƙa alamun cutar SARS-CoV-2.
WHO ta ce gina iyawa da inganta kiwon lafiya ga masu cutar COVID-19 sune mahimman matakan magance cutar.
ECDC da WHO na Turai sun ba da jagororin don ɗaukar albarkatun da ake samu don asibitoci da sabis na farko na kiwon lafiya zuwa matakai daban-daban, gami da mai da hankali kan sabis na dakin gwaje-gwaje don gwajin COVID-19, soke hanyoyin madadin idan ya yiwu, ware marasa lafiya waɗanda suka gwada tabbatacce na COVID-19, da haɓaka ƙarfin kulawa ta hanyar horar da ma'aikata da haɓaka adadin masu amfani da iska da gadaje da ake da su, da sauransu.
Akwai ra'ayoyi da yawa game da inda aka gano farkon yanayin (wanda ake kira mai cutar Zero).
Ana iya gano farkon cutar ta novel coronavirus a ranar 1 ga Disamba, 2019 zuwa Wuhan, Hubei, China.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya karu a hankali.
An gano wasu mutane da ke fama da cutar sankarar bargo a ranar 26 ga watan Disamba kuma an kula da su a asibitin lardin Hubei ta hanyar Dr. Zhang Jixian, wanda ya shaida wa Wuhan CDC a ranar 27 ga watan Disamba.
A ranar 30 ga watan Disamba, wata ƙungiyar likitoci a asibitin Wuhan ta gargadi abokan aikinsu game da "SARS-Tatsum coronavirus".
Likitoci takwas, ciki har da Lee Wenling, sun sha gargadin 'yan sanda game da yada jita-jita, kuma wani, Mai Fan, ya sha gargadin manyan jami'anta game da irin wannan gargadin.
Hukumar birni ta Wuhan ta ba da sanarwar ga jama'a kuma ta sanar da WHO.
An ba da rahoton yawancin cututtukan cutar sankarar bargo ga jami'an kiwon lafiya a Wuhan, wanda ya haifar da fara binciken a farkon watan Janairu, wanda ke ninka adadin cutar kusan kowace kwana bakwai da rabi a farkon barkewar cutar.
A farkon da tsakiyar watan Janairu na 2020, saboda ƙaura da ke faruwa a lokacin Sabuwar Shekarar Sin, da kuma Wuhan, babban cibiyar sufuri da kuma babban wurin canzawa ko haɗuwa da jirgin ƙasa, cutar ta bazu zuwa sauran lardunan China.
A ranar 20 ga Janairu, kusan mutane 140 ne suka kamu da cutar a cikin kwana daya a kasar Sin, ciki har da biyu a Beijing da daya a Shenzhen.
Bayanai na baya-bayan nan sun nuna cewa mutane 6174 sun riga sun fara nuna alamun cutar a ranar 20 ga Janairu, 2020. A ranar 26 ga Maris, Amurka ta zarce China da Italiya a duniya a cikin adadin masu kamuwa da cutar. A ranar 9 ga Afrilu, 2020, an sami rahoton kamuwa da cutar miliyan 1.61, sama da mutane 97,000 sun mutu, kuma sama da 364,000 sun warke.
An samu aƙalla mutum ɗaya da ya kamu da cutar a ƙasashe da yankuna kusan 200.
Yayin da duniya ke jujjuyawa a Turai, ƙasashe da dama a yankin Schengen sun kafa takunkumi kan 'yancin motsi da kuma tsare kan iyakoki.
Amsoshin ƙasa sun haɗa da matakan hana yaduwa (manun zama a gida, umarnin zama a wurin da kuma kulle-kulle) da keɓewa. A ranar 2 ga Afrilu, kusan mutane miliyan 300 a Amurka, ko kuma kashi 90% na yawan jama'a suna cikin wasu nau'ikan kulle-kulle, sama da mutane miliyan 50 a Philippines, kusan mutane miliyan 59 a Afirka ta Kudu, da mutane biliyan 1.3 a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya suna cikin wani irin kulle-kullen, wanda ya karu zuwa biliyan 2.6 a cikin kwanaki biyu - wanda ya kai kashi ɗaya bisa uku na yawan mutanen duniya.
An gano farkon tabbataccen shari'ar COVID-19 a Wuhan kafin 1 ga Disamba, 2019, tare da wani ba a tabbatar da shi ba a ranar 17 ga Nuwamba.
An gano wani tarin cututtukan cutar huhu da ba a san dalilin su ba a ranar 26 ga watan Disamba, bayan da asibitin su ya sanar da Wuhan Jianghan CDC a ranar 27 ga watan Disamba.
Gwajin kwayar halitta na farko na samfurin marasa lafiya na 27 ga Disamba ya nuna kasancewar SARS-like coronavirus.
A ranar 31 ga Disamba, Hukumar Lafiya ta Wuhan ta ba da sanarwar sanar da jama'a.
An sanar da WHO a ranar.
Kamar yadda wannan sanarwar ta faru, likitoci a Wuhan sun sami gargadi daga 'yan sanda game da yada jita-jita game da barkewar cutar.
Hukumar Lafiya ta kasa ta kasar Sin ta fara da cewa babu wata hujja ta tabbatar da cewa cutar ta iya yaduwa daga mutum zuwa mutum.
A kwanakin Janairu, gwamnatin kasar Sin ta kaddamar da wani yunkuri na kawo karshen cutar, wanda daga baya Sakatare Janar na Jam'iyyar Kwaminis ta Sin, Xi Jinping ya bayyana a matsayin "yaƙin mutane" na dakile yaduwar cutar.
An sanar da jerin abubuwan tsabtace tsabtace abin da aka bayyana a matsayin "babban keɓewa a tarihin ɗan adam" a ranar 23 ga Janairu, wanda ya haifar da dakatar da tafiye-tafiye na ciki da na waje a Wuhan wanda daga baya aka faɗaɗa zuwa birane 15 na Hubei wanda ya shafi mutane miliyan 57.
An hana amfani da motoci masu zaman kansu a cikin birni.
An soke bukukuwan bikin Sabuwar Shekarar Sin (Janairu 25) a wurare da yawa.
Jami'an sun kuma sanar da gina asibitin wucin gadi mai suna Huseenshan Hospital, wanda aka kammala cikin kwanaki 10.
An gina wani asibiti don kula da ƙarin marasa lafiya, asibitin Lieshanshen.
Baya ga sabbin asibitocin da aka gina, China ta maida wasu wurare a Wuhan kamar cibiyoyin taro da wuraren wasanni zuwa asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta ɗauki ƙarin matakai don shawo kan barkewar COVID-19, gami da sanarwar kiwon lafiya ga matafiya da tsawaita hutun bazara.
An rufe jami'o'i da makarantu a kasar.
An kuma yi wasu matakai musamman a fannin makarantu da jami'o'i a Hong Kong da Macau.
An tsara hanyoyin aiki na nesa a wurare da yawa na kasar Sin.
An sanya takunkumi kan tafiye-tafiye na cikin gida da na waje a Hubei.
An yi canje-canje a tsarin sufuri na jama'a kuma an rufe gidajen tarihi na ɗan lokaci a duk faɗin ƙasar Sin.
An sanya takunkumin hana zirga-zirgar jama'a a birane da dama, kuma an kiyasta cewa mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci takunkumin hana zirga-zirga na waje. Lokacin da barkewar cutar ta kai duniya a watan Maris, jami'an kasar Sin sun dauki tsauraran matakai don hana cutar shiga kasar Sin daga wasu ƙasashe.
Misali, Beijing ta tilasta wa duk matafiya na duniya da ke zuwa birnin su keɓe kansu na tsawon kwanaki 14. A ranar 23 ga Maris, kawai wani mutum ne da ya kamu da cutar a cikin gida a cikin ƙasar Sin, wanda ya zo daga Istanbul zuwa Guangzhou kwanaki biyar da suka gabata.
A ranar 24 ga Maris, 2020, Shugaban China Li Keqiang ya ba da rahoton cewa yaduwar cututtukan da aka samu a cikin gida ya tsaya kuma annobar ta kasance a ƙarƙashin iko a China.
A wannan ranar, an sassauta takunkumin tafiye -tafiye a Hubei, ban da Wuhan, watanni biyu bayan aiwatar da dokar kulle. A ranar 26 ga Maris, Ma'aikatar Harkokin Wajen Sin ta sanar da cewa za a dakatar da ingancin biza ko masu riƙe da izinin zama bayan 28 ga Maris, ba tare da ba da takamaiman bayani game da lokacin da dakatarwar za ta ƙare ba.
Waɗanda suke son zuwa China dole ne su nemi a ofishin jakadancin China ko ofishin jakadancin.
Gwamnatin China ta karfafa sake buɗe kasuwanci da masana'antu a ranar 30 ga Maris, tare da ba da tallafin kuɗi ga masana'antu. Kwamitin Jiha ya sanar da cewa za a fara ranar makoki ta minti uku a duk faɗin ƙasar a ranar 4 ga Afrilu da ƙarfe 10 na safe. Duk da cewa wannan ranar ita ce ranar Qingming, gwamnatin tarayya ta nemi iyalai su nuna godiyarsu ta kan layi don hana sake barkewar COVID-19 ta hanyar nisantar jiki.
An tabbatar da yaduwar COVID-19 daga China zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020.
Hukumar Lafiya ta kasar ta bayar da rahoton karuwar adadin wadanda aka tabbatar da cutar a ranar 20 ga Fabrairu, wanda aka danganta ga taron sabon addini na Shincheonji Church of Jesus a Daegu.
An yi zargin cewa masu bautar Shincheonji da ke ziyartar Wuhan da ke Daegu ne suka haddasa barkewar cutar.
A ranar 22 ga Fabrairu, 1261 daga cikin mabiyan Cocin 9336, kimanin kashi 13 cikin 100 na masu cutar sun nuna alamun cutar.
A ranar 28 ga Fabrairu, an samu sama da mutane 2000 da suka kamu da cutar a Koriya, wanda ya karu zuwa 3150 a ranar 29 ga Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan gwajin da aka yi na gano cewa sojojin uku sun kamu da cutar.
Koriya ta Kudu ta fara wani shiri da ake ganin shine mafi girma a duniya da kuma mafi yawan shirye-shirye don gwada cutar a kan manyan mutane, ware waɗanda ke da cutar, gano su, da kuma ware waɗanda suka yi hulɗa da su.
Hanyoyin gwajin sun hada da shigar da masu shigowa cikin gida da kansu ta hanyar wayar salula, gwajin gwaji na motar, wanda ke nuna cewa ba za a iya samun sakamako ba, da kuma kara karfin gwajin wanda zai iya daukar mutane 20,000 a kowace rana.
An yi la'akari da shirin Koriya ta Kudu na samun nasarar shawo kan barkewar cutar ba tare da ware birane ba. An fara gabatar da shi ne a matsayin martani ga rikicin da Shugaba Moon Jae-in ya yi.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman tuhumar Moon ko kuma yabonsa saboda yadda gwamnatin kasar ta yi amfani da cutar.
A Koriya ta Kudu, an ba da rahoton cewa mafi ƙarancin adadin waɗanda aka ba da rahoton a cikin kwana ɗaya a cikin makonni huɗu ya kasance a ranar 23 ga Maris.
A ranar 29 ga Maris, an sanar da cewa daga ranar 1 ga Afrilu, duk masu shigowa daga ƙasashen waje za a keɓe su na tsawon makonni biyu.
A ranar 1 ga Afrilu, kafofin watsa labarai sun ruwaito cewa Koriya ta Kudu ta sami buƙatun daga ƙasashe daban-daban 121 don taimakawa gwajin kwayar cutar.
Iran ta ba da rahoton farkon tabbatar da cutar SARS-CoV-2 a ranar 19 ga Fabrairu, inda aka sami mutuwar daga baya a ranar, a cewar Ma'aikatar Lafiya da Ilimin Likita.
Matakan da aka fara sanar da su sun hada da soke kide kide da wake-wake da sauran al'adu, wasanni da sallar Juma'a, rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ware tiriliyan biyar na Riyal don yaki da cutar.
Shugaban kasar Hassan Rouhani ya ce a ranar 26 ga Fabrairu, 2020 cewa babu wani shiri na keɓewar yankunan da cutar ta shafa kuma za a keɓe mutane ne kawai.
An sanar da tsare-tsaren da za su rage tafiye-tafiye tsakanin birane, amma har yanzu ana ci gaba da zirga-zirgar manyan motoci tsakanin birane har zuwa bayan Sabuwar Shekarar Farisa.
A cikin watan Fabrairu, Iran ta zama cibiyar watsa cutar bayan China.
A yayin da ake ikirarin rufe yaduwar cutar a Iran, sama da kasashe 10 sun gano yawan wadanda suka kamu da cutar a Iran har zuwa ranar 28 ga Fabrairu, suna mai nuna cewa cutar ta fi yawan wadanda suka kamu da cutar 388 da gwamnatin Iran ta ruwaito a wannan ranar.
An dakatar da majalisar dokokin Iran a ranar 3 ga Maris, bayan da mambobin majalisar su 23 daga cikin 290 suka gwada tabbatacciyar cutar.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci jami'an gidan yarin na Iran da su saki wadanda suka yi adawa da cin zarafin bil'adama da suka kama saboda rashin jituwa, ba tare da wani sharadi ba, da kuma sake sauran fursunoni da suka cancanci hakan.
Ya kuma ce a wuraren da aka tsare mutane kamar cibiyoyin tsare mutane, inda babu isassun wuraren kiwon lafiya, akwai babban haɗarin yaduwar cutar.
A ranar 15 ga watan Maris, gwamnatin Iran ta sanar da mutuwar mutane 100 a rana daya, wanda ya kasance mafi girma a kasar tun lokacin da annobar ta barke.
A ranar 17 ga watan Maris, aƙalla 'yan siyasa da jami'an gwamnati 12 na yanzu ko na baya sun mutu.
Har zuwa ranar 23 ga Maris, ana samun sabbin mutane 50 a kowace awa da kuma mutuwa guda a kowane minti 10 a Iran.
Wani jami'in WHO ya ce akwai yiwuwar adadin wadanda suka kamu da cutar ya ninka na Iran sau biyar.
An kuma nuna cewa takunkumin da Amurka ta sanya wa Iran na iya shafar ikon tattalin arzikin kasar wajen magance barkewar cutar.
Babban jami'in kare hakkin dan adam na Majalisar Dinkin Duniya ya bukaci sassauta takunkumin tattalin arziki a kan wasu kasashe, ciki har da Iran, wadanda cutar ta fi shafa a duniya.
An tabbatar da yaduwar cutar a Italiya a ranar 31 ga Janairu, lokacin da matafiya biyu na kasar Sin suka gwada tabbataccen SARS-CoV-2 a Rome.
Yayin da adadin masu kamuwa da cutar ke ƙaruwa, gwamnatin Italiya ta dakatar da duk jiragen da ke zuwa da kuma zuwa China kuma ta ayyana dokar ta baci.
An gano wani gungu na marasa alaƙa na COVID-19 a Lombardy a ranar 21 ga Fabrairu, wanda ya fara da 16 da aka tabbatar. A ranar 22 ga Fabrairu, Majalisar Ministocin ta ba da sanarwar sabon dokar hana fita don shawo kan barkewar cutar, wanda ya haɗa da keɓewar mutane sama da 50,000 a cikin 11 daban-daban gundumomi a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "Ba za a iya shiga ko fita daga yankin da aka yi wa barazanar ba".
An riga an ba da umarnin dakatar da ayyukan aiki da wasanni a yankin. "A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i saboda mutuwar mutane 100 a Italiya. "
Duk manyan wasannin wasanni, ciki har da wasannin kwallon kafa na Serie A, za a gudanar da su a cikin gida har zuwa watan Afrilu, amma an dakatar da duk wasannin wasanni a ranar 9 ga Maris na akalla wata daya.
A ranar 11 ga Maris, Firayim Minista Kante ya ba da umarnin rufe kusan dukkanin kasuwancin, ban da manyan kantuna da kantunan magunguna. A ranar 6 ga Maris, Kwalejin Italiya ta Anesthesia, Anesthesia, Recessing da Intensive Care (SIAARTI) ta ba da shawarar ƙa'idodin likita waɗanda ke ba da shawarar kiyayewa yayin kula da cutar.
A ranar 19 ga watan Maris, Italiya ta zarce kasar Sin a matsayin kasar da ta fi kowacce mace-mace a duniya da cutar korona, inda ta yi rahoton mutuwar mutane 3,405.
An ruwaito cewa a ranar 22 ga watan Maris, Rasha ta aika da jiragen sama tara na soja zuwa Italiya dauke da kayan aikin kiwon lafiya.
A Italiya, an samu mutane 128,948 da suka kamu da cutar a ranar 5 ga watan Afrilu, mutane 15,887 sun mutu, kuma mutane 21,815 sun warke, kuma mafi yawansu sun kasance a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa yawan tsofaffin mutanen Italiya da rashin iya yin gwajin duk waɗanda suka kamu da cutar a yau na iya haifar da babban adadin mutuwa.
Amsar da Burtaniya ta bayar game da cutar ta kasance mafi sauki a cikin sauran ƙasashe da suka kamu da cutar, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya kowane irin keɓewa na zamantakewa ko keɓewar jama'a a kan 'yan ƙasa ba.
A sakamakon haka, an soki gwamnati da rashin sanin saurin da kuma tsananin amsa matsalolin da mutane ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar ba da shawara kan kauce wa duk tafiye-tafiye marasa mahimmanci da hulɗar jama'a, yana ba da shawarar mutane su yi aiki daga gida idan ya yiwu, kuma su guji wuraren shan giya, gidajen cin abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta sanar da cewa duk wuraren nishaɗi kamar shagunan giya da wuraren motsa jiki za a rufe su da wuri-wuri, kuma ta yi alƙawarin ba da kashi 80% na albashin ma'aikata har zuwa £ 2,500 a kowane wata don kauce wa rashin aikin yi a lokacin rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da ƙarin tsauraran matakan nisantar zamantakewar jama'a, wanda ya haɗa da haramta haɗuwa da mutane fiye da biyu, ƙuntatawa kan tafiya da aiki na waje kawai.
Wannan ya bambanta da yadda aka yi a dā, inda aka tilasta wa 'yan sanda su yi horo kuma a tarwatsa mutane.
An ba da umarnin rufe yawancin kasuwancin, ban da kasuwancin da aka ɗauka "mai mahimmanci" wanda ya haɗa da manyan kantuna, shagunan likitanci, shagunan kayan aiki, famfunan mai da garages.
An tabbatar da sanadin farko na COVID-19 a ranar 20 ga Janairu a cikin Pacific Northwest State na Washington a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rundunar White House ta yaki da cutar coronavirus a ranar 29 ga watan Janairu.
A ranar 31 ga Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya kuma ta sanya takunkumi kan shigowar matafiya daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka, babbar hukumar kiwon lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa ta haɓaka kayan gwajin kanta.
Duk da haka, ba a san ainihin yaduwar cutar ba saboda ƙananan gwajin da ake yi a Amurka.
Gwaje-gwajen sun kasance cikin matsala saboda rashin ingantattun kayan aikin gwaji da gwamnatin tarayya ta yi a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan aikin gwaji na ba da izini (wanda aka yi ta hanyar ilimi, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma ka'idojin da suka dace don mutane su cancanci yin gwaji (daga baya ya zama dole a umarci likita) har zuwa farkon Maris.
A ranar 27 ga watan Janairu, jaridar Washington Post ta ruwaito cewa an yi gwaje-gwaje kasa da 4,000 a Amurka.
Har zuwa 13 ga watan Maris, Atlantic ta ba da rahoton cewa an yi gwaji ƙasa da 14,000.
A ranar 22 ga Maris, kamfanin dillancin labarai na Associated Press ya ruwaito cewa, mutane da ke da alamun cutar da kuma umarnin likitoci na yin gwaji suna ɗaukar sa'o'i da kwanaki don yin gwaji. Bayan an sami mutuwar farko a Amurka a Washington a ranar 29 ga Fabrairu, Gwamna Jay Insley ya ayyana dokar ta baci a jihar, matakin da wasu jihohi suka bi.
An soke darussan a makarantun yankin Seattle a ranar 3 ga Maris, kuma a tsakiyar Maris, makarantu a duk faɗin ƙasar sun rufe. A ranar 6 ga Maris, 2020, masana a fannin cututtukan cuta na Kwalejin Imperial ta London sun ba da shawara ga Amurka game da yiwuwar abin da sabon coronavirus zai iya yi wa ƙasar.
A wannan ranar, Shugaba Trump ya sanya hannu kan Dokar Shirye-shiryen da Amsawa ta Coronavirus, wanda ya ba da tallafin gaggawa na $8.3 ga hukumomin tarayya don magance barkewar cutar.
Kamfanoni sun sanya takunkumin tafiye tafiye na ma'aikata, sun soke tarurruka, kuma sun karfafa ma'aikata suyi aiki daga gida.
An soke wasannin motsa jiki da kuma kakar wasa. A ranar 11 ga Maris, Trump ya sanar da takunkumin tafiye -tafiye na kwanaki 30 daga ranar 13 ga Maris, daga Burtaniya zuwa yawancin Turai.
Washegari, suka faɗaɗa takunkumin zuwa na United Kingdom da Ireland.
A ranar 13 ga Maris, ya ayyana dokar ta baci ta kasa, wanda ya samar da kudaden tarayya don magance matsalar.
A farkon ranar 15 ga watan Maris, kamfanoni da dama a fadin Amurka sun rufe ko rage awoyi don rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da cutar a duk jihohi 50 da gundumar Columbia. A ranar 23 ga Maris, an ba da rahoton cewa New York City tana da 10,700 na cutar coronavirus, wanda ya fi adadin mutanen Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce ya ga kamar nisantar jama'a na kawo sakamako, yayin da kimar ninka yawan masu kamuwa da cutar ta ragu daga kwanaki 2.0 zuwa kwanaki 4.7.
Har zuwa 28 ga Maris, New York City tana da mutane 32,308 da aka tabbatar da cutar, kuma mutane 672 sun mutu daga cutar. A ranar 26 ga Maris, Amurka ta ba da rahoton mafi yawan masu kamuwa da cutar coronavirus a duniya, ciki har da China da Italiya. Har zuwa 8 ga Afrilu, Amurka ta tabbatar da mutane 4,003,335 da suka mutu, tare da mutane 12,841.
Rahotanni na kafofin watsa labarai na ranar 30 ga Maris sun nuna cewa Shugaba Trump na Amurka ya tsawaita ka'idojin nesa da juna har zuwa ranar 30 ga Afrilu.
A wannan rana, jirgin asibiti mai ɗauke da gado 1,000, USS Comfort ya isa birnin New York.
A ranar 3 ga Afrilu, Amurka ta sami adadin mutuwar mutane 884 a cikin awanni 24.
Rahoton ya ce, "A watan Afrilu, adadin masu kamuwa da cutar a jihar New York ya zarce 100,000, kuma an soki fadar White House kan yadda take rage girman barazanar da kuma yadda take daidaita sanarwar jama'a da kuma sanarwar cutar ta hanyar sarrafa saƙonnin kai tsaye daga jami'an kiwon lafiya da masana kimiyya, tare da bin shugaban kasa Mike Pence.
Dukkanin tunanin gwamnatin Trump game da matsalar ya kasance mai tsaka tsaki da son zuciya.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayayyaki masu mahimmanci daga China, gami da kayayyakin kiwon lafiya masu mahimmanci.
An yi amfani da nazarin samfuran tafiye -tafiye na iska don gano yaduwar yaduwar kuma an buga a cikin tsakiyar Janairu a cikin Jaridar Tafiya ta Tafiya.
Ƙungiyar Jirgin Sama ta Duniya ta 2018 ta ba da rahoton cewa fasinjoji da ke tashi daga Wuhan zuwa Bangkok, Hong Kong, Tokyo da Taipei sun fi yawa.
An kuma ba da rahoton cewa Dubai, Sydney da Melbourne sune wuraren da mutane ke zuwa Wuhan.
Daga cikin shahararrun wurare 20, Bali an ba da rahoton cewa ita ce mafi rashin ƙarfi don magance kamuwa da cuta, yayin da biranen Austria suka ba da rahoton cewa su ne mafi ƙarfi.
Ya ce akwai sauran bincike game da COVID-19 kuma Australia za ta mai da hankali kan kula da iyakoki don sanar da amsarsu ga wannan annobar ta duniya.
An ayyana dokar ta-baci ta lafiyar dan adam a Australia a ranar 21 ga watan Maris.
Saboda yadda aka keɓe hanyoyin sufuri na jama'a a Wuhan da Hubei, ƙasashe da yawa suna shirin fitar da 'yan ƙasa da ma'aikatan ƙasashen waje daga yankin, musamman ta hanyar jirgin da aka yi rajista na ƙasarsu da kuma tare da yardar jami'an China.
Kasashen Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand sun kasance na farko da suka fara shirin kwashe 'yan kasarsu.
Pakistan ta ce ba za ta sake tura 'yan kasarta daga China ba.
A ranar 7 ga Fabrairu, Brazil ta kwashe 'yan ƙasar Brazil 34 ko danginsu, ciki har da' yan Poland 4, ɗan China 1 da ɗan Indiya 1.
'Yan ƙasar Poland, China da Indiya sun sauka a Poland inda jirgin Brazil ya tsaya kafin ya koma Brazil.
An killace mutanen Brazil da suka koma birnin Wuhan a wani sansanin soja da ke kusa da Brazil.
A wannan ranar, an kwashe 'yan Kanada 215 (mai lamba 176 daga jirgin farko da 39 daga jirgin na biyu da gwamnatin Amurka ta yi haya) daga Wuhan zuwa CFB Trenton don keɓewa na makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama mai dauke da 'yan Kanada 185 daga Wuhan ya sauka a CFB Trenton.
A ranar 3 da 4 ga Fabrairu, jami'an Australiya sun kai mutane 277 zuwa Cibiyar Kula da Tsibirin Kirsimeti, wanda aka sake mayar da shi cibiyar keɓewa, inda suka zauna na kwanaki 14.
Lokacin da jirgin da ke dauke da mutanen New Zealand ya isa Auckland a ranar 5 ga Fabrairu, fasinjojin da ke cikin jirgin (waɗansu daga cikinsu 'yan asalin Australiya ne da na Pacific) an killace su a sansanin sojan ruwa na Whangaporoa, a Arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe 'yan Amurkan da ke cikin jirgin ruwa mai suna Diamond Express.
Jirgin da ke dauke da fasinjoji 129 daga Diamond Princess ya sauka a Trenton, Ontario, a ranar 21 ga Fabrairu.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran. A ranar 14 ga watan Maris, jirgin South African Airways da gwamnatin Afirka ta Kudu ta amince da shi ya kwashe 'yan Afirka ta Kudu 112.
An gudanar da gwajin likita kafin a fitar da su, kuma an ajiye 'yan Afirka ta Kudu huɗu waɗanda ke nuna alamun cutar ta Corona don kiyaye haɗari.
Sai dai 'yan Afirka ta Kudu da suka yi gwajin ba su da lafiya ne kawai aka mayar da su gida.
Sakamakon gwajin ya saki dukkan 'yan Afirka ta Kudu, ciki har da ma'aikatan jirgin sama, ma'aikatan otal,' yan sanda da sojoji waɗanda ke cikin aikin jin kai, waɗanda suka zauna a wurin shakatawa na Ranch a ƙarƙashin kulawa da keɓewa na kwanaki 14 a matsayin matakin kariya.
A ranar 20 ga watan Maris, saboda annobar, Amurka ta fara janye dakarunta daga Iraqi.
A ranar 5 ga Fabrairu, Ministan Harkokin Wajen China ya bayyana cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Misira da Iran) sun aika da taimakon likita zuwa China.
Wasu daliban kasar Sin a jami'o'in Amurka sun hada kai da wani hadin gwiwa a Greater Chicago don tura taimako zuwa yankin da cutar ta shafa na kasar Sin, wanda aka ce kungiyar ta gudanar da aika kayan rufe fuska 50,000 N 95 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu. Kungiyar agaji ta Direct Relief, a cikin hadin gwiwa tare da FedEx, ta aika da kayan rufe fuska 200,000 tare da sauran kayan kariya na mutum kamar safofin hannu da sutura zuwa asibitin Wuhan Union a ranar 30 ga Janairu, ta hanyar jiragen sama na gaggawa.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun ba da gudummawar dala miliyan 100 ga WHO don tallafawa bincike kan allurar rigakafi da kuma kula da jama'a a Afirka da Afirka ta Kudu.
InterAxione ya ruwaito cewa a ranar 6 ga Fabrairu, gwamnatin China ta ba da gudummawar masks 200,000 ga Philippines bayan Sanata Richard Gordon ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kamfanin RedCrown na Singapore ya sanar da cewa zai tura tallafin dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan ɗaya zuwa Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da kayan aikin likita sama da tan 13 zuwa Wuhan, Malaysia ta sanar da bayar da gudummawar safar hannu na likita miliyan 18 zuwa China, Jamus ta ba da kayan aikin likita guda dubu 10, gami da tufafin kariya daga abubuwa masu haɗari, Amurka ta ba da gudummawar kayan aikin likita tan 17.8 zuwa China, tare da ba da tabbacin ƙarin dala miliyan 100 a matsayin taimakon kuɗi ga ƙasashen da abin ya shafa.
A watan Maris, China, Cuba da Rasha sun aika da kayayyakin kiwon lafiya da masana zuwa Italiya don magance barkewar cutar.
Jack Ma, wani dan kasuwa ya tura kayan gwaji miliyan 1.1 zuwa Addis Ababa, Habasha, da abin rufe fuska miliyan 6 da kuma kayan kariya 60,000 ga kungiyar tarayyar Afirka.
Daga baya suka aika da kayan gwaji 5,000 zuwa Panama, da abin rufe fuska 100,000, da kuma na'urorin motsa jiki biyar.
Ma ya kuma ba da gudummawar kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkey, Georgia da Jamhuriyar Czech sun nuna damuwa game da abin rufe fuska da kayan gwajin da aka yi da kasar Sin.
Misali, Spain ta kwashe kayan gwajin cutar korona na kasar Sin 58,000 wadanda suka nuna cewa sun samu kashi 30 cikin 100 na daidaito, yayin da Netherlands ta dawo da kayan rufe fuska na kasar Sin 60,000 da suka nuna cewa sun samu nakasa.
Belgium ta dawo da kayan rufe fuska 10,000 da aka yi zaton sun fito ne daga China amma na gaske daga Colombia.
A wani bangare kuma, tallafin da kasar Sin ke bayarwa ya samu karbuwa a yankunan Latin Amurka da Afirka. A ranar 2 ga watan Afrilu, Bankin Duniya ya fara ba da tallafin gaggawa ga kasashe masu tasowa.
WHO ta yaba wa jami'an kasar Sin kan kokarin da suke yi na shawo kan cutar.
WHO ta ba da rahoton bambancin da ke tsakanin barkewar cutar SARS a tsakanin 2002-2004 lokacin da aka zargi jami'an kasar Sin da yin ɓoye-ɓoye wanda ya haifar da matsaloli a ƙoƙarin hana cutar ta hanyar hana cutar, da kuma rikicin na yanzu inda gwamnatin tarayya ke ba da bayanai akai-akai don kauce wa fargaba a gaban Sabuwar Shekarar Hasken rana.
A martani ga shawarar da jami'an WHO suka yanke na hana zirga-zirga a Wuhan a ranar 23 ga Janairu, wakilin WHO, Gauden Galle, ya ce shawarar WHO ba ta dace ba kuma alama ce ta jajircewar da aka yi na kawo cutar a inda cutar ta fi yawa, yana mai kiran hakan "wani abin da ba a taɓa gani ba a tarihin kiwon lafiyar jama'a". Bayan tabbatar da kamuwa da cutar daga mutane zuwa mutane a China a ranar 30 ga Janairu, da kuma karuwar adadin cututtuka a wasu ƙasashe, WHO ta ayyana wannan annobar a matsayin gaggawa ta lafiyar jama'a ta duniya (IPHC), wanda shine na shida na duniya na cutar HIV da aka fara aiwatarwa a lokacin da aka fara aiwatar da shirin cutar a shekarar 2009.
Daraktan WHO Tedros Adhanom ya ce PHEYIC na da barazanar yaduwa a duniya, musamman a ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi inda tsarin kiwon lafiya ba shi da ƙarfi.
Da yake mayar da martani ga takunkumin tafiye -tafiye, Tedros ya ce "babu buƙatar ɗaukar matakan da ba dole ba waɗanda ke tsoma baki tare da tafiye -tafiye da kasuwancin duniya" kuma "WHO ba ta ba da shawarar sanya takunkumi kan kasuwanci da motsi".
A ranar 5 ga Fabrairu, WHO ta yi kira ga al'ummar duniya da su ba da tallafin dala miliyan 675 a matsayin kudade na shirye-shiryen shirye-shirye a ƙasashe masu ƙarancin kuɗi, kuma a cikin wannan, ta ga buƙatar tallafawa ƙasashe waɗanda ba su da tsarin gano mutanen da ke kamuwa da cutar, koda kuwa suna fuskantar farawar cutar.
Tedrosny ya ci gaba da bayyana cewa "mu masu karfi ne kamar yadda muke da mafi raunin sarkarmu" kuma ya bukaci al'ummar duniya da su "saka hannun jari a yau ko su biya karin gobe". A wani taron manema labarai da WHO ta yi a ranar 11 ga Fabrairu, ta sanya sunan cutar COVID-19.
A wannan ranar, Tedros ya ce Sakatare Janar na Majalisar Dinkin Duniya, António Guterres ya amince da cewa zai ba da ikon dukan tsarin Majalisar Dinkin Duniya don amsa.
Sakamakon haka, an kunna rukunin kula da rikice-rikice na Majalisar Dinkin Duniya kuma an ba shi damar daidaita duk amsar Majalisar Dinkin Duniya, wanda WHO ta ce zai ba su damar mai da hankali kan amsar kiwon lafiya da kuma amfani da ƙwarewar sauran hukumomi don magance tasirin zamantakewar jama'a, tattalin arziki da ci gaba.
A ranar 14 ga Fabrairu, an ƙaddamar da wani rukuni na haɗin gwiwa tare da China wanda WHO ke jagorantar don samar da ƙwararrun WHO da na duniya don taimakawa gudanar da gida a China da kuma kimantawa tare da gudanar da bita kan cutar da kuma yaduwar cutar da kuma tarurruka tare da manyan ƙungiyoyi a matakin ƙasa, da kuma ziyarar da za a yi zuwa yankunan birane da na karkara a matakin lardi da ƙasa don bincika tasirin ayyukan amsawa. A ranar 25 ga Fabrairu, WHO ta sanar da cewa "dole ne a yi aiki sosai don magance cutar ta kwayar cutar ta duniya da duniya za ta iya fuskanta" kuma duk da cewa duniya tana cikin yanayin annobar, ya kamata kasar ta kasance cikin shiri don cutar.
A cikin martani ga barkewar cutar a Iran, WHO ta aika da wani rukuni na haɗin gwiwa don bincika halin da ake ciki. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a ƙara yawan binciken cutar ta coronavirus a duniya daga "yawan" zuwa "yawan" zuwa matakin mafi girma na faɗakarwa da kuma gwajin haɗari.
A wata sanarwa, Darakta na gaggawa na shirin kiwon lafiya na WHO, Mike Ryan ya yi gargadin cewa lokaci ya yi da kowace gwamnati a duniya za ta yi nazari.
Ya kuma jaddada cewa, idan aka dauki matakan da suka dace, zai taimaka wa duniya ta guji mafi munin.
Ryan ya kara da cewa, bayanan da ake da su a yanzu ba su nuna cewa jami'an kiwon lafiya na duniya sun amince da sanar da cutar ba, kuma ya ce, yin hakan na nufin cewa, a zahiri, muna yarda cewa kowane mutum a duniya zai iya kamuwa da cutar.
A ranar 11 ga watan Maris, WHO ta ayyana barkewar cutar coronavirus a matsayin annoba ta duniya.
Darakta-Jami ya ce WHO na da "tashin hankali game da karuwar yaduwar cutar da kuma tsananin cutar da kuma matakin rashin aiki". An yi ta sukar WHO sosai saboda nuna rashin kulawar da aka yi da cutar ta duniya, wanda ya hada da jinkirin sanar da gaggawa ta kiwon lafiya da kuma rarraba cutar a matsayin cutar ta duniya.
Amsar da aka ba da ita ta haɗa da takardar neman a yi murabus daga mukamin Tedros Adhanom, Darakta-Janar na WHO, wanda mutane 733,000 suka sanya hannu a kai har zuwa ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, masana 'yancin bil'adama da dama sun yi kira ga girmama haƙƙin kowane mutum a lokacin annobar COVID-19.
Waɗannan masana sun ce kowa yana da 'yancin shiga tsakani da zai ceci ransa kuma wannan hakkin gwamnati ne.
Wannan rukunin ya nanata cewa rashin kayan aiki ko rashin inshorar lafiya ba za a iya amfani da su ba a matsayin hujja na nuna bambanci ga wasu mutane.
Masana sun jaddada cewa kowa yana da hakkin kiwon lafiya, wanda ya hada da masu nakasa, wadanda suka fito daga kananan kungiyoyi, wadanda suka kamu da cutar, wadanda suka rasa gidajensu, wadanda ke rayuwa cikin matsanancin talauci, wadanda ke cikin gidajen yari, da kuma wadanda suka nemi mafaka da sauran wadanda ba a bayyana su ba da bukatar taimakon gwamnati.
Hukumomin duniya suna magance tasirin tattalin arziki da zamantakewar rikicin COVID-19.
Kungiyar Tattalin Arziki da Ƙasa ta kafa dandamali da ke ba da cikakken bayani da kuma shawarwari game da shirye-shiryen amsawa a duniya.
Daga shirye-shiryen ƙarfafa tsarin kiwon lafiya da tattalin arziƙin duniya zuwa magance tasirin kulle-kulle da ƙuntatawa kan tafiye-tafiye, cibiyar dijital ta ƙunshi bin diddigin shirye-shiryen ƙasa, kuma tana da nufin taimakawa ƙasashe su koya daga juna da sauƙaƙe amsawar duniya mai daidaitawa ga ƙalubalen cutar ta corona.
Ministan Amurka, Ministan ofishin majalisar ministocin Burtaniya Michael Glove, da ɗan shugaban Brazil Jair Bolsonaro, Eduardo Bolsonaro, sun soki gwamnatin China kan yadda ta gudanar da harin duniya da aka kaddamar a lardin Hubei na kasar Sin.
An kori wasu jami'an jam'iyyar kwaminis ta kasar Sin (CPC) a matakin lardi saboda yadda suka gudanar da kokarin ware kai a tsakiyar kasar Sin, wanda ke nuna rashin jin dadinsu da yadda jam'iyyar siyasa ta kafa ta mayar da martani ga barkewar annobar.
Wasu masu sharhi sun ce manufar wannan matakin ita ce ta kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a game da barkewar cutar.
Wasu jami'an kasar Sin, kamar Zhao Lijian, sun yi watsi da cewa cutar ta COVID-19 ta samo asali ne daga Amurka ko Italiya, suna mai da hankali kan ka'idar da ta nuna cewa cutar ta fara ne daga Wuhan.
Gwamnatin Donald Trump ta Amurka ta kira kwayar cutar "kwayar cutar Sin" ko kuma "kwayar Wuhan" kuma ta ce "sirrin kasar Sin ya sanya cutar ta zama annoba ta duniya" wanda wasu masu sukar suka yi tir da cewa "ta kasa magance cutar".
Jaridar Daily Beast ta samu sakon waya daga gwamnatin Amurka wanda ke nuna cewa shirin yaudarar abokan gaba ne wanda ya samo asali ne daga taron tsaro na kasa da ke cewa shirin "yana da komai game da China".
Ana gaya mana mu yi ƙoƙari mu fallasa saƙon ta kowace hanya, kamar taron manema labarai da halartar talabijin, da dai sauransu. Kafofin watsa labarai kamar Politico, Foreign Policy da Bloomberg sun yi iƙirarin cewa ƙoƙarin aika taimako zuwa yankunan da cutar ta shafa na China ƙoƙari ne na yaɗa labarai don mamaye duniya.
Joseph Borel, shugaban manufofin kasashen waje na EU ya yi gargadin cewa, "yanayin siyasa na 'yanci' wani bangare ne na geopolitics wanda ya kunshi gwagwarmayar mulki.
Borel ya kuma ce, China tana aika saƙo da cewa ita ce abokiyar tarayya mai aminci fiye da Amurka.
China ta nemi Amurka ta dage takunkumin hana shigar Syria da Venezuela da Iran, kuma ta ce ta tura tallafi zuwa Venezuela da Iran.
An dakatar da taimakon Jack Ma na 10,000 na rufe fuska ga Cuba a ranar 3 ga Afrilu saboda takunkumin Amurka.
An kuma zargi jami'an Amurka da karkatar da tallafin da aka bai wa wasu ƙasashe zuwa ƙasarsu.
An kuma bayar da rahoton rikice-rikice game da abin rufe fuska a wasu ƙasashe, misali Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Bugu da kari, Turkiyya ta kwace daruruwan na'urorin motsa jiki da aka tura zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta zargi Tarayyar Turai da rashin nuna haɗin kai ga Italiya da ke fama da cutar.
Ma'aikatar Tarayyar Turai a Italiya Maurizio Massari ta ce "China ce kawai ta ba da amsa ta bangare biyu".
Hakika, wannan ba alama ce mai kyau ba ta haɗin kan Turai".
A wata tattaunawa ta tarho da Firayim Ministan Italiya Giuseppe Conte a ranar 22 ga watan Maris, Shugaban Rasha Vladimir Putin ya sanar da shirin sojojin Rasha na tura kayan aikin soja, motocin kashe wuka na musamman da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta yi magana game da wani "babban jami'in siyasa" da ba a san shi ba, cewa kashi 80 cikin dari na kayan agaji da Rasha ta aika ba su da amfani ko kuma ba su da amfani ga Italiya.
Majiyar ta zargi Rasha da gudanar da kamfen na "ta'addanci da kuma diplomasiyya".
Shugaban Lombardy Attilio Fontana da Ministan Harkokin Wajen Italiya Luigi Di Maio sun musanta rahoton kuma sun nuna godiya.
Rasha ta kuma aika da jirgin jigilar kayayyaki da ke dauke da kayan kiwon lafiya zuwa Amurka.
Dmitry Piskov, mai magana da yawun Kremlin ya ce, "A lokacin da yake ba da taimako ga abokan aikinsa na Amurka, [Putin] ya yi la'akari da cewa idan masu samar da kayan kiwon lafiya da kayayyaki na Amurka suka yi sauri, su ma za su biya daidai idan an buƙata. "
Za a yi shirin "Defender 2020" na NATO a cikin ƙananan ƙasashe kamar Jamus, Poland da Baltic, wanda shine babban taron NATO tun ƙarshen Cold War.
Sakatare Janar na Kamfen na Rashin Nukiliya Kate Hudson ya soki shirin Defender 2020: "A cikin rikicin kiwon lafiya na yanzu, wannan shirin ba kawai yana barazana ga sojojin Amurka da na wasu ƙasashen Turai ba, har ma da mazaunan ƙasashen da suke aiki". Gwamnatin Iran ta sami mummunan tasiri daga kwayar cutar kuma ta kamu da kusan 'yan majalisa dozin biyu, da kuma wasu manyan' yan siyasa na yanzu ko na baya.
Shugaban Iran Hassan Rouhani ya rubuta wasika ga shugabannin duniya a ranar 14 ga Maris, 2020 don neman taimako, yana mai cewa kasarsa tana fama da cutar saboda takunkumin Amurka da ke kan ta, wanda ya hana ta shiga kasuwannin duniya. Wannan annobar ta sa Amurka ta amince da tsarin zamantakewar da aka saba da shi a sauran kasashe masu arziki, wanda ya hada da Universal Health Care, Universal Child Care, hutun dangi mai biya, da kuma karin kudade ga lafiyar jama'a.
Masu sharhi a fannin siyasa sun yi hasashen cewa hakan zai yi tasiri a kan sake zaben shugaban kasa na Donald Trump a shekarar 2020.
Koriya ta Kudu ta soki "ƙoƙarin da ba a sani ba da kuma rashin aikin yi na Japan" lokacin da Japan ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu za a ware shi na makonni biyu a wuraren da gwamnati ta tsara.
Da farko dai al'ummar Koriya ta Kudu sun kasance masu tsaka-tsaki ko kuma sun ware kansu daga shugaban kasar Moon Jae-in a kan yadda ya amsa matsalar.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman a hukunta Moon ko kuma a yaba wa Moon saboda yadda gwamnati ta bi da annobar. Kasar na iya kafa dokar ta baci a matsayin martani ga wannan annoba ta duniya.
Wasu masu sukar sun nuna damuwa cewa wannan zai ba gwamnatoci damar da za su kara karfafa ikon su.
A Hungary, majalisar dokoki ta kada kuri'ar ba wa Firayim Minista Viktor Orban damar yin mulki har abada, ta soke majalisa da zaɓen, da kuma kafa gwamnatin da ke fuskantar ƙalubale, da kuma kafa waɗanda ake ganin suna yaɗa ƙarya game da cutar.
An zargi barkewar cutar ta Corona saboda abubuwa da yawa, gami da karancin kayayyaki, wanda ya samo asali daga karuwar amfani da kayan aikin rigakafin cutar a duniya, sayayya da aka yi firgita, da kuma katsewar masana'antu da sufuri.
Hukumar Abinci da Magunguna ta Amurka ta yi gargadin cewa akwai karancin magunguna da kayan aikin likita saboda karuwar bukatar mabukaci da kuma katsewar masu samar da kayayyaki.
An ga cewa an yi sayayya cikin tsoro a yankuna da yawa, kuma sakamakon haka, kayan masarufi kamar abinci, takardar wanka, da ruwan kwalba sun ɓace daga kantunan shaguna, kuma hakan ya haifar da karancin kayayyaki.
An gargadi masana'antun fasaha, musamman, game da jinkirin jigilar kayayyakin lantarki.
A cewar Tedros Adhanam, manajan daraktan WHO, bukatar kayan kariya ta mutum ya ninka sau 100.
Sakamakon wannan karuwar bukatar, farashin ya karu da ninki ashirin fiye da yadda ya saba, kuma ana jinkirta isar da kayayyakin kiwon lafiya har tsawon makonni hudu zuwa shida.
Hakan ya haifar da karancin kayan kariya na mutum a duniya, wanda WHO ta yi gargadin cewa zai iya sanya ma'aikatan kiwon lafiya cikin hadari.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu sayar da daigu su sayar da kayayyakin Australiya zuwa China.
Wannan ya haifar da karancin kayan abinci a wasu manyan kantuna, kuma daga baya gwamnatin Australia ta hana shi. Duk da yawan adadin COVID-19 da kuma bukatar abinci mai zuwa, arewacin Italiya da yankin Wuhan sun tsira daga matsanancin karancin abinci.
Tallafin da aka yi a kan ajiyar kayayyaki da kuma sayar da kayayyakin masarufi da aka yi a ƙasar Sin da Italiya ya yi nasara, kuma hakan ya hana a yi gagarumin ƙarancin abinci da ake tsammani a Turai da kuma Arewacin Amirka.
A arewacin Italiya, yawan amfanin gona bai ragu ba, amma masana'antu sun ce farashin zai iya ƙaruwa.
A Wuhan ma, lokacin da shaguna suka rasa abinci, ba a daɗe ba, sai ma'aikatan kasar suka buɗe taskar naman alade don ciyar da yawan jama'a.
A Italiya, ana da irin wannan dokar, kuma dole ne masu shuka abinci su ajiye abinci don irin wannan gaggawa.
Wani rahoto na kafofin watsa labarai na ranar 16 ga Maris ya nuna cewa tattalin arzikin China ya yi matukar rauni a farkon watanni biyu na shekarar 2020 saboda matakan da gwamnatin China ta dauka na hana yaduwar cutar, tare da rage tallace-tallace da kashi 20.5 cikin dari.
Kasar Sin, babbar tattalin arziki da cibiyar samar da kayayyaki, ana ganin barkewar cutar a matsayin babbar barazana ga tattalin arzikin duniya.
Agathe Demarris, na sashen bincike na tattalin arziki, ya yi hasashen cewa kasuwanni za su ci gaba da zama marasa ƙarfi har sai an ga sakamakon da zai iya zuwa.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa koma bayan tattalin arzikin duniya da cutar ta haifar zai iya wuce lokacin barkewar cutar SARS a 2002-2004.
Wani masani a jami'ar Washington da ke St. Louis ya kiyasta cewa za a yi amfani da dala biliyan 300+ a kan sarkar samar da kayayyaki a duniya, kuma za ta iya wucewa na shekaru biyu.
Kungiyar Kasashen Da Ke Fitar Da Man Fetur (OPEC) ta ce farashin mai ya yi rauni saboda raguwar bukatar da kasar Sin ke yi.
Kasuwannin hannun jari na duniya sun fadi a ranar 24 ga Fabrairu, sakamakon karuwar adadin COVID-19 a wajen babban yankin China.
A ranar 27 ga Fabrairu, saboda karuwar fargabar barkewar cutar coronavirus, wasu alamun hannun jari na Amurka, ciki har da NASDAQ-100, S&P 500 da Dow Jones Industrial Average, sun nuna raguwa mafi girma tun shekara ta 2008, inda Dow ta fadi da maki 1191, mafi girma a cikin kwana ɗaya tun bayan rikicin tattalin arzikin 2007-08.
Dukkanin alamomin uku sun rufe kasa da kashi 10 cikin dari a wannan makon.
A ranar 28 ga watan Fabrairu, kamfanin kimantawa na GMBH ya amince da kimantawar da kasar Sin ta yi, amma ya ci gaba da nuna rashin amincewa.
Kasuwanci sun sake faɗuwa a cikin tsoro na cutar coronavirus, mafi girma a ranar 16 ga Maris.
Mutane da yawa suna jin tsoron koma bayan tattalin arziki.
Masanin tattalin arziki Mohammed Al Ariyan ya yaba wa babban bankin kasar da kuma jihohi saboda matakan gaggawa da suka dauka a kan lokaci.
Babban bankuna suna amsawa da ƙarfi fiye da lokacin koma bayan tattalin arziki na 2008.
Yawon shakatawa shine mafi munin abin da ya faru yayin da aka dakatar da tafiye-tafiye, tare da rufe wuraren jama'a, gami da wuraren shakatawa, da kuma shawarwarin da gwamnatoci suka bayar game da ba tafiya ko'ina a duniya.
Sakamakon haka, kamfanonin jiragen sama da yawa sun soke zirga-zirgar su saboda rashin buƙata, gami da British Airways, China Eastern Airlines da Quantus, yayin da kamfanin jirgin sama na Burtaniya FlyBee ya rufe.
Tasirin masana'antar yawon shakatawa ya kai matakin da ba a taɓa gani ba.
An rufe tashoshin jiragen kasa da jiragen ruwa da yawa.
Cutar ta barke ne a lokacin hutun Sabuwar Shekara ta kasar Sin, wato Chunyang.
An soke taron jama'a da yawa daga gwamnatocin ƙasa da na gida, gami da bukukuwan Sabuwar Shekara na shekara-shekara, kuma kamfanoni masu zaman kansu sun rufe shagunan su da wuraren shakatawa kamar Hong Kong Disneyland da Shanghai Disneyland.
An rufe wasu abubuwan bikin Sabuwar Shekara da abubuwan jan hankali na yawon bude ido don hana taron jama'a, gami da garin Farbidden da kuma bikin al'adun gargajiya na Beijing.
A cikin larduna 24 daga cikin 31 na kasar Sin, hukumomi da yankuna sun tsawaita hutun sabuwar shekara har zuwa 10 ga Fabrairu, kuma sun umarci yawancin wuraren aiki da kada su bude har zuwa wannan ranar.
Wannan yanki na wakiltar kashi 80 cikin 100 na GDP na kasar da kuma kashi 90 cikin 100 na fitar da kayayyakin kasar.
Hong Kong ta kara yawan maganin cutar kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris, kuma ta soke bikin Sabuwar Shekara.
A Turai da Latin Amurka, adadin abokan cinikin da ke zuwa kantin sayar da kayayyaki ya ragu da kashi 40 cikin dari.
A Arewacin Amirka da Gabas ta Tsakiya, an samu raguwar kashi 50 zuwa 60 cikin ɗari.
Sakamakon haka, masu cin kasuwa a cikin manyan kantuna sun ragu da kashi 33 zuwa 43% a watan Fabrairu idan aka kwatanta da watan Maris.
Masu gudanar da cibiyoyin kasuwanci a duniya sun ba da ƙarin umarni kamar su tsaftace tsabta, sanya masu duba yanayin zafi, da soke abubuwan da suka faru. A cewar Hukumar Tattalin Arzikin Majalisar Dinkin Duniya don Latin Amurka, koma bayan tattalin arziki na duniya zai jefa mutane miliyan 14 zuwa 22 a Latin Amurka cikin matsanancin talauci fiye da yadda suke a lokacin da babu cutar.
A lokacin da annobar ta yi zafi a birnin Wuhan, kusan mutane miliyan biyar sun rasa ayyukansu a watan Janairu da Fabrairu.
Kusan ma'aikatan karkara na karkara miliyan 300 na kasar Sin sun makale a gida a lardunan cikin gida ko kuma a lardin Hubei. Sama da Amurkawa miliyan 10 sun rasa ayyukansu a watan Maris na 2020 kuma sun nemi taimakon gwamnati.
Bankin Tsaro na St. Louis ya kiyasta cewa annobar cutar coronavirus za ta iya janye ayyuka miliyan 47 a Amurka, tare da karuwar rashin aikin yi zuwa 32%. A Indiya, an rasa ayyukan dubun miliyoyin ma'aikatan baƙi na Indiya (waɗanda ke samun albashi a kowace rana) saboda kulle-kullen. Binciken da Angus Reed ya gudanar ya gano cewa kashi 44% na iyalai a Kanada sun sami wani nau'in rashin aikin yi. A Spain, kusan 900,000 sun rasa ayyukansu tun lokacin da aka fara kulle-kullen a tsakiyar Maris.
A cikin rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi taimakon rashin aikin yi na wucin gadi, kuma ma'aikata miliyan 1 na Burtaniya sun nemi tsarin bashi na duniya. A Jamus, kusan kamfanoni miliyan biyar sun tura ma'aikatansu zuwa ayyukan aiki na ɗan gajeren lokaci, wanda ake kira Kurabytes, wanda gwamnati ke tallafawa.
Faransa da Burtaniya sun amince da shirin biyan diyya na ɗan gajeren lokaci na Jamus.
Wannan annoba ta duniya ta yi tasiri sosai a kan fannonin fasaha da al'adun al'adu na gabatarwa, kuma ta shafi ƙungiyoyi da mutane - masu aiki da marasa aiki - a duniya.
Ƙungiyoyin al'adu da al'adu sun yi ƙoƙari su ci gaba da kamfen ɗin su (mafi yawan kuɗin da aka ba da kuɗi) wanda ya haɗa da ba wa al'umma damar sanin al'adun al'adu, kiyaye lafiyar ma'aikatansu a wuraren jama'a, da kuma tallafa wa masu fasaha a duk lokacin da zai yiwu.
A watan Maris na 2020, an rufe gidajen tarihi da dakunan karatu da wuraren baje kolin da sauran cibiyoyin al'adu a duk faɗin duniya har abada, kuma an soke ko kuma jinkirta nune-nunen su, abubuwan da suka faru, da kuma gabatarwar su.
A sakamakon haka, an yi ƙoƙari sosai don samar da sabis na madadin ta hanyar dandamali na dijital. Wani nau'in da ke raguwa a halin yanzu saboda cutar shine soke ayyukan addini, manyan wasanni da sauran abubuwan zamantakewa kamar kide kide da wake-wake, taron fasaha da nunin tufafi.
Har ila yau, masana'antar fim ta fuskanci matsala. Vatican ta sanar da cewa za a soke bikin mako na addini a Roma, wanda ya kasance a makon ƙarshe na lokacin tuba na Kirista na Lent.
Wasu majami'u suna ba da sabis na coci ta hanyar rediyo, watsa shirye-shiryen kan layi, ko talabijin, yayin da wasu majami'u ke ba da zaɓi na yin addu'a a cikin mota.
Yayin da yankunan da ke ƙarƙashin ikon Bishop na Roman Katolika ke rufe majami'unsu da ɗakunan su, kuma St. Peter's Square ya zama fanko, sauran ƙungiyoyin addini sun dakatar da ayyuka kuma sun iyakance taruwar mutane a cikin majami'u, masallatai, majami'u, wuraren ibada da gurus.
Ma'aikatar Lafiya ta Iran ta soke sallar Juma'a a yankin da cutar ta bulla kuma ta rufe bayan tarurrukan, yayin da Saudi Arabiya ta hana masu yawon bude ido na kasashen waje da mazauna yankin zuwa wuraren ibada na Makka da Madina.
Cutar ta haifar da rikice-rikice masu yawa a cikin jadawalin wasanni a duniya tun bayan yakin duniya na biyu.
An soke ko kuma an jinkirta manyan wasannin wasanni da yawa, ciki har da 2019-20 UEFA Champions League, 2019-20 Premier League, UEFA Euro 2020, 2019-20 kakar NBA da kuma 2019-20 kakar NHL.
Barkewar ta katse shirin gasar Olympics ta bazara ta 2020, wanda aka tsara a farkon watan Yuli; Kwamitin Olympic na International ya sanar a ranar 24 ga Maris cewa "za a sake tsara jadawalin abubuwan da za a yi bayan 2020, amma kafin lokacin bazara na 2021". An rufe gidajen caca da sauran wuraren caca a duniya, kuma an jinkirta ko soke wasannin karta.
Wannan ya sa 'yan caca da yawa suka fara yin caca ta yanar gizo, wanda ya haifar da ƙaruwa mai yawa a cikin sabbin masu shiga cikin shafukan caca ta yanar gizo.
Wasu manyan gidajen wasan kwaikwayo kamar su Broadway sun jinkirta gwajin su.
Wasu masu zane-zane sun gano hanyoyin da za su ci gaba da samar da zane-zane da kuma raba su a kan Intanet a matsayin madadin ga al'adun gargajiya na yau da kullun, kamar gabatar da wasan kwaikwayo na yau da kullun ko ƙirƙirar "bikin" na yanar gizo don masu zane-zane su gabatar, rarraba da kuma tallata ayyukansu.
An yi wasu labaran yanar gizo game da cutar korona, da yawa daga cikinsu suna da ban dariya da kuma jan hankali a cikin wannan yanayi na rashin tabbas.
Tun bayan barkewar COVID-19, akwai ƙiyayya da nuna bambanci da nuna bambanci da nuna bambanci tsakanin mutanen China da yankin gabashin Asiya da kuma masu sha'awar Turai, Amurka da sauran ƙasashe.
Musamman: An sami labarai na tsoro, shakka da kuma ƙiyayya a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amurka da yankin Asiya da Pacific.
Rahoton na watan Fabrairu (lokacin da mafi yawan shari'o'in har yanzu suna cikin China) ya nuna cewa jama'ar kasar Sin sun cancanci cutar ko kuma suna samun abin da ake kira fansa mai adalci.
Wasu kasashen Afirka ma sun ga karuwar adawa da kasar Sin.
Yawancin 'yan kasar Wuhan da Hubei sun nuna cewa an nuna musu wariya bisa ga asalin yankin.
Akwai tallafi ga mutanen China da kuma waɗanda ke cikin yankunan da cutar ta shafa, ta hanyar layi da wajen layi.
Mutane a Italiya, ƙasar Turai ta farko da ta fara fuskantar mummunan ɓarkewar COVID-19 bayan yaduwar cutar a cikin sabbin wuraren ci gaba, na iya zama masu ra'ayin mazan jiya da kuma jin tsoron jin tsoron jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin daɗin jin jin jin jin jin jin daɗin jin jin jin jin daɗin jin daɗin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin jin
A Japan, #ChineseDontKatuJapan ya zama babban batun tattaunawa a Twitter.
'Yan kasar Sin da sauran mutanen Asiya a Ingila da Amurka sun bayar da rahoton karuwar nuna wariya da kuma hare-hare.
Shugaban Amurka Donald Trump ya fuskanci suka saboda ambaton cutar coronavirus a matsayin "Cinese virus", wanda masu sukar ke daukarsa a matsayin mai nuna wariyar launin fata da kuma adawa da kasar Sin.
Masu zanga-zanga a Ukraine sun kai hari kan wata motar bas da ke dauke da 'yan kasar Ukraine da kuma 'yan gudun hijirar kasashen waje daga Wuhan zuwa Novi Sad.
Dalibai daga arewa maso gabashin Indiya, waɗanda ke zuwa daga yankin kan iyakar China kuma suna karatu a manyan biranen Indiya, an ba da rahoton cewa sun sami wahalar da ke tattare da barkewar cutar.
Shugaban Jam'iyyar Bharatiya Janata a West Bengal, Dilip Ghosh, ya bayyana cewa Sinawa sun lalata yanayi kuma "don haka Allah ya rama su".
Ofishin Jakadancin China a Kolkata daga baya ya yi tir da wannan sanarwar, yana mai cewa "rashin daidaito". A cikin kasar Sin, cutar ta haifar da tsoratar da mutanen da ba 'yan kasar Sin ba, inda ake bayyana baƙi a matsayin "ƙazantar da baƙo" kuma ana niyya don "sarrafawa".
Wasikun da ke da paywalls a yanzu sun cire wasu ko duk paywalls don kiyaye su daga cutar coronavirus.
Masu wallafa kimiyya da yawa sun ba da bincike game da fashewar a fili.
Wasu masana kimiyya sun zaɓi hanyar da za su iya raba sakamakon su cikin sauri a kan sabobin buga takardu kamar bioRxiv.
Cutar da ke tasowa - Cutar da ke tasowa ta hanyar ƙwayoyin cuta, sau da yawa ba a iya sanin ko za ta iya yaɗuwa ko kuma yadda za ta yaɗu.
Duniya da Cututtuka - Duniya da Cututtuka Suna Yaduwa
Jerin annoba da annoba - yawan mutuwar cututtuka masu yaduwa
Cinikin namun daji da cin naman alade - haɗarin kiwon lafiya da ke tattare da cinikin namun daji na musamman
Gwajin gwaji na cutar coronavirus na numfashi na 2019 (COVID-19) da kuma cutar SARS-CoV-2 masu alaƙa sun haɗa da hanyoyin da ke gano kasancewar kwayar cutar da kuma maganin rigakafi da aka samar a cikin martani na kamuwa da cuta.
Ana tabbatar da kasancewar kwayar cutar a cikin gwajin ta hanyar RT-PCR, wanda ke gano RNA na kwayar cutar.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano RNA na SARS-CoV-2.
Ana amfani da shi don gano cutar da ta riga ta faru ko kuma tana aiki.
Ana iya amfani da gwajin maganin rigakafi don duka biyun (ƙwayar cuta) da kuma kulawar yawan jama'a.
Gwajin maganin rigakafi na nuna yawan mutanen da ke da cutar, har da mutanen da ke da alamun cutar da ba su da yawa ko kuma marasa alamun cutar.
Sakamakon gwajin zai iya ba da cikakken bayani game da mutuwar cutar da kuma matakin rigakafin wani rukuni a cikin al'umma.
Saboda iyakancewar gwaji, babu wata ƙasa da ke da tabbataccen bayani game da yaduwar cutar a cikin al'ummarta har zuwa Maris 2020.
Babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawan jama'arta har zuwa 23 ga Maris, kuma akwai bambance-bambance masu yawa a cikin adadin gwajin da aka yi tsakanin ƙasashe.
Wannan canji na iya yin tasiri sosai a kan adadin mutuwar da aka ruwaito, wanda a wasu ƙasashe ba shi da ma'ana.
Ana iya yin gwajin ta hanyar amfani da ainihin lokacin jujjuyawar jujjuyawar polymerase chain reaction (RRT-PCR) akan samfuran numfashi da aka samo ta hanyoyi daban-daban, gami da samfurin nasopharyngeal swab ko samfurin hanci.
Sakamakon yakan kasance cikin sa'o'i kadan zuwa kwana biyu.
Gwajin RT-PCR na hanci da hanci yana da tabbaci a cikin makon farko na cutar.
Bayan haka, kwayar cutar za ta iya ɓacewa daga cikin makogwaro kuma ta ci gaba da ƙaruwa cikin hanzari a cikin huhu.
A cikin mako na biyu na gwajin, ana iya ɗaukar samfurin daga cikin iska mai zurfi ta hanyar catheter na tsotsa ko kuma ta hanyar yin amfani da kayan bayan tari.
A cikin Janairu 2020, an haɓaka ɗayan farkon gwajin PCR a Charity a Berlin wanda ke amfani da ainihin lokacin jujjuyawar jujjuyawar polymer (RRT-PCR) kuma ya kasance tushen saiti na gwaji 250,000 da Hukumar Lafiya ta Duniya (WHO) ta samar don rarrabawa.
A ranar 28 ga Janairu, 2020, kamfanin Kogenbiotech na Koriya ta Kudu ya haɓaka ingantaccen, PCR-based SARS-CoV-2 na'urar ganowa (Powercheck Coronavirus).
Gwajin yana gano kwayar "E" da aka raba ta duk kwayar cutar beta corona da kuma kwayar RdRp wacce ta kebanta da SARS-CoV-2. BGI Group na ɗaya daga cikin kamfanoni na farko da suka sami izinin gaggawa daga Hukumar Kula da Kayayyakin Kiwon Lafiya ta China don kayan aikin gano SARS-CoV-2 na PCR a China. Cibiyoyin Kula da Cututtuka da Rigakafi (CDC) a Amurka suna ba da isar da 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel ta hanyar Resurse na International.
Wani daga cikin uku na gwajin kwayoyin cuta a cikin tsofaffin sigogin gwajin ya haifar da sakamakon rashin daidaito kuma ya hana gwaji a CDC a Atlanta; sakamakon haka, an sami nasarar aiwatar da samfura ƙasa da 100 a kowace rana a cikin watan Fabrairu 2020.
Har zuwa 28 ga Fabrairu, 2020, gwajin da aka yi ta amfani da abubuwa biyu ba a ɗauka cewa ya tabbata ba, kuma har zuwa wannan lokacin ba a ba da izinin fara gwajin a dakunan gwaje-gwaje na jihar da na gida ba.
An amince da gwajin ta Hukumar Abinci da Magunguna a ƙarƙashin izinin amfani da gaggawa. Laboratoriyoyin kasuwanci a Amurka sun fara gwaji a farkon Maris 2020.
A ranar 5 ga Maris, 2020, Lab Corp. ya sanar da samuwar gwajin COVID-19 bisa RT-PCR a duk fadin kasar.
Hakazalika, a ranar 9 ga Maris, 2020, Quest Diagnostics ta samar da gwajin COVID-19 a duk faɗin ƙasar.
Babu wani iyaka da aka ayyana a kan adadi; dole ne a yi tarin samfura da sarrafa su daidai da bukatun CDC.
An haɓaka gwajin COVID-19 a cikin Rasha ta Cibiyar Nazarin Jiha ta Virology da Biotechnology Vector.
A ranar 11 ga Fabrairu, 2020, an yi rajistar gwajin ta hanyar sabis na tarayya don lura da kiwon lafiya. A ranar 12 ga Maris, 2020, an bayar da rahoton cewa Mayo Clinic ta haɓaka gwajin don gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ya sami amincewa daga FDA don gwajin da za a iya yi a cikin manyan awoyi 3.5, ta haka ne a ba da izinin injin guda ɗaya don yin kusan gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba Abbott Laboratories izinin gaggawa (EUA) don yin gwaji akan tsarin Abbott M2000; FDA ta ba da izini irin wannan a baya ga Hologic, LabCorp da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Safied ta samu EUA daga FDA don gwajin da zai ɗauki kimanin minti 45.
FDA ta amince da gwajin da ke amfani da fasahar isothermal nucleic acid amplification maimakon PCR.
Ba ya buƙatar jerin zafin jiki na zafin jiki, saboda haka wannan hanyar na iya ba da sakamako mai kyau a cikin ƙasa da minti biyar da sakamako mara kyau a cikin minti 13.
A halin yanzu, akwai kimanin na'urori 18,000 a Amurka, kuma Abbott yana sa ran haɓaka samarwa zuwa gwaje-gwaje 50,000 a rana. Gwajin da ke amfani da maganin rigakafi na monoclonal wanda ke ɗaure da furotin nucleocapsid (N) na Novel Coronavirus, wanda ake haɓaka a Taiwan, ana tsammanin zai ba da sakamako iri ɗaya kamar gwajin saurin mura a cikin mintuna 15 zuwa 20.
A cikin rahoton da aka yi a watan Maris na 2020, an kammala cewa "X-ray na kirji ba shi da amfani sosai wajen yin ganewar asali, yayin da CT [computed tomography] zai iya bayyana kafin bayyanar cututtuka".
Abubuwan da ke cikin CT sun haɗa da rarrabawar gefe mai banƙyama tare da bilateral multilobar ƙasa-gilashin opacification.
Yayin da cutar ke ci gaba, ana samun ci gaba da samun yankuna masu yawa, da kuma hawan hauka da kuma haɗuwa.
Nazarin kwatancen PCR da CT a Wuhan a asalin cutar ta yanzu ya ba da shawarar cewa CT, duk da rashin halaye na musamman, ya fi PCR mahimmanci saboda ya haɗa da yawancin siffofin sa na hoto da sauran cututtukan cutar pneumonia da na cuta.
A watan Maris na 2020, Kwalejin Kula da Radiology ta Amurka ta ba da shawarar cewa "ba za a yi amfani da CT ba a matsayin gwajin farko da za a yi don bincika ko gano COVID-19". CDC ta ba da shawarar PCR don fara bincike a farkon Maris na 2020.
Ana samar da maganin rigakafi tare da IgM da IgG a matsayin wani ɓangare na amsawar rigakafi ga kamuwa da cuta.
Ana iya amfani da waɗannan gwaje-gwajen don gano kamuwa da cuta, ƙayyade rigakafi, da kuma lura da yawan jama'a, a cikin kimanin kwanaki 7 ko kuma bayan bayyanar cututtuka, ana iya yin su a cikin dakin gwaje-gwaje na tsakiya (CLT) ko ta hanyar gwajin Point of Care (PoCT).
Yawancin dakunan gwaje-gwaje na asibiti za su iya yin wannan gwajin ta hanyar tsarin sarrafa kansa mai yawa wanda aka tsara ta hanyar wasu matakai a cikin lokaci, amma wadatar su zai dogara ne akan farashin samarwa ga kowane tsarin.
Ko da yake ana iya amfani da samfurori da yawa don gano amsawar rigakafi, ana amfani da samfurin jini guda ɗaya don CLT.
Ainihin tsarin POCT shi ne samun jini guda ɗaya ta hanyar huda fata.
Ba kamar hanyoyin PCR ba, ba a buƙatar cirewa kafin a bincika. A ranar 26 ga Maris, 2020, FDA ta bayyana sunayen abubuwa 29 waɗanda suka ba da shawara ga hukumar kamar yadda ake buƙata kuma saboda haka suna iya isar da gwajin rigakafin su.
A ƙarshen Maris 2020, EuroEmun Medical Laboratory Diagnostics da Epithom Diagnostics sun sami amincewa daga EU don kayan gwajin su, wanda zai iya gano IgG da IgA antibodies a kan yanayin cutar a cikin jinin.
Ana iya yin gwajin sau da yawa, ana iya yin gwajin daruruwan samfura a cikin 'yan sa'o'i, kuma wannan gwajin ya ninka gwajin PCR na gargajiya na RNA sau da yawa.
A farkon watan Afrilu, Ingila ta sami gwajin rigakafin da ba ta da isasshen amfani.
Hong Kong ta shirya wani shiri wanda a ciki marasa lafiya masu zargi za su iya zama a gida, "sashen gaggawa zai ba da samfurin tube ga mai haƙuri", su yi tsotsa a ciki, su aika da shi, kuma a wani lokaci za su sami sakamakon gwajin. NHS na Burtaniya ta bayyana cewa suna nazarin shirin farko na gwajin marasa lafiya a gida, wanda idan sun shiga asibiti, ba za su iya cutar da wasu ba ko kuma ba za a buƙaci a kashe wani mai amfani da motar asibiti ba.
A Jamus, a ranar 2 ga Maris, Ƙungiyar Likitocin Lafiya ta Ƙasa ta Ƙasa ta tabbatar da cewa suna da damar yin gwaji kusan 12,000 a rana a cikin tsarin tafiye-tafiye, kuma sun yi gwaji 10,700 a makon da ya gabata.
Idan likita ya ce a yi gwajin, asusun inshorar lafiya ne ke biyan kuɗin.
A cewar shugaban Robert Koch Institute, Jamus tana da damar yin gwaji 1,60,000 a kowane mako.
A ranar 19 ga Maris, an ba da gwajin a cikin manyan birane da yawa.
Ba a san adadin gwajin da aka yi a Jamus ba har zuwa 26 ga Maris, 2020, saboda an sami sakamako mai kyau kawai.
Binciken farko a cikin dakin gwaje-gwaje ya gano cewa aƙalla samfura 4,83,295 ne aka gwada har zuwa makon kalanda na 12/2020 da makon 12/2020, kuma 33,491 (6.9%) sun tabbatar da tabbatacce ga SARS-CoV-2. Masu bincike a asibitocin Technion da Rambam a Isra'ila sun haɓaka kuma sun yi amfani da hanyar yin gwajin marasa lafiya 64 a lokaci guda, wanda duk samfuran da aka tattara aka tattara su tare kuma an yi gwajin gaba idan samfurin ya tabbatar da tabbatacce. A ranar 5 ga Fabrairu, 2020, kamfanin BIO ya buɗe wani dakin gwaje-gwaje na gaggawa mai girman murabba'in mita 2,000 a Wuhan, wanda ake kira "Huo-han" (Chinese: ko Ingilishi "Temporary"), wanda zai iya aiwatar da samfuran sama da 10,000 a rana.
An gina shi cikin kwanaki 5 a ƙarƙashin kulawar Wang Jian, wanda ya kafa BGI, kuma wannan ƙirar ta nuna cewa idan ba a fara wannan ƙarfin gwajin ba a kan lokaci, Hubei zai sami ƙarin shari'o'i 47% kuma zai ninka farashin da ke tattare da sarrafa keɓewa.
An bi Wuhan a hankali ta hanyar Huayyan Labs a cikin birane 12 na kasar Sin, kamar su Shenzhen, Tianjin, Beijing da Shanghai.
A ranar 4 ga Maris, 2020, yawan gwajin yau da kullun ya kai 50,000. Tsarin buɗe tushen da aka buga ta Origami Asseed, wanda ke da ƙirar Multiplex, zai iya gwada samfuran marasa lafiya 1122 don COVID-19 ta amfani da gwaje-gwaje 93 kawai.
Har zuwa watan Maris, ƙarancin mai amsawa da isasshen isasshen abu sun kasance cikas ga gwaji mai yawa a cikin EU, UK da Amurka.
Wannan ya sa wasu marubuta suka fara gwadawa ta hanyar amfani da yarjejeniyar shirye-shiryen samfurin wanda ya haɗa da dumama samfuran zuwa 98 ° C (208 ° F) na mintuna 5 don sakin kwayar halittar RNA don ƙarin gwaji. An sanar a ranar 31 ga Maris cewa UAE yanzu tana yin gwaji don kwayar cutar coronavirus a cikin mutane fiye da kowace ƙasa a cikin yawan jama'arta, kuma tana kan hanyar haɓaka matakan gwaji don isa ga mafi yawan jama'a.
Wannan ya kasance tare da haɗin gwiwar drive-through da sayen ɗakunan gwaje-gwaje masu yawa daga Group 42 da BGI (bisa ga "Huo-Yan" na gaggawa na bincike a China).
An gina shi cikin kwanaki 14, wannan dakin gwaje-gwaje na iya yin dubban gwajin RT-PCR a kowace rana kuma shine na farko a duniya da aka yi irin wannan babban gwaji a wajen kasar Sin.
An haɓaka ayyukan gwaji daban-daban a cikin China, Faransa, Jamus, Hong Kong, Japan da Amurka waɗanda ke niyya ga ɓangarori daban-daban na bayanan kwayar cutar.
Hukumar Lafiya ta Duniya ta amince da matakin Jamus na tura kayan aikin ga ƙasashe masu ƙarancin kuɗi waɗanda ba su da albarkatun samar da nasu.
An buga aikin Jamus a ranar 17 ga Janairu, 2020; yarjejeniyar da Cibiyoyin Kula da Cututtuka na Amurka suka haɓaka ba ta kasance ba har zuwa 28 ga Janairu, wanda ya dakatar da gwajin da ke akwai a Amurka. A farkon barkewar cutar, China da Amurka suna da matsaloli game da amincin kayan gwajin, kuma waɗannan ƙasashe da Ostiraliya ba za su iya samar da isassun kayan aikin ba don biyan shawarwarin gwaji daga buƙatu da masana kiwon lafiya.
Akasin haka, samun isassun gwaje-gwaje a Koriya ta Kudu ya taimaka wajen rage yaduwar cutar Novel Coronavirus.
Gudanarwar Koriya ta Kudu ta gina babban ƙarfin gwaji a cikin dakin gwaje-gwaje na masu zaman kansu a cikin shekaru.
A ranar 16 ga Maris, WHO ta ba da umarnin a kara shirin gwaji a matsayin hanya mafi kyau ta rage yaduwar cutar ta COVID-19. Babban buƙatar gwaji saboda yaduwar kwayar cutar ya haifar da raguwar daruruwan gwaje-gwaje a dakunan gwaje-gwaje masu zaman kansu a Amurka, da kuma karancin wadatar swabs da magungunan sinadarai.
A watan Maris na 2020, China ta ba da rahoton matsaloli game da daidaito a cikin tarin gwajin su.
A Amurka, kayan gwajin da CDC ta haɓaka suna da "laifi"; daga baya gwamnati ta cire shingen da ke hana gwajin masu zaman kansu. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Co., Ltd., na China, amma an gano cewa sakamakon ba daidai ba ne.
Kamfanin ya bayyana cewa sakamakon ba daidai ba na iya zama sakamakon rashin samun samfuran ko rashin amfani da saiti yadda ya kamata.
Ma'aikatar Spain ta ce za ta dawo da saitin da aka ba da sakamakon da ba daidai ba kuma a maimakon haka za ta ba da saitin gwajin daban da Shenzhen Bioeci ya bayar. Jamhuriyar Czech ta ba da sakamakon kuskure a kashi 80% na saitin gwajin da aka saya daga China. Slovakia ta sayi saitin gwaji miliyan 1.2 daga China wanda aka gano ba daidai ba.
Firayim Minista Matovic ya ba da shawarar a zubar da waɗannan kayan aikin a Danube. Ates Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan aikin da Turkiyya ta saya daga China suna da "manyan kurakurai" kuma ba su "yi amfani da su ba". Burtaniya ta sayi kayan aikin gwaji miliyan 35 daga China amma ta sanar a farkon Afrilu 2020 cewa ba su dace da amfani ba.
Gwajin, da keɓewar marasa lafiya da suka gwada tabbatacce, da kuma bin diddigin waɗanda suka yi hulɗa da waɗanda suka sami tabbatacce na SARS-CoV-2, sun ba da kyakkyawan sakamako.
Masu bincike a garin Vô, wanda shine farkon mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje biyu a cikin kusan kwanaki goma a kan yawan jama'a 3,400.
Rabin mutanen da suka kamu da cutar ba su da wata alama kuma an ware su.
Ta hanyar hana mutane yin tafiya, an hana kamuwa da cutar gaba daya.
Tare da sa ido mai ƙarfi, ƙuntatawa kan tafiye -tafiye na cikin gida, gwaji da keɓewa, annobar cutar coronavirus ta 2020 a Singapore ta yi jinkiri sosai fiye da sauran ƙasashe masu tasowa, kuma ba a sanya takunkumi masu ƙarfi kamar rufe gidajen abinci da wuraren sayar da kayayyaki ba.
An soke ayyuka da yawa kuma Singapore ta fara ba da shawarar jama'a su zauna a gida tun daga ranar 28 ga Maris, amma makarantu sun sake buɗewa a ranar 23 ga Maris a lokacin da aka tsara bayan hutun.
Wasu ƙasashe da yawa kamar Iceland da Koriya ta Kudu sun gudanar da annobar ta hanyar sa ido kan hulɗa, hana tafiye -tafiye na cikin gida, gwaji da keɓewa, amma tare da ƙuntatawa.
Binciken ya nuna cewa ƙasashe da suka yi gwaji fiye da yadda suka yi mutuwar, suna da ƙananan mutuwar saboda sun iya gano mutane marasa ciwo ko marasa alamun cutar.
WHO ta ba da shawarar cewa ƙasashe waɗanda ba su da ƙarfin gwaji kuma waɗanda ke da ƙarancin ƙwarewar gwajin COVID-19 na ƙasashe su aika da samfuran COVID-19 na farko guda biyar masu kyau da na farko 10 masu ƙarancin gwaji zuwa ɗaya daga cikin dakunan gwaje-gwaje 16 da WHO ta ambata don tabbatarwa.
Daga cikin dakunan gwaje-gwaje 16 da aka ba da shawarar, bakwai suna Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amurka, ɗaya kuma a Ostiraliya.
Kasashen da suka kafa tsarin gwajin suna nuna yawan masu gwajin da suka nuna cewa suna da tabbaci.
Duk da haka, ko da kuwa akwai alamun cutar ko babu, za a sami kashi mai yawa na masu cutar idan aka kwatanta da ƙasar da ke gwada duk mazauna, wanda ke gwada waɗanda ke asibiti kawai.
Wanke hannu (ko wanke hannu), wanda ake kira tsabtace hannu, aikin wanke hannu ne da mutum yake yi da nufin kawar da datti, lubricant, microorganisms, ko wasu abubuwa marasa kyau.
Wanke hannu a lokatai masu wuya a rana zai iya hana yaduwar cututtuka da yawa, kamar zawo da kuma ciwon shan inna, wanda ke sa hannuna su shiga baki.
Mutane na iya kamuwa da cututtukan numfashi kamar su mura ko sanyi, alal misali, idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hanci, ko baki (watau, mucous membrane).
Muhimman lokatai biyar na rana da ya kamata a wanke hannaye da sabulu sune: kafin da bayan zuwa bayan gida, bayan wanke jariri ko canza sutura, kafin a shayar da jariri, kafin a ci abinci da kuma bayan dafa abinci, ko kafin da bayan sarrafa nama, kifi ko tsuntsaye.
Idan ba a samu ruwa da sabulu ba, za a iya wanke hannu da wuka, Hukumar Lafiya ta Duniya ta bada shawarar wanke hannu a lokutan da suka biyo baya:
Kafin a dafa abinci, a lokacin da ake dafa abinci, da kuma bayan an gama.
Kafin mu kula da wani da yake rashin lafiya da kuma bayan hakan.
Bayan an canja rigar ko kuma bayan an wanke kafafun yaro da ya je makaranta.
Bayan shan hanci, tari, ko kuma yin tari.
Bayan ka taɓa dabba, abincin dabba, ko kuma kwandon dabba.
Tsabtace hannu na likita shine al'adar tsabtace jiki da ke da alaƙa da hanyoyin kiwon lafiya.
Wanke hannu kafin a ba da magani ko kuma a yi jinya zai iya hana ko rage yaduwar cutar.
Babban manufar wanke hannu shine tsabtace hannu daga abubuwan da ke haifar da cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta da ke haifar da cuta) da kuma sunadarai masu cutarwa ko waɗanda ke haifar da cuta.
Wannan yana da muhimmanci musamman ga waɗanda suke sarrafa abinci ko kuma waɗanda suke aiki a fannin kiwon lafiya, amma yana da muhimmanci ga jama'a.
Wanke hannu yana da fa'idodi da yawa na kiwon lafiya, ciki har da rage yaduwar mura, kwayar cutar corona da sauran cututtukan da ke yaduwa; hana cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututttukan cututttukan cututttukan
Kuma ya haɗa da rage yawan mutuwar yara a cikin haihuwar gida.
Wani bincike na 2013 ya nuna cewa gyaran hanyoyin wanke hannu na iya haifar da ɗan ci gaba a cikin tsayin yara a ƙarƙashin shekaru biyar.
A ƙasashe masu tasowa, ana iya rage mutuwar yara da ke tattare da cututtukan numfashi da na farji ta hanyar sauya halaye masu sauƙi kamar wanke hannu da sabulu.
Wannan mataki mai sauki zai iya rage mutuwar mutane da kashi 50 cikin dari.
Matakan da ke inganta wanke hannu na iya rage yawan zawo da kusan kashi daya bisa uku, kuma yana iya zama daidai da samar da ruwa mai tsafta a cikin ƙananan masu samun kudin shiga.
48% na raguwar yawan zawo na iya danganta ga wanke hannu da sabulu. Wanke hannu da sabulu, wanda aka saba yi a gidaje, makarantu da al'ummomi a duniya, shine hanya mafi inganci da araha don hana zawo da cututtukan numfashi (ARI).
Ciwon huhu, wanda shine babban ARI, shine babban dalilin mutuwar yara 'yan kasa da shekaru biyar, wanda ke kashe kusan yara miliyan 18 a kowace shekara.
An kiyasta cewa guda miliyan 35 na yara suna mutuwa kowace shekara saboda zawo da ciwon huhu.
UNICEF ta ce, yin amfani da sabulu wajen wanke hannu kafin cin abinci da bayan wanka zai iya ceton rayuka fiye da duk wani allurar rigakafi ko kuma magani, yana rage mutuwar mutane da kashi biyu cikin dari da kuma cututtukan numfashi da kashi ɗaya cikin huɗu.
Ana haɗa wanke hannu tare da sauran ayyukan tsabtace jiki a matsayin ɓangare na ayyukan ruwa, tsabtace jiki da tsabta (wash).
Wanke hannu yana taimakawa wajen kare kai tsaye daga cutar Impetigo, wanda ke yaduwa ta hanyar saduwa ta jiki.
Wani mummunan sakamako na wanke hannu shine cewa yawan wanke hannu yana iya sanya fata ta bushe kuma ya cutar da fata.
Wani bincike da aka yi a Denmark a shekara ta 2012 ya nuna cewa yawan wanke hannu yana iya haifar da cututtukan fata kamar su itching da kuma zubar da hanci, wanda ake kira hand rash, ko kuma cututtukan fata, wanda ya fi yawa a tsakanin ma'aikatan kiwon lafiya.
Wanke hannu sau da yawa kuma ana ganin alama ce ta rashin tausayi na tunani (OCD).
Akwai lokuta biyar a rana inda ya kamata a wanke hannaye da sabulu don rage yaduwar cututtuka ta hanyar amfani da hannayena a baki: bayan zuwa gidan wanka (tashin jiki, fitsari), bayan wanke jariri (canja sutura), kafin a shayar da jariri, kafin a ci da kuma dafa abinci, ko kafin / bayan sarrafa nama, kifi ko kaji.
Sauran lokutan da ya kamata a bi da hanyoyin wanke hannu don hana yaduwar cutar sun hada da kafin da bayan kula da wani rauni ko wata raunuka; bayan tsotsewa, tari ko hanci; bayan taɓawa da kwandon dabba ko taɓawa dabba da sharar gida.
A ƙasashe da yawa, ba a wanke hannaye da sabulu sosai ba.
Wani bincike na 2014 ya nuna cewa Saudi Arabiya ce ke da kashi 95 cikin 100 na yawan masu wanke hannu, Amurka tana da kashi 77 cikin 100 na yawan masu wanke hannu, kuma China tana da kashi 23 cikin 100 na yawan masu wanke hannu. Wasu hanyoyin canza halayya yanzu suna nuna cewa wanke hannu da sabulu yana ƙaruwa a lokuta masu mahimmanci.
Shirin Kula da Kiwon Lafiya na Dole da Ma'aikatar Ilimi ta yi a Philippines misali ne na auna aikin don inganta lafiyar yara da ilimi.
Yin maganin kashe ƙwayoyin cuta sau biyu a shekara, tare da wanke hannuwanmu da sabulu kowace rana, da kuma goge haƙoranmu da fluoride, suna cikin muhimman abubuwan da ake yi a ƙasar.
An yi amfani da shi sosai a Indonesia.
Ana ƙara cire ƙwayoyin cuta daga fata ta hanyar amfani da sabulu ko ruwa mai tsabta.
Babban aikin sabulu da na'urar wankewa shine rage hana maganin da kuma kara narkewa.
Ruwa kaɗai bai isa ya tsabtace fata ba domin kitse da furotin da ke cikin ƙasa ba sa narkewa cikin ruwa nan take.
Duk da haka, ana yin tsabta ta hanyar iskar ruwa mai kyau.
Saboda yadda muke sake amfani da sabulu, akwai yiwuwar cewa sabulu mai yawa yana da kwayoyin cuta daga amfani da suka gabata.
Wasu nazarin da aka yi game da ƙaurawar ƙwayoyin cuta ta hanyar sabulu mai ƙwayoyin cuta sun kammala cewa ba za su iya ƙaura ba saboda ƙwayoyin cuta sun halaka ta hanyar kumfa.
CDC har yanzu tana cewa "Ya fi kyau a yi amfani da sabulu mai narkewa wanda ba a taɓa shi da hannu".
An yi amfani da sabulu mai maganin rigakafi sosai a cikin jama'a da suke da tabbacin lafiyarsu.
Har zuwa yau, babu wata hujja da ta nuna cewa ana amfani da maganin kashe ƙwayoyin cuta ko kuma maganin kashe ƙwayoyin cuta don maganin rigakafin ƙwayoyin cuta a yanayi.
Duk da haka, sabulu na maganin rigakafi yana dauke da abubuwan da ake kira antibiotics kamar trichlosan, wanda ke da jerin abubuwan da ke hana kwayoyin cutar.
Saboda haka, ba a zaɓi maganin rigakafin tashin hankali na ƙwayoyin cuta don sabulu na kashe ƙwayoyin cuta ba, amma ba zai iya zama mai tasiri kamar yadda aka ambata ba.
Baya ga masu amfani da fata da masu kare fata, ingantaccen tsari kamar masu daidaita pH na iya ƙunsar acid (acetic acid ascorbic acid, lactic acid), antibacterial mai aiki benzoic acid, da sauran masu sanyaya fata (kayan lambu, bitamin, menthol, tsire-tsire). Wani bincike mai zurfi da Jami'ar Oregon School of Public Health ta gudanar ya nuna cewa sabulu suna da tasiri wajen hana cututtuka da kawar da ƙwayoyin cuta kamar sabulu na yau da kullun na masu amfani da trichlosan.
Ruwan zafi, wanda yake da kyau a wanke hannu, bai isa ya kashe ƙwayoyin cuta ba.
Kwayoyin cuta suna girma sosai a zafin jiki (37° C).
Duk da haka, ruwan dumi ya fi ruwan sanyi da sabulu tasiri wajen kawar da man da ke tattare da ƙasa da ƙwayoyin cuta.
Duk da haka, akasin abin da mutane suke yi imani da shi, nazarin kimiyya ya nuna cewa ruwan dumi ba shi da tasiri wajen rage nauyin kwayoyin halittar da ke hannayenka.
Hand sanitizer ko kuma Hand antiseptic wani abu ne na tsabtace hannu wanda ba shi da ruwa.
A ƙarshen 1990s da farkon karni na 21st, kayan aikin tsabtace hannu marasa ruwa (wanda aka fi sani da alcohol-based hand rub, antiseptic hand rub, ko kuma hand sanitizer) sun fara zama sananne.
Yawancin su suna cikin nau'in gel tare da isopropyl alcohol ko ethanol da aka tsara tare da mai narkewa kamar carbomer (polymer na acrylic acid) ko a cikin ruwa mai laushi kamar glycerin, ko kuma a cikin kumfa don sauƙaƙe amfani da rage tasirin busassun giya.
Hanyar hydrogen peroxide tana ƙara aikin rigakafi. Aƙalla kashi 60 zuwa 90 cikin ɗari na barasa da ke cikin kayan tsabtace hannu yana kashe ƙwayoyin cuta.
Rub ɗin giya yana kashe ƙwayoyin cuta masu tsabta, ƙwayoyin cuta masu ƙin magani da yawa (MRSA da VRE), tarin fuka, da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, vaccina, influenza, da hepatitis) da fungi
Alcohol Rub Sanitizer yana da kashi 70% na barasa kuma yana kashe kashi 99.97% (rage log 3.5, daidai da rage decibel 35) da kuma kashi 99.99% zuwa 99.99% (rage log 4-5) na ƙwayoyin cuta a cikin minti ɗaya bayan an yi amfani da shi.
Maganin tsabtace hannu na tushen giya ba shi da tasiri sosai a kan ƙwayoyin cuta kamar norovirus (ko norvac), wanda shine mafi yawan dalilin cututtukan gastroenteritis. Ya kamata a yi amfani da maganin antiseptic mai yawa ko kuma ruwan shafawa na giya don tsabtace hannaye sosai.
Ka shafe gaba da baya na hannayenka biyu da kuma tsakanin dukkan yatsun hannu har zuwa ruwa, kumfa ko gel sand na kimanin dakika 30.
Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta Amurka ta ba da shawarar cewa idan kuna da ƙazantar hannu, ku wanke hannuwanku da maganin tsabtace hannu bayan wanka.
Amfani da waɗannan kayan yana ƙaruwa saboda sauƙin amfani da saurin kashe ƙwayoyin cuta; duk da haka, kada su zama maye gurbin wanke hannu yadda ya kamata idan sabulu da ruwa basu samuwa.
Yin amfani da na'urar tsabtace jiki ta hanyar barasa zai iya sa fata ta bushe, don haka ya kamata a yi amfani da kayan shafawa da / ko moisturizer.
Za a iya rage ko kawar da tasirin bushewar giya ta hanyar ƙara glycerin da / ko wasu masu laushi a cikin wannan tsari.
A gwaje-gwajen tiyata, masu tsabtace hannu na giya da ke dauke da emollients sun nuna cewa sun rage kumburi da bushewar fata fiye da sabulu ko magungunan maganin rigakafi.
Rashin jin daɗi na haɗuwa da cututtukan fata, ciwon hanta, ko kuma rashin jin daɗin shan giya ko kuma abubuwan da ke cikin hannu.
An gano cewa, idan aka kwatanta da wanke hannu da sabulu da ruwa, tuntuɓe mai saurin fushi yana da ƙarancin haɗarin haifar da cututtukan fata.
Duk da ingancin su, masu amfani da ruwa ba sa wanke hannayen kayan da aka yi da su, sai dai su kashe su.
Wannan shi ne dalilin da ya sa kayan wanke hannu ba su da tasiri kamar sabulu da ruwa wajen hana yaduwar kwayoyin cuta, domin kwayoyin cuta suna zaune a hannu.
Ingancin tsabtace hannu na ba da barasa ya dogara da yawancin abubuwan da aka tsara da kuma tsari, kuma ya wuce giya da barasa a tarihi.
Kwanan nan, dabaru masu amfani da benzalkonium chloride sun nuna ci gaba da kuma tarin maganin rigakafi, sabanin giya, inda aka nuna raguwar aiki bayan amfani da yawa, mai yiwuwa saboda ci gaba da mummunan halayen fata.
Mutane da yawa a cikin ƙananan al'ummomi ba su iya sayan sabulu ba, kuma suna amfani da toka da ƙasa.
Ash da ƙasa na iya zama mafi tasiri fiye da ruwa amma ba su da tasiri fiye da sabulu.
Wani abin damuwa shi ne, idan gurɓataccen abu ya shiga cikin ƙasa ko kuma toka, zai iya ƙara yaduwar cutar maimakon rage ta.
Kamar sabulu, ƙasa tana kashe ƙwayoyin cuta domin idan ta haɗu da ruwa, tana samar da wani maganin ƙanshi.
WHO ta ba da shawarar yin amfani da toka ko yashi a matsayin madadin lokacin da sabulu ba ya samuwa.
A cikin jerin hanyoyin da Cibiyar Kula da Cututtuka ta Amurka ta ba da shawarar don hana yaduwar cutar, wanke hannu ya ƙunshi waɗannan matakan:
Ruwan ruwa mai dumi ko ruwan zãfi.
Ana ba da shawarar ruwa mai gudana saboda tafkuna masu tsayawa na iya zama masu gurɓataccen abu, kuma yanayin zafin ruwan bai nuna bambanci ba.
Ka sanya sabulu mai yawa a hannunka, ka shafa a bayan hannunka, tsakanin yatsanka, da kuma ƙarƙashin ƙusa.
Sabulu yana kawar da kwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu sosai idan suna amfani da sabulu fiye da ruwan wanki.
Ka yi wanka na akalla sakan 20.
Yin tsotsa yana haifar da ƙyama, wanda ke kawar da ƙwayoyin cuta daga fata, kuma tsotsa na dogon lokaci yana kawar da ƙwayoyin cuta da yawa.
Ka wanke hannunka a ƙarƙashin ruwan da ke gudana.
Wanke hannu a cikin tafki na iya sake gurɓata hannayen.
Ka wanke hannunka da tawul mai tsabta ko kuma ka bar shi ya bushe.
Hannun da suka yi zafi da kuma mai laushi suna da saurin gurɓata. Yatsun hannu, wuyan hannu, tsakanin yatsun hannu, da kuma ƙusa sune wuraren da aka saba cirewa yayin wanke hannu.
Na'urar sanya ƙusa da kuma goge goge na'urar na iya zama mafaka ga ƙwayoyin cuta.
Ana yawan ba da shawarar yin amfani da man shafawa don hana hannuwan bushewa; bushewar fata na iya lalata fata wanda zai iya ƙara haɗarin kamuwa da cuta.
Za a iya yin zaɓuɓɓuka masu tsada don sauƙaƙe wanke hannu a wuraren da babu ruwan famfo da / ko sabulu, misali, idan ya cancanta a cikin ƙasashe masu tasowa, zuba ruwa tare da ramuka masu dacewa da / ko amfani da toka daga jingina ko gwangwani. A cikin yanayin da ke da iyakancewar samar da ruwa (kamar makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai zaɓuɓɓukan kiyaye ruwa kamar "Tippy Taps" da sauran zaɓuɓɓukan farashi.
Tape tap wani fasaha ne mai sauki da ake amfani da shi wajen zuba ruwa a kan hannu da sabulu, wanda ake rataye da igiya a kan wani gwangwani da kuma wani abin motsawa da za a iya motsawa da ƙafa.
Yin bushewar hannu yadda ya kamata wani muhimmin bangare ne na tsabtataccen aikin, amma akwai ɗan muhawara game da mafi ingancin bushewa a cikin gidan wanka na jama'a.
Ƙaruwar bincike ya nuna cewa tawul ɗin takarda sun fi tsabta fiye da na'urar bushe hannu na lantarki da ake amfani da ita a cikin ɗakunan wanka.
Wani bincike da aka gudanar a shekarar 2008 da jami'ar Westminster ta London da kuma wanda aka shirya ta European Tissue Symposium, masana'antar takarda, ya kwatanta matakin tsabtace da takarda ke bayarwa, da na'urar bushe hannu mai amfani da iska mai zafi da na'urar bushe hannu mai amfani da iska mai iska.
Bayan an wanke hannayenka da bushewar iska, an ga cewa adadin kwayoyin cuta a kan yatsunsu ya karu da kashi 194 cikin dari, kuma a kan tafki, ya karu da kashi 254 cikin dari.
Bayan an bushe su da na'urar busar iska, adadin kwayoyin cuta a yatsunsu ya karu da kashi 42 cikin dari, kuma a kan kafafu ya karu da kashi 15 cikin dari.
Bayan wanke hannu da bushewa da tawul ɗin takarda, adadin ƙwayoyin cuta a kan yatsunsu ya ragu da kashi 76 cikin ɗari, kuma a kan kwanon rufi ya ragu da kashi 77 cikin ɗari.
Jirgin iska mai bushewa wanda ke fitar da iska daga cikin naúrar a cikin saurin mita 180 a sakan (650km / h; 400Mph), yana iya hura kwayoyin cuta daga hannu da naúrar kuma ya gurɓata masu amfani da ɗakin wanka da yanayin wanka har zuwa mita 2.
A cikin na'urar bushewa mai zafi, ƙwayoyin cuta suna iya shiga cikin na'urar bushewa har zuwa mita 0.25 daga cikin na'urar.
Babu wani abu da ya nuna cewa takarda takarda ta ba da izini. A cikin 2005, binciken da TUV Produkt und Umwelt ya gudanar ya kimanta hanyoyi daban-daban na juya hannu.
Bayan an bushe hannu, an ga wasu canje-canje a yawan ƙwayoyin cuta:
Akwai masana'antun bushe hannu da yawa, kuma an kwatanta bushe hannu da bushewa da tawul.
A lokacin tafiya, idan sabulu da ruwa ba su samuwa, wanke hannu yana da wani zaɓi na wanke hannu.
Dole ne mai tsabtace hannu mai barasa ya kasance aƙalla kashi 60 cikin ɗari na barasa.
Wanke hannu ya zama dole a asibiti bayan likitan Hungary Ignaz Semmelweis ya gano tasirinsa don hana cututtuka a cikin yanayin asibiti (a cikin 1846).
Akwai na'urorin lantarki da ke tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya nuna cewa amfani da su ya rage yawan kamuwa da cuta.
Wanke hannu na likita yana da tsawon mintuna 15 wanda ya ƙunshi yin amfani da sabulu mai yawa da ruwa ko kuma gel, da kuma wanke kowane ɓangare na hannu.
Ya kamata a haɗa hannayenka a cikin juna kuma a yi su tare.
Idan akwai datti a cikin kusoshi, za a iya amfani da buroshi na bristle don cire shi.
Yana da muhimmanci a wanke hannayenka kuma a goge su da tawul mai tsabta domin ruwa na hannayenka na iya zama kwayoyin cuta.
Bayan an bushe, ka yi amfani da takarda don rufe ruwa (kuma ka buɗe ƙofar fita idan ya cancanta)
Wannan zai hana hannayenku daga sake gurɓata su.
A kiwon lafiya, manufar wanke hannu shine kawar da kwayoyin cuta ("kwayoyin cuta") da kuma hana su yaduwa.
Jaridar New England Journal of Medicine ta ruwaito cewa rashin wanke hannu ya zama abin ƙyama a yawancin yanayin kiwon lafiya, inda yawancin likitoci da ma'aikatan jinya suka manta da wanke hannu kafin su taɓa marasa lafiya, kuma hakan yana haifar da kamuwa da ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da kuma wasu ayyuka masu sauƙi na iya rage kamuwa da cututtukan da ke tattare da catheter da kashi 66 cikin dari.
Za a iya samun takardar jagora ta hukumar kan tsaftace hannu a shafin yanar gizon su don ra'ayoyin jama'a.
Whitby da sauransu sun tsara bita game da wannan.
Idan ana buƙatar nunawa na yau da kullun, kayan aikin kasuwanci na iya auna da inganta tsabtace hannu.
Hukumar Lafiya ta Duniya ta ba da "lokaci biyar" game da wanke hannu:
Idan jini ya yi magana da wani abu a jikin mutum
Kafin a yi aikin kashe ƙwayoyin cuta,
Bayan kulawar mai haƙuri. Idan sabulu ya cika da sinadarai masu kashe ƙwayoyin cuta ("magani" ko "antibacterial" sabulu) saurin kashewa a cikin ruwan wanke hannu.
Ana iya buƙatar kashewa kafin tiyata ko a wuraren da ke da ƙwayoyin cuta masu ƙin rigakafi, bututun da za a iya kunnawa da kashewa ba tare da taɓa hannu ba don 'shafe' hannu don motsawa, wanka na chlorhexidine ko iodine, tawul ɗin kashe ƙwayoyin cuta don bushewa bayan wanke hannu, da goga mai tsabta don shafawa, da sauran kayan tsabtace ƙafa don tsabtace yatsunsu.
Dole ne a cire duk kayan ado.
Don wannan aikin, ana buƙatar wanke hannu da wuyan hannu daga kusurwa zuwa kusurwa na tsawon minti 2-6.
Ba za ka yi gogewa na dogon lokaci ba (minti 10).
Ya kamata a guji ruwa daga wuyan hannu zuwa kusurwa a baya bayan wanka.
Bayan an gama wanke hannu, ana bushe hannu da kayan tsabta kuma ana saka rigar tiyata a jikin mutum.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu ko amfani da maganin kashe ƙwayoyin cuta kafin da kuma bayan kula da mai ciwo.
Don sarrafa kamuwa da cutar Staphylococcus a asibiti, an gano cewa mafi girman fa'idar wanke hannu yana zuwa daga farkon 20% na wankewa, kuma lokacin da aka ƙara yawan wanke hannu sama da 35%, an sami ƙarin fa'ida kaɗan.
Idan aka kwatanta wanke hannu da sabulu mai dauke da barasa da wanke hannu da sabulu mai dauke da barasa a kowane sakan 30, an nuna cewa wanke hannu da sabulu mai dauke da barasa ya rage kamuwa da kwayoyin cuta da kashi 26 cikin dari.
Amma sabulu da ruwa sun fi ruwan sha mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa mai amfani da ruwa.
Ana bukatar ƙarin bincike kan waɗanne daga cikin waɗannan hanyoyin ne suka fi tasiri a cikin yanayin kiwon lafiya daban-daban.
A ƙasashe masu tasowa, wanke hannu da sabulu ya zama hanya mai arha da kuma dole don samun ƙoshin lafiya da abinci mai gina jiki.
Amma rashin isasshen ruwa, rashin sabulu ko wanke hannu a gidajen mutane, makarantu da wuraren aiki, ya zama ƙalubale ga cimma daidaiton wanke hannu.
Alal misali, a yawancin yankunan karkara na Afirka, duk da cewa akwai hanyoyin da za a iya amfani da su wajen wanke hannu, babu tabarau na wanke hannu a kusa da kowane gidan wanka na jama'a ko na masu zaman kansu.
Duk da haka, rashin wanke hannu na iya zama sakamakon halaye da suka mutu fiye da rashin sabulu ko ruwa.
Ƙarfafawa da kuma ba da kyauta ga wanke hannu da sabulu na iya shafar yanke shawara na manufofi, wayar da kan jama'a game da fa'idodin wanke hannu, da kuma sauya halayen jama'a na dogon lokaci.
Don a yi amfani da shi yadda ya kamata, ana bukatar a riƙa sa ido a kan abin da ake yi.
Wani nazari na tsari na nazarin 70 ya gano cewa tsarin zamantakewar al'umma yana da tasiri wajen haɓaka yawan wanke hannu a cikin LMICs, yayin da ayyukan tallace-tallace na zamantakewa ba su da tasiri. Wani misali na inganta wanke hannu a makarantu shine "tauraron taurari uku" ta UNICEF wanda ke ƙarfafa makarantu don samar da mafita mai sauƙi, mai araha don tabbatar da cewa ɗalibai suna wanke hannayensu da sabulu, tare da sauran bukatun tsabta.
Idan aka cimma matsakaicin matsakaicin, makarantu za su iya zuwa daga tauraro daya zuwa uku.
Kafa wuraren wanke hannu na iya zama wani ɓangare na inganta wanke hannu don rage cututtuka da mutuwar yara.
Ranar Wanke Hannun Duniya, wacce ke ƙoƙarin kawo canji a cikin halayyar, wani misali ne na yunƙurin wayar da kan jama'a. UNICEF ta inganta karɓar emojis na wanke hannu a sakamakon annobar cutar coronavirus a cikin 2019-20.
Wasu nazarin sun yi la'akari da yadda Dally ke guje wa yawan kuɗin wanke hannu a ƙasashe masu tasowa.
Amma, wani bincike ya nuna cewa, inganta wanke hannu da sabulu ya fi sauran hanyoyin tsabtace jiki da ruwa tsada.
Ga mutanen da ke cikin yanayi na musamman na rashin lafiya - kamar uwaye da suka haihu ko kuma sojoji da suka ji rauni a asibitoci - a farkon tsakiyar karni na 19, manyan masana tsabtace hannu biyu sun fahimci mahimmancin wanke hannu ga lafiyar ɗan adam: likitan Hungary Ignaz Semeles da ke aiki a Vienna, Austria, da "mai kafa Ingilishi na aikin jinya na zamani" Florence Nightingale.
A lokacin, mutane da yawa sun gaskata cewa ƙanshin da ake kira Miamas yana sa mutane su kamu.
A cikin 1980, sakamakon barkewar cututtukan abinci da cututtukan kiwon lafiya, Cibiyoyin Kula da Cututtuka da Rigakafi a Amurka sun ƙara ƙarfafa wanke hannu a matsayin babban mataki na hana yaduwar kamuwa da cuta.
Cutar mura ta alade a shekarar 2009 da kuma cutar COVID-19 a shekarar 2020 sun sa mutane su san muhimmancin wanke hannu da sabulu don kare kansu daga cututtukan da ke dauke da cutar.
Alal misali, a Jamus, an saka zane-zane a bayan wanka a wuraren wanka na jama'a da kuma gine-ginen ofishi da kuma a tashar jiragen sama da ke nuna "daidaitaccen wanke hannu".
Wanke hannuwan wani abu magana ce da ke nuna rashin son ɗaukar alhakin wani abu ko kuma raba abubuwan da ke ciki.
Wannan ya samo asali ne daga nassi na Littafi Mai Tsarki a cikin Matta inda Pontius Pilate ya wanke hannunsa game da yanke shawarar gicciye Yesu Kristi, amma a cikin wasu al'ummomin Ingilishi, wannan magana ta zo da amfani mafi yawa.
A Shakespeare's Macbeth, Lady Macbeth tana nuna lamirinta na laifi game da laifin da ta aikata da kuma wanda mijinta ya sa ta aikata, ta kuma yi kokarin wanke ta da karfi don wanke tabo na almara.
An kuma gano cewa mutane suna wanke hannayensu sau da yawa fiye da sauran mutane idan sun tuna ko kuma suna tunanin ayyukan lalata, kuma suna da sha'awar sanya kayan wanke hannu a gaba.
Haka kuma, mutanen da aka ba su damar wanke hannayensu bayan yin irin wannan tunani ba su da damar shiga wasu ayyukan "tsabta" da ke kawo sauyi, kamar aikin sa kai.
Addinai suna ba da shawarar wanke hannu don dalilai na tsabta da alama. Yin amfani da ruwa don wanke hannu, amma ba tare da yin amfani da sabulu ba shine wanke hannu na alama, wanda shine ɓangare na al'adar wanke hannu, wanda ya haɗa da Baha'u'u'llah, Hindu, Tewlah da Netilah a cikin Yahudanci, Lawab a cikin Kiristanci da Wudu a cikin Islama. Addinai suna ba da shawarar wanke hannu bayan wasu ayyuka na yau da kullun, musamman don tsabta.
A addinin Hindu, Yahudanci da Musulunci, wanke hannu bayan zuwa bayan gida yana da muhimmanci.
Kuma a addinin Hindu, Buddha, Sikh, Yahudanci da Musulunci, wanke hannu wajibi ne kafin kowane abinci da kuma bayan cin abinci.
Gudanar da haɗarin aiki na COVID-19
Kula da haɗarin aiki na COVID-19 shine aikace-aikacen aikin lafiya da kiwon lafiya don kula da haɗarin rigakafin cutar coronavirus 2019 (COVID-19).
Kulawa da haɗari a wurin aiki ya dogara da yanayin aiki da yanayin aiki, wanda ya dogara da tushen kamuwa da cuta, tsananin cutar a cikin al'umma, da kuma abubuwan haɗarin kowane ma'aikaci wanda zai iya zama mai rauni ga COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyukan da ke da ƙananan haɗarin kamuwa da cuta suna da ƙarancin hulɗa da mutane da sauran abokan aiki, waɗanda aka ba da shawarar matakan rigakafin kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida yayin rashin lafiya, ladabi na numfashi, da tsabtace wuri na yau da kullun da kuma kashe kwayoyin cuta.
Ayyuka masu matsakaicin haɗarin kamuwa da cuta sun haɗa da ayyukan da ke buƙatar haɗuwa ta kai tsaye ko kusa da waɗanda ba a san ko ba a yi zargin cewa suna da COVID-19 ba, amma waɗanda za su iya kamuwa da cutar ta hanyar kamuwa da cuta ta hanyar jama'a ko tafiya ta duniya.
Wannan ya haɗa da ma'aikata da suke hulɗa da jama'a, kamar su makarantu, wuraren aiki masu yawan jama'a, da kuma wasu manyan wuraren sayar da kaya.
Baya ga matakan rigakafin kamuwa da cuta, kula da haɗari ga wannan rukunin ya haɗa da kula da iska ta amfani da matattarar iska mai ƙarfi, amfani da masu tsaron sneez, da kuma samun kayan kariya na mutum idan mutum ya fuskanci COVID-19.
OSHO tana ɗaukar ma'aikatan kiwon lafiya da ma'aikatan jana'izar da suka haɗu da wanda aka sani ko wanda ake zargi da cutar COVID-19 a matsayin haɗarin kamuwa da cuta, wanda ya haɗa da ma'aikacin da ke aiwatar da aikin samar da aerosol ko tattara ko sarrafa samfuran wanda aka sani ko wanda ake zargi da cutar COVID-19, wanda ke ƙara haɗarin kamuwa da cutar.
Hanyoyin sarrafa haɗari waɗanda suka dace da waɗannan ma'aikata sun haɗa da sarrafa injiniya kamar ɗakunan iska masu matsin lamba da kayan kariya na mutum wanda ya dace da takamaiman aikin.
Cutar COVID-19 na iya haifar da tasiri mai yawa a wuraren aiki.
Ma'aikata na iya yin rashin aiki saboda rashin lafiya, bukatar kula da wasu, ko kuma tsoron kamuwa da cuta.
Hanyoyin kasuwanci na iya canzawa a cikin ma'anar abin da ake buƙata da kuma yadda ake samun su (kamar sayayya a lokacin da ba a cika jama'a ba ko sayayya ta hanyar isarwa ko sabis na tuki).
A ƙarshe, COVID-19 na iya kawo cikas ga jigilar kaya daga yankuna masu tasiri sosai. Shirye-shiryen cututtukan cututtuka da amsawa na iya amfani da su don ɗaukar matakan kariya.
Shirin yana magance matakan haɗari da ke tattare da wurare daban-daban na aiki da ayyuka, gami da tushen kamuwa da cuta, abubuwan haɗari da ke tasowa daga cikin gida da zamantakewar jama'a, da abubuwan haɗari ga kowane ma'aikaci, kamar tsufa ko yanayin rashin lafiya na yau da kullun.
Suna kuma tsara tsare-tsaren gaggawa don yanayin da za a iya tasowa daga ɓarkewar da kuma matakan da ake buƙata don magance waɗannan haɗarin.
Shirye-shiryen cututtuka da kuma shirin amsawa na iya zama batun shawarwari na ƙasa ko na ƙasa.
Manufofin amsawa ga fashewar sun haɗa da rage watsawa ga ma'aikata, kare mutanen da ke cikin haɗarin haɗarin rikitarwa na rashin lafiya, kiyaye ayyukan kasuwanci, da rage tasirin tasirin abubuwa a cikin sarkar samar da su.
A inda kasuwancin ke, yana shafar yadda al'umma ke amsa cutar.
Tsarin tsarin kula da haɗari wanda aka yi amfani da shi a cikin lafiyar sana'a da lafiya shine tsarin tsarin kula da haɗari wanda aka yi amfani dashi a cikin aikin lafiya da lafiya don rarraba haɗari ta hanyar tasirin tasirin.
Inda ba za a iya kawar da haɗarin COVID-19 gaba ɗaya ba, mafi ingantattun sarrafawa sune sarrafa injiniya, sannan sarrafawa na gudanarwa, kuma a ƙarshe, kayan kariya na mutum.
Gudanar da injiniya ya ƙunshi ware ma'aikata daga haɗarin aiki ba tare da dogaro da halayen ma'aikaci ba, kuma yana iya zama mafi arha don aiwatarwa.
Gudanarwa na nufin sauya manufofi ko hanyoyin aiki da ma'aikaci ko mai aiki ke bukatar a bi.
Kayan kariya na mutum (PPE) ba su da tasiri sosai fiye da na injiniya da na gudanarwa, amma suna iya taimakawa wajen hana wasu kamuwa da cuta.
Ya kamata a zaɓi duk nau'ikan PPE bisa ga haɗarin da ma'aikaci ke fuskanta, ya dace da amfani (misali, masu numfashi) kuma ya dace da sawa, a bincika shi akai-akai, a kula da shi kuma a canza shi kamar yadda ake buƙata, kuma a cire shi, tsabtace shi, da kuma adana shi ko kuma a zubar da shi yadda ya kamata don hana kamuwa da cuta.
Bisa ga Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHO), ayyuka masu ƙarancin haɗarin kamuwa da cuta suna da ƙarancin hulɗa da jama'a da sauran abokan aiki.
Ana ba da shawarar ɗaukar matakan rigakafin kamuwa da cuta na asali ga kowane irin wurin aiki, gami da wanke hannu sama da gaba ɗaya, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, kiyaye ladabi na numfashi, gami da rufe fuska yayin tari da tari, samar da kwandon shara da takarda, kasancewa a shirye don sadarwa ko yin gyare-gyare na yau da kullun idan ya cancanta, hana ma'aikata amfani da kayan aiki da kayan aikin wasu, da tsaftacewa da kuma aikin aikin aikin yau da kullun.
Ganowa da kuma warewar mutane masu cutar da wuri-wuri mataki ne mai mahimmanci na kare ma'aikata, abokan ciniki, baƙi da sauran mutane a wuraren aiki.
Cibiyoyin Kula da Cututtuka da Rigakafi na Amurka (CDC) sun ba da shawarar cewa ma'aikata waɗanda ke nuna alamun cututtukan numfashi masu tsanani su zauna a gida har tsawon awanni 24 ba tare da shan maganin rage zazzabi ko wasu magungunan da ke canza alamun ba, har sai suna da zazzabi, alamun zazzabi da sauran alamun, kuma akwai manufofin hutu na rashin lafiya masu sassauci, waɗanda ke ba ma'aikata damar zama a gida don kula da dangin su da ke rashin lafiya, kuma ma'aikata sun san waɗannan manufofin.
OSHA ta ce, ayyukan da ke da matsakaicin haɗarin kamuwa da cuta sun haɗa da ayyukan da ke buƙatar haɗuwa da mutane masu nisan ƙafa shida (1.8 m) waɗanda ba a san ko ba a yi zargin cewa suna da cutar COVID-19 ba, amma saboda yaduwar al'umma da ke gudana a kusa da yankin kasuwanci, ko kuma saboda mutumin ya yi tafiya ta duniya kwanan nan zuwa inda COVID-19 ya yadu, yana iya kamuwa da cutar SARS-CoV-2.
Wannan ya hada da sanya ma'aikata waɗanda suka sami hulɗa da jama'a, kamar makarantu, wuraren aiki masu yawan jama'a, da wasu manyan wuraren sayar da kaya, da sauransu. Ƙirƙirar ƙwarewar injiniya don sarrafawa da kuma mafi yawan haɗarin haɗari sun haɗa da shigar da filtata mai inganci, ƙara yawan hannuwan hannu, sanya masu toshe jiki kamar su sneeze guards na filastik, da kuma sanya windows a cikin windows don sabis na abokin ciniki. Gudanar da kulawa na lokaci don ƙungiyoyin haɗari da waɗanda ke da haɗari, samar da ma'aikata marasa lafiya waɗanda ke da sha'awar zama a gida, samar da kayan aiki na kama-da-wane maimakon haɗuwa ta zahiri, kafa shirye-shiryen horarwa daban-daban, samar da ingantaccen tsarin kula da lafiyar COVID-19, gami da rufe wuraren da ke da haɗari, kafa dandamali na horo da horo ga masu amfani da ke buƙatar yin aiki, samar da ingantaccen tsarin kula da lafiyar jama'a da kuma ingantaccen tsarin kula da COVID-19, samar da dandamali na sadarwa da horo ga masu amfani da ke buƙatar yin aiki, samar da hanyoyin sadarwa da hanyoyin sadarwa na yau da kullun, samar da hanyoyin sadarwa na yau da kullun, samar da hanyoyin sadarwa na yau da kullun da ke taimakawa wajen magance COVID-19.
Ma'aikata da ke cikin wannan rukunin masu haɗari ba sa bukatar yin amfani da na'urar numfashi.
Idan mutum ya kamu da cutar a cikin jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da ware mutumin daga sauran mutane na tsawon ƙafa 6, sanya memba na ma'aikata don kula da mutumin da ke fama da cutar, da kuma ba wa mutumin da ke fama da cutar abin rufe fuska, ko kuma gaya wa mai cutar ya rufe bakinsa da hanci da takarda yayin da yake tari ko tari.
Lokacin kula da matafiyi mai rashin lafiya ko taɓa ruwan jikinsa ko ɓangarorin da ke iya kamuwa da cutar, dole ne a saka safofin hannu na likita, kuma idan matafiyi mai rashin lafiya yana da zazzabi, yana yin tari ko yana da wahalar numfashi, dole ne ma'aikatan jirgin su sanya ƙarin kayan kariya na sirri.
Gloves da sauran abubuwa masu zubarwa dole ne a zubar da su a cikin jaka mai haɗari sannan a tsabtace kuma a kashe wuraren da ke da cutar. Don jiragen ruwa masu yawon shakatawa da sauran jiragen ruwa na kasuwanci, gami da jiragen ruwa masu fasinjoji, matakan haɗari sun haɗa da jinkirta tafiya yayin rashin lafiya da kuma keɓe kai idan akwai zazzabi ko wasu alamun bayyanar cututtuka a cikin jirgin.
A matsayin manufa, ana buƙatar bin diddigin likita a cikin ɗakin keɓewa. CDC ta ba da shawarar rufewa na ɗan lokaci don tsabta da kuma tsabtace jiki, ko da kuwa ana iya yada cutar a cikin al'umma ko a'a, a makarantu da wuraren kula da yara.
Inda yaduwar al'umma ta kasance mai matsakaici, ana iya amfani da manufofin nisantar jama'a, kamar dakatar da tafiye -tafiye na filin, taron jama'a da sauran manyan tarurruka, gami da koyar da motsa jiki ko azuzuwan addu'a ko cin abinci a gidajen cin abinci, ƙara tazarar tebur, sauya lokutan isowa da fita, iyakance baƙi marasa mahimmanci, da kuma kafa wuraren shakatawa daban don yara masu alamun cutar mura.
Idan akwai kamuwa da cuta a cikin al'umma, tare da dabarun nisantar zamantakewa, ana iya yin la'akari da rufe makarantu na tsawon kwanaki. CDC ta yi la'akari da cewa ma'aikatan tilasta bin doka waɗanda ke yin ayyukan yau da kullun suna da ƙananan haɗarin lafiya.
Jami'an tilasta bin doka waɗanda ke buƙatar yin hulɗa tare da wasu waɗanda ke da cutar COVID-19 ko waɗanda ake tsammanin suna da cutar, ana ba da shawarar su bi ƙa'idodin kamar yadda ake yi wa masu fasahar likita na gaggawa, tare da kayan kariya na mutum.
Idan akwai kusanci a lokacin kulawa, ma'aikata su tsabtace su da kuma kashe su ta hanyar amfani da mai tsabtace gida ko shafawa kafin sake amfani da belin aikinsu da kayan aiki, kuma su bi ƙa'idodin aiki don sarrafawa da kuma zubar da PPE da aka yi amfani da su, ware tufafi, da wankewa.
OSHA ta yi la'akari da wasu ma'aikatan kiwon lafiya da na jana'iza da ke da babban ko kuma babban haɗarin kamuwa da cuta.
Ayyukan da ke da haɗarin kamuwa da cuta sun haɗa da isar da kiwon lafiya, taimako, dakin gwaje-gwaje da ma'aikatan jigilar likitoci waɗanda suka haɗu da waɗanda aka sani ko waɗanda ake zargi da cutar COVID-19.
Akwai haɗarin kamuwa da cutar a kan waɗanda aka sani ko ake zargi da cutar COVID-19 idan ma'aikata suna gudanar da aikin samar da aerosol ko tattara ko sarrafa samfurori daga irin waɗannan marasa lafiya.
Tsarin samar da aerosol ya hada da intubation, hanyoyin shigar da cuff, bronchoscopes, wasu tsarin hakori, da kuma gwajin ko tarin samfurin kai tsaye.
Ayyukan jana'izar da ke da haɗarin kamuwa da cuta sun haɗa da ma'aikatan da ke aiki a kan shirya gawawwakin mutanen da aka sani ko kuma ake zargi da cutar COVID-19 a lokacin mutuwa; idan sun yi autopsy, suna da haɗarin kamuwa da cuta sosai.
A wasu wuraren kiwon lafiya da kuma gine-ginen gawa, ƙwararrun iska mai guba na iya zama mai kyau.
Za a sarrafa samfurori tare da matakan tsaro na 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa idan ana zargin masu zuwa da cutar COVID-19, to a ware su a cikin ɗakunan jira. Kamar sauran PPE, OSHA ta ba da shawarar cewa a ba da izinin yin amfani da na'urar numfashi ga ma'aikatan da ke aiki a cikin ƙafa 6 na waɗanda aka sani ko ake zargi da cutar SARS-CoV-2.
A cikin Amurka, dole ne a yi amfani da masks masu numfashi na N95 da aka amince da NIOSH, ko mafi kyau, a cikin mahallin cikakke, tsarin kariya na numfashi na rubuce-rubuce, wanda ya haɗa da gwajin lafiya, horo, da kuma binciken likita.
Wasu nau'ikan masu kare numfashi na iya samar da kariya mafi kyau da kuma sa ma'aikata su fi jin daɗi. WHO ba ta ba da shawarar yin kariya ga jiki gaba ɗaya ba, saboda COVID-19 cuta ce ta numfashi, ba ta yaduwa ta sauran ɓoyayyen jiki.
WHO ta ba da shawarar cewa ma'aikatan bincike ne kawai za su yi amfani da abin rufe fuska.
WHO ta ba da shawarar cewa ma'aikatan da ke tattara, kula ko jigilar samfuran numfashi na marasa lafiya na COVID-19 waɗanda ke cikin magani ba tare da wani aikin samar da aerosol ba, su yi amfani da abin rufe fuska, tufafi da safar hannu, ko kuma abin rufe fuska.
Idan an aiwatar da aikin samar da aerosol, a maimakon abin rufe fuska, a yi amfani da N95 ko FFP2 masu kariya na numfashi.
Dangane da isasshen isar da PPE a duniya, WHO ta ba da shawarar yin amfani da shinge na zahiri kamar telemedicine, tsabtace windows, don samun damar shiga cikin ɗakunan da ke dauke da COVID-19 tare da masu ba da lafiya kai tsaye tare da PPE kawai don takamaiman aiki, rage buƙatar amfani da PPE a gare su, amfani da abin numfashi ɗaya ba tare da rarrabewa ba yayin kula da marasa lafiya da yawa tare da ganewar asali, kula da daidaitawa a cikin sarkar samar da PPE, da kuma samar da sabis ba tare da ƙarfafa masu amfani da abin rufe fuska ba.
By: Catherine Meher, Shugaba na Gidauniyar Wikimedia
Ga: duk ma'aikatan Wikimedia Foundation
Jigon: [COVID-19] Rage Nauyin da Shirya don Nan gaba
Ranar da aka aika: 14 ga Maris, 2020, 00:24 UTC
lasisi: CC0: Babu haƙƙoƙi
A wannan watan, mun ga cewa muna cikin yanayi mai muhimmanci.
COVID-19 na duniya shine abin da ke nuna alaƙar ɗan adam da haɗin kai da kuma nauyin da muke da shi ga juna.
Ba mu taɓa fuskantar irin wannan kalubalen ba, amma mun san cewa amsarmu mafi kyau ta dogara ne da tausayawa, haɗin kai da kuma gina ƙungiya da ke zuciyar ƙungiyarmu.
Wani tabbaci na musamman na yadda muke sa'ar yin aiki tare da mutane masu ban mamaki shine kyakkyawar sha'awa da kulawa da muke samu a tsakanin abokan aikinmu ta hanyar imel, waya, da hira.
Ba zan iya zama mai godiya da alfahari ba don kiran ku abokan aikina.
A makon da ya gabata, wani ya yaba mini da aikinku.
Ya tunatar da ni cewa yana da muhimmanci a karanta Wikipedia a wannan lokacin kuma yana da alama mai ƙarfi cewa wannan muhimmin kayan aiki yana kan layi kuma yana samuwa ga kowa.
Ko kuna ci gaba da sabunta shafin ko biyan abokan aikinmu ko kuma kiyaye ƙungiyarku, duk abin da kuka yi ya faru ne saboda aikinku.
Duniya tana bukatar bayanin da Wikipedia ke bayarwa fiye da yadda Ervi ke bukata.
Wannan lokaci ne da ba abin da muke yi ba, amma yadda muke yi zai yi tasiri mai ma'ana a duniya.
Muhimmancin wannan kamfen da kuma matsayinku a ciki zai sa mu yi wasu canje-canje masu muhimmanci a yadda muke aiki tare, wanda zai fara a mako mai zuwa.
A wasu lokatai, muna iya yin wasu canje-canje a tsarinmu na aiki.
Kamar yadda Robin ya ambata a baya, ƙungiyar C-Team ta yi taro a daren jiya don tattauna hangen nesa da jadawalinmu a cikin kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun yi tunani game da yadda za mu bi da abin da muke fuskanta da kuma yadda za mu iya ci gaba da kasancewa da ƙungiya a wannan lokacin.
Muna da sha'awar kawar da damuwa da kuma tallafa wa aikinmu na dogon lokaci.
Idan kana son sake kira, ba matsala.
Ga dukan ma'aikata, 'yan kwangila da ma'aikatan kwangila:
Za mu yi aiki na awa 4 a rana ko kuma awa 20 a mako har sai an ba da umurni.
Ba ma sanar da ranar hutu - idan za ku iya yin aiki na yau da kullum, za ku iya yin amfani da ku a cikin wannan kamfen.
Amma, duniya ba ta da tabbas a yanzu, kuma ko kuna son kula da ƙaunatattunku, ko ku kawo kayan masarufi, ko ku je wurin likita, lafiyarku ita ce fifiko.
Ba ma bin diddigin lokacinku.
Idan kana rashin lafiya, kada ka yi aiki.
Ba lallai ba ne a faɗi haka, amma muna faɗi.
Babu bukatar hutu na rashin lafiya ko PTO - kawai gaya wa manajanka kuma ka taimaki tawagarka wajen gyara kalanda da kuma jadawalin, domin ka tabbata cewa an gama sassan aikin.
(Idan ka kamu da cutar COVID-19, don Allah ka gaya wa Brian a T&C Ops, don T&C ta iya tallafa maka da kuma tabbatar da cewa an kula da yanayinka.)
Za a biya ma'aikatan da ke aiki na sa'o'i cikakken albashi.
Mun riga mun faɗi kuma mun sake maimaita alkawarinmu na girmama alkawarinmu ga 'yan'uwanmu na kwangila da ma'aikatan da ke aiki a kan lokaci.
Za a biya kowa daidai da sa'a da ya yi a yanayin da ya saba.
Wannan ya haɗa da rashin lafiya da kuma rashin iya aiki.
Idan kana son yin aiki, za mu taimake ka.
Mutane da yawa suna amfani da aiki a matsayin hanyar da za su iya kawar da matsin lamba game da duniya da ke kewaye da su.
Abin da za mu iya yi, musamman a irin wannan lokacin, zai iya kawo sakamako mai ban mamaki.
Kuma, wannan kuma game da kula da kanka ne.
Abin da muke so shi ne ku tattauna da shugabanninku, domin mu san abin da za mu yi tsammani kuma mu yi gyara da ya dace.
Wasu ayyuka ana ɗaukansu da muhimmanci.
Akwai wasu abubuwa da ya kamata mu ci gaba da yi.
SRE, HR Ops, Trust & Safety, da kuma ƙungiyar tara kuɗi (a tsakanin wasu) suna da ayyuka masu muhimmanci da za su iya bukatar ƙarin taimako.
Za mu fara aiki tare da dukkan sassan don kimanta manufofinmu na yanzu kuma mu mai da hankali kan tallafawa abubuwan da suka dace da aikinmu.
Akwai aiki da yawa da za a yi wa kowa, bari mu mai da hankali kan manyan ayyuka.
Idan ka yi aiki a hankali yanzu, ba za ka yi hasara ba.
Da zarar an gama wannan hargitsi na duniya, ba mu da shirin "aiki sau biyu don a gama aikin".
Ba za a ƙara sa ran yin awoyi da yawa ba don a yi aiki a kan lokaci da ba zai yiwu ba.
Mun yarda cewa yanayi ya canja, kuma za mu yi aiki don kafa sababbin manufofi da kuma jadawalin lokacin da ya dace.
Menene ya faru da APP?
Yayin daidaita tsammanin sabon gaskiyarmu da lokutan aiki na yau da kullun, muna da niyyar daidaita lokacin don isar da shirinmu na shekara-shekara na 2020-2021.
Manufarmu ita ce ta ba da shawarar fadada shirinmu na 2019-2020, wanda zai ba ma'aikata ƙarin lokaci don tsara kasafin kuɗi don fifita mahimman ayyuka, kula da kansu da kula da abokan hulɗarsu, waɗanda ke buƙatar yin aiki a cikin makonni masu zuwa ko waɗanda ke son yin aiki na ɗan gajeren lokaci, yayin haɗa su.
Wannan tsawaitawar lokaci zai rage yawan aiki da matsin lamba a cikin dukan ƙungiyar.
Za mu gabatar da shawararmu ga kwamitin mako mai zuwa kuma idan an tabbatar mana da hakan, za mu sanar da wakilanmu da ƙungiyoyinmu game da abin da za mu yi.
Na gode wa tawagar APP don jagorancinku a cikin wannan.
Aikin ofishi, cuta, da kuma tsabta
A makon da ya gabata, mun sami labarin cewa wani ma'aikacinmu a yankin SF yana iya kamuwa da cutar COVID-19.
Duk da haka, tare da taka tsantsan, mun tura ƙungiyar tsabtace ƙwayoyin cuta don kashe duk wani yanki a ofisoshinmu na San Francisco.
Suna amfani da maganin kashe ƙwayoyin cuta mai inganci da ake amfani da shi a asibitoci don kashe kowace farfajiya, har da bakin ɗakunan da kuma na'urar da ke hawa bene.
Wannan ginin yana amfani da kayayyakin da take da su na kiyayewa da kuma kiyaye masu haya.
Muna farin ciki cewa idan muka yanke shawarar dawowa, waɗannan ofisoshin za su kasance a shirye don aiki.
Ofishinmu na DC yana cikin yankunan WeWork, inda aka raba mana da sauran ma'aikatan yankin DC game da matakan COVID-19.
A makon da ya gabata, ofishinmu na DC ya canza zuwa cikakken saiti mai nisa bisa ga jagororin da muka raba tare da San Francisco.
Kamar yadda wasu abokanmu a yankin New York suka sani, muna tattaunawa ne game da yin hayar wani wuri a Brooklyn.
Ana ci gaba da tattaunawa, amma za mu iya jinkirta.
Wasu abokan aikinmu suna aiki daga nesa a karon farko.
Abokan aikinmu na dogon lokaci sun san cewa wannan zai zama daidaitawa ne kawai, kuma suna son ba da wasu shawarwari:
Ka ƙayyade lokacin taronka zuwa awa ɗaya ko biyu.
Idan ana bukatar dogon zaman, ka yi tunanin yadda za a raba shi zuwa kwanaki da yawa.
Ka bayyana musu tsarin ayyukan taron da kyau kuma ka aika musu da littattafai da suka dace.
Don sauƙaƙe haɗin kai da haɗin kai, yi amfani da kayan aikin da aka tsara ta hanyar Google Docs da Zoom don yin bidiyo ta hanyar tsoho.
Don sauƙaƙa kowane taro, ka sa wani ya yi shugabanci, wanda zai lura da hira don tambayoyin da aka yi, kuma ya duba jerin masu magana, kuma ya sa wani ya taimaka wajen yin rubutu (ko kuma yin rubutu tare).
Idan kana son na'urar sauraron sauti mai kyau, ka aika imel zuwa ga mai taimakon fasaha.
Ku yi amfani da kuɗin da kuka samu don cin abincin safe.
Shiga tashar #Remote ta Slack don tattaunawa da abokan aikinka game da aikin da aka ba ku.
Ƙungiyar HR Operations tana neman 'Webinar-Based Ergonomics' don taimakawa wajen haɓaka aikin da aka rarraba a cikin ƙungiyar.
A makon da ya gabata mun nemi duk masu karɓar tallafin al'umma da su dakatar da taron jama'a da Wikimedia ke tallafawa kamar su "Editathons" har sai WHO ta sanar da ƙarshen cutar.
Mun gaya musu cewa mun fahimci cewa roƙonmu na jinkiri da sauran takunkumi zai hana su cika lokacin da suka yarda da shi, kuma ba za a hukunta kowa ba saboda wannan jinkirin da kuma canza wannan burin.
A mako mai zuwa, za mu ci gaba da lura da ƙarin jagora da aka bayar don Wikimedia da sauran taron yanki da na al'umma.
Akwai wani abu da ya sa jama'a a duniya duka suka yi baƙin ciki game da wannan rikici, amma kuma suna farin ciki game da wannan haske da kuma iyawarmu na mayar da hankali ga al'ummarmu, Wikimedia da sauransu.
A gaba, CRT tana aiki don kafa shafi a kan Meta-Wiki don samar da sarari ga al'umma don lura da tasirin da kuma lura da sadarwa tare da su.
Kasancewa cikin hulɗa da batutuwan da suka shafi COVID-19.
Za mu aika muku da gayyatar a kalandarku don taron ma'aikata na musamman da za a yi ranar Alhamis mai zuwa, 14: 00 UTC / 7: 00 PT.
Za mu yi amfani da wannan lokacin don raba ƙarin sabuntawa, amsa tambayoyinku, da kuma ɗan ɗan fahimtar juna.
Muna tare da ku a wannan kuma muna shirye mu taimaka yadda za mu iya.
A halin yanzu, ku ci gaba da samun bayanai ta wannan imel ɗin da kuma sauran mahimman bayanai game da COVID-19 a kan Wiki-office.
CRT zai ci gaba da sabunta shafukan kuma ya ajiye duk bayanan a wuri guda.
Muna kuma aiki don ci gaba da sadarwa tare da ma'aikatanmu, waɗanda ke zaune a ƙasashe waɗanda ke fama da mummunan rauni a halin yanzu.
Idan kana da tambayoyi game da tafiye-tafiye, wani biki, wani babban aiki, ko wata ƙalubale da ake tunani, ko wani abu da kake bukatar taimako, kada ka yi jinkirin sanar da CRT da kuma yin aiki tare da su.
Muna nan don taimakawa da kuma tallafawa, kuma don tuntuɓar idan an buƙata.
Idan kana da wani abu mai sirri ko kuma mai saukin ganewa, ka aika da imel zuwa ga Brian Judan, darektan hukumar kula da ayyukan dan adam a duniya.
Kada mu ɗauki waɗannan canje-canje a matsayin abin da zai hana mu yin aikinmu.
Maimakon haka, dole ne su amince da cewa a wannan lokacin, dole ne mu ɗauki ayyukanmu da kuma wajibai a hanyar da ba mu taɓa yi ba.
Waɗannan su ne matakan da muke ganin ya kamata mu bi don mu ci gaba da aiki, don mu iya biyan bukatunsu, da kuma samar musu da ayyukan da suke dogara da su.
A lokacin da lokaci ya yi, waɗannan ayyukan da muka shirya za su taimaka mana.
A yanzu, lokaci ya yi da za mu haɗa kai da kuma shirya sarari don ayyuka masu muhimmanci da za su fuskanta a mako mai zuwa da wata mai zuwa.
Don mu cim ma wannan, muna bukatar ku duka, don haka, kuna bukatar ku kula da kanku da kuma iyalanku, domin ku ba da mafi kyau a lokacin da ake bukata.
Yanzu, don Allah, ku wanke hannuwanku, kuma kada ku taɓa fuskarku.
Catherine, CRT (Amanda K., Amy V., Brian J., Doreen D., Gregory V., Joel L., Linet L., Ryan M., da Tony S.) da kuma sauran 'yan ƙungiyar shugabanci (Grant I., Heather W., Jamie V., Jenine U., Liza S., Robin A. Ryan M., da Toby N.).
B'angiotensin-converting enzyme 2 ((ACE2)) enzyme ne wanda ke haɗe da ƙwayoyin cuta a cikin huhu, jijiyoyin jini, zuciya, koda, da hanji.
Ta hanyar rage adadin angiotensin -II da haɓaka adadin Ang ((1-7) yana hana aikin ACE2 na enzymes masu canza angiotensin (ACE) kuma saboda haka yana da alamar magani don maganin cututtukan zuciya da jijiyoyin jini.
An kira kwayar halitta na enzyme hACE2.
Angiotensin-converting enzyme 2 wani zinc-containing metallolenzime ne wanda yake a cikin endothelial da sauran kwayoyin halitta.
Kwayar ACE2 tana da yankin N-terminal peptidase M2 da kuma yankin C-terminal collectrin renal amino acid transporter.
ACE2 shine kwayar halitta mai ƙarancin ƙwayar cuta wanda ke aiki ta hanyar enzymes a cikin ƙwayoyin cuta a cikin huhu da sauran ƙwayoyin.
Ƙarin yankin kwayar halitta na ACE2 an cire shi daga wata na biyu mai suna transmembrane da ake kira shades kuma sakamakon haka an saki furotin mai narkewa cikin jini kuma a ƙarshe ya narke cikin fitsari.
ACE2 yana cikin kusan dukkanin gabobin jiki: an haɗa shi da membrane na nau'in II na alveolar a cikin huhu, enterocytes a cikin ƙananan hanji, endothelial ƙwayoyin jijiyoyi da jijiyoyi, da kuma ƙwayoyin jijiyoyin jini a yawancin gabobin jiki.
ACE2 mRNA tana cikin ƙwayar kwakwalwa, a cikin tsakiya, a cikin hypothalamus, da kuma cikin kwakwalwa.
Aikin farko na ACE2 shine ya zama mai hana ACE.
ACE yana ba da damar hawan angiotensin I zuwa angiotensin II mai ƙuntata jini.
ACE2 a madadinsa yana fashe amino acid na carboxyl-terminal daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana hydrolyze shi zuwa angiotensin mai kwakwalwa (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
[des-Arg9]- ACE2 na iya karya wasu peptides da dama, ciki har da bradykinin, apelin, neurotensin, dinorphine A, da ghrelin.
ACE2 kuma yana daidaita jigilar membrane na mai ɗaukar amino acid mai tsaka tsaki SLC6A19 kuma yana cikin cututtukan zuciya.
A matsayin furotin mai wucewa, ACE2 yana aiki a matsayin babban wurin shigar da kwayar halitta ga wasu ƙwayoyin cuta, ciki har da HCoV-NL63; SARS-CoV (wanda ke haifar da SARS); da SARS-CoV-2 (wanda ke haifar da COVID-19).
Musamman, ƙulla yankin enzymatic na ACE2 akan farfajiyar ƙwayoyin cuta tare da furotin na SARS-CoV da SARS-CoV2 Spike S1 yana haifar da endocytosis, kuma ana iya samun sauyawar cutar da enzyme a cikin endosomes da ke cikin ƙwayoyin.
Shigarwa kuma yana buƙatar mai masaukin baki mai suna Serine Protease TMPRSS2 don yin amfani da S protein, wanda aka hana a matsayin magani mai yiwuwa a cikin binciken da ake yi. Wannan ya haifar da wasu yanke shawara cewa rage matakan ACE2 a cikin ƙwayoyin zai taimaka wajen yaƙar kamuwa da cuta.
Koyaya, yawancin ƙungiyoyin kasuwanci da hukumomin sarrafawa sun ba da shawarar ci gaba da daidaitaccen mai hana ACE da maganin ARB.
Wani nazari da aka yi a kan tsarin da aka yi da kuma wani bincike da aka yi a kan yadda ake yin maganin da aka yi a ranar 11 ga Yuli, 2012, ya gano cewa "yin amfani da maganin hana ciwon huhu yana da alaƙa da rage haɗarin kamuwa da ciwon huhu da kashi 34% idan aka kwatanta da na rigakafi.
Bugu da ƙari, waɗanda ke da haɗarin kamuwa da cutar huhu, musamman waɗanda ke fama da bugun jini da kuma rashin ƙarfi, sun rage haɗarin shan maganin ACE.
Ko da yake tasirin ACE inhibitor bai kai na gaba ɗaya ba, amma amfani da ACE ya kasance mai alaƙa da rage yawan mutuwar da ke da alaƙa da cutar huhu.
Ana ganin sake hada mutum ACE 2 (rhACE2) a matsayin sabon magani don mummunan rauni na huhu, kuma an nuna ingantaccen yanayin hawan jini da kuma yawan iskar oxygen a cikin jariran aladu da ke da cutar lipopolysaccharide-induced acute respiratory distress syndrome.
A cikin mutane, rabin rayuwar rhACE2 na kimanin awa 10, kuma yana ɗaukar mintuna 30 kafin ya fara aiki, kuma tsawon lokacinsa awa 24.
Yawancin sakamakon ya nuna cewa rhACE2 na iya zama mai ba da bege ga waɗanda ke da rashin haƙuri ga cututtukan da ke da raunin raunin renin-angiotensin-sistemic inhibitors (RAS inhibitors) ko kuma rashin daidaituwa na rashin ƙarfi. An kimanta rhACE2 da aka shayar a gwaji na asibiti don maganin cututtukan numfashi mai tsanani.
b-COVID-19 Apps aikace-aikacen software ne a cikin wayar hannu, waɗanda aka tsara don taimakawa sadarwa a cikin martani ga annobar cutar coronavirus ta 2019-20, wanda shine, hanyar gano mutumin da ya kasance tare da mutumin da ke da cutar ("saduwa").
An kuma samar da aikace-aikace da yawa tare da tallafin gwamnati a wasu larduna da yankuna.
An tsara tsarin da yawa don ƙirƙirar aikace-aikacen gano alaƙa.
An nuna damuwa game da sirrin sirri, musamman a cikin tsarin da ke bin diddigin yanayin yanayin masu amfani da aikace-aikacen.
Zaɓuɓɓukan da ba a taɓa yin amfani da su ba sun haɗa da amfani da siginar Bluetooth don yin rajistar abubuwan da ke faruwa tare da sauran wayoyin salula na mai amfani.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa ayyukan don tallafawa irin waɗannan aikace-aikacen masu tushen Bluetooth kai tsaye a cikin tsarin aikin su na Android da iOS.
A cikin haɗin gwiwa tare da Alipay a China, gwamnatin China ta samar da wani app wanda zai ba da damar 'yan ƙasa su bincika ko sun kasance cikin hulɗa da mutanen da ke da COVID-19.
An yi amfani da shi a birane fiye da 200 a China, kuma a Singapore, ana amfani da shi a wani app mai suna Trace Together.
An samar da manhajar ta hanyar al'ummar IT na gida kuma an samar da ita a matsayin mai budewa kuma za a mika ta ga gwamnati. Arewacin Macedonia ta ƙaddamar da app na "Stop Corona" mai tushen BlueTooth don tuntuɓar mutanen da ke da cutar da kuma saurin amsawa ga jami'an kiwon lafiya.
An haɓaka APP ta Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya.
Har zuwa 14 ga Afrilu, 2020, App yana jiran amincewa daga Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, 2020, gwamnati ta ce ana ci gaba da ci gaba da aikace-aikacen kuma za a samar da shi a cikin 'yan makonni. An kuma shirya irin wannan aikace-aikacen a Ireland da Faransa ("Dakatar da COVID").
Australia da New Zealand suna la'akari da aikace-aikacen da suka dogara da Trace Together da Blue Tooth na Singapore. Rasha tana da niyyar gabatar da aikace-aikacen geofencing don tabbatar da cewa marasa lafiyar COVID-19 da ke zaune a Moscow ba za su bar gida ba.
Ross Anderson, Farfesa a fannin tsaro na injiniya a Jami'ar Cambridge, ya lissafa wasu matsaloli masu yuwuwa a tsarin da ke amfani da aikace-aikace, ciki har da kuskuren kuskure da kuma rashin yiwuwar tasiri idan amfani da aikace-aikacen ya iyakance ga ƙananan yawan jama'a.
Da yake nuna damuwa game da yaduwar aikace-aikacen "coronavirus" masu ɓatarwa ko cutarwa, Apple ya sanya iyaka kan irin ƙungiyoyi da za su iya ƙara aikace-aikacen da suka shafi cutar coronavirus a cikin shagon aikace-aikacen su, yana iyakance su ga "gwamnati" ko kuma sauran ƙungiyoyi masu daraja.
Google da Amazon sun kafa irin wannan takunkumi.
Masu fafutukar tsare sirri sun nuna damuwa game da tasirin sa ido mai yawa ta amfani da aikace-aikacen cutar ta Corona, musamman idan za a lalata abubuwan da aka tsara don sa ido da aka tsara don magance cutar ta Corona.
Kungiyar Amnesty International da wasu kungiyoyi 100 sun yi kira ga gwamnati da ta sanya iyaka kan irin wannan sa ido.
Ƙungiyoyi sun bayyana sharudda takwas don ayyukan gwamnati:
Dole ne a yi sa ido "daidai, dole, kuma tabbatacce";
Za a yi amfani da dokar ta-da-karewa don a ƙara sa ido da kuma sa ido;
Amfani da bayanai ya zama iyakance ga dalilai na COVID-19.
Za a tabbatar da tsaro da kuma asirin bayanai kuma a nuna cewa an kiyaye su bisa ga abin da aka bayar;
Dole ne a guji nuna bambanci da rashin kulawa ta hanyar sa ido ta hanyar dijital;
Sharuɗɗan bayanai tare da ɓangare na uku ya kamata a ayyana a cikin doka;
'Yancin 'yan ƙasa su kare kansu daga zalunci kuma su amsa zalunci;
Ana buƙatar sa hannu mai ma'ana na duk "masu ruwa da tsaki" tare da ƙwararrun masanan kiwon lafiya da ƙungiyoyin da aka yi watsi da su. Ƙungiyar Kwamfuta ta CCC ta Jamus da Masu Ba da Labarai Ba Tare da Kan iyakoki (Reporters ohne Grenzen) (RSF) sun kuma ba da jerin abubuwan bincike.
Manufar shirin na Google/Apple da aka gabatar shine magance matsalar cire tsarin bin diddigin na'urorin su daga tsarin aiki na dindindin da zarar babu buƙatar bin diddigin.
Wasu ƙasashe suna amfani da hanyar sadarwar tushen wuri maimakon aikace-aikace, wanda ke kawar da buƙatar saukar da aikace-aikace da ikon guje wa bin sawu.
An amince da bin hanyar sadarwa a Isra'ila.
Hanyoyin sadarwa da ke da damar samun bayanai na wuri suna da matsala mai tsanani game da tsare sirri.
Duk da haka, ba duk tsarin da ke da uwar garken tsakiya ba ne ke buƙatar samun damar yin amfani da bayanan wuri na mutum; an gina tsarin tsare sirri da yawa waɗanda ke amfani da uwar garken tsakiya don sadarwa kawai.
A Koriya ta Kudu, an yi amfani da wata hanyar da ba ta dogara da APP ba wajen gabatar da hanyar gano mutane.
Maimakon amfani da aikace-aikacen da aka keɓe, tsarin ya haɗa da bayanan bin diddigin abubuwa da yawa, gami da bayanan bin diddigin na'urar hannu da bayanan ma'amala na katin, kuma ya haɗa da sanarwar saƙon rubutu ga masu yiwuwar kamuwa da cuta.
Baya ga amfani da wannan bayanin don faɗakarwa game da yiwuwar tuntuɓar, gwamnati ta ba da bayanin wurin jama'a, saboda canje-canje masu nisa a cikin dokar sirrin bayanai bayan barkewar cutar MERS a cikin ƙasar, wani abu da aka ba da izini.
An ba da wannan bayanin ta hanyar aikace-aikace da shafukan yanar gizo da yawa, wasu ƙasashe, har da Jamus, sun yi tunanin tsarin da ke da ikon sarrafawa da kuma tsare sirri.
Ba a bayyana cikakken bayani ba har zuwa 6 ga Afrilu, 2020.
Sirri - Tsaro na hulɗa mai mahimmanci shine kyakkyawan ra'ayi, wanda ke da takardun bincike tun daga 2013. A ranar 7 ga Afrilu, 2020, fiye da gungun masana goma sha biyu suna aiki akan hanyoyin sada zumunta, kamar amfani da Bluetooth Low Energy (BLE) don yin rajistar kusanci mai amfani da wasu wayoyin salula.
Duk da haka, PEPP-PT wani shiri ne na daidaitawa wanda ke da tsari na tsakiya da na rarraba kuma ba yarjejeniya ɗaya ba. Tsarin rarraba ya haɗa da tsare sirri na rarraba - gano kusanci (DP-PPT/DP-3T), lambobin tuntuɓar wucin gadi (TCN, fka Contact Event Numbers, CEN), tsare sirri da kuma tsarin kula da tuntuɓar wayar hannu (PACT) da sauransu.
A cikin waɗannan ladabi, bayanan mutum ba sa barin na'urar kuma duk haɗin yana kan na'urar.
Kungiyar tsare sirri a MIT Media Lab suna haɓaka SafePath, dandamali don amfani da fasahohin kariya na sirri yayin tattarawa ko amfani da wuri ko hanyar shiga don bin diddigin yaduwar COVID-19.
Wannan yana dogara ne akan bincike a cikin wani farar takarda da aka buga a watan Maris na 2020 mai taken "Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic". Wani irin wannan yunƙuri shine SafeTrace, wani kamfanin haɓaka fasahar tsare sirri wanda Enigma MPC ya kirkira, wanda aka kafa a MIT Media Lab.
Ta amfani da fasahar kayan aikin kayan aiki na SafeTrace, mai amfani yana ba da damar raba wuri mai mahimmanci da bayanan kiwon lafiya tare da sauran masu amfani da hukumomi ba tare da yin sulhu da sirrin bayanan ba.
A ranar 5 ga Afrilu, 2020, an kafa TCN Alliance na Duniya ta ƙungiyoyi waɗanda suka haɗu a kusa da irin wannan tsarin da kuma manyan ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin.
A ranar 9 ga Afrilu, 2020, Gwamnatin Singapore ta sanar da cewa ta bude tushen yarjejeniyar BlueTrace da ake amfani da ita ta hanyar aikace-aikacen hukuma na hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na wayar hannu na Android da iOS, sun ba da sanarwar wani shiri don gano tuntuɓar da aka dogara da haɗin fasahar Bluetooth Low Energy da kuma ɓoye sirrin sirri, wanda suke da'awar cewa za a kiyaye sirrin.
Ya kuma bayyana takamaiman fasahar da ake amfani da ita a cikin tsarin.
A cewar Apple da Google, za a iya raba tsarin zuwa matakai uku:
Rarraba kayan aiki don ƙarfafa gwamnatoci don ƙirƙirar sirrin gwamnati - Kare aikace-aikacen gano cutar Corona.
Haɗa wannan aikin kai tsaye zuwa iOS, Android, Google da Apple yana shirin magance matsalolin ci gaba da kulawa ta hanyar rarraba tsarin ta hanyar sabunta tsarin aiki da farko da kuma magance matsalar ta hanyar hanyar da aka yi amfani da ita bayan an magance barazanar.
B'Drug repositioning (wanda kuma ake kira da sake dawo da magani, sake fasalin, sake fasalin ko sauyawar magani) shine ainihin amfani da magani wanda aka yarda dashi don cutar ɗaya ko cutar don magance wata cuta.
Wannan shine kawai binciken kimiyya da ake yi a halin yanzu don haɓaka ingantaccen magani don COVID-19.
Kwayar cutar SARS-CoV-2 tana da sunadarai 66 da za a iya shan magani, kowannensu yana da wurare masu ɗaure da yawa.
Nazarin irin wannan wurin haɗin yana ba da damar samar da ingantaccen maganin rigakafi na COVID-19 akan sunadarai.
Abubuwan da ke da mahimmanci na SARS-CoV-2 sun hada da sunadarai masu kama da Papane, RNA mai dogara da RNA polymerase, Helicase, S protein, da ADP ribophosphatease.
Hussain AA da sauransu sun yi nazarin wasu magungunan da aka zaɓa sannan suka bincika su don gano kamanceceniya da maganin da aka amince da shi, wanda zai iya haifar da ingantaccen maganin SARS-CoV-2 a cikin binciken su na farko don ba da shawarar a cikin tsarin gwajin asibiti.
Chloroquine magani ne na hana ciwon daji wanda ake amfani da shi wajen magance wasu cututtuka na kai tsaye.
A ranar 18 ga Maris, WHO ta sanar da cewa magungunan guda huɗu da za a yi nazari a kansu a matsayin ɓangare na gwajin asibiti na Solidarity sun haɗa da chloroquine da hydroxychloroquine mai alaƙa.
Gwamnan New York Andrew Cuomo ya sanar da cewa za a fara gwajin jihar New York akan chloroquine da hydroxychloroquine daga ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin izinin amfani da gaggawa ((EUA).
Ba a ba da izinin maganin ba ta hanyar FDA ta hanyar gwajin asibiti kuma an ba da izinin a ƙarƙashin EUU don kawai magani na gwaji ga marasa lafiya waɗanda aka kwantar da su amma ba za su iya samun magani a cikin gwajin asibiti ba.
CDC ta ce "ba a tabbatar da amfani, adadin, ko tsawon lokacin da za a yi amfani da hydroxychloroquine ba don rigakafi ko maganin cutar SARS-CoV-2".
Likitoci sun ce ana amfani da wannan magani ne idan "babu sauran mafita".
Wani karamin bincike da aka gudanar a Istanbul, Turkiyya, ya yi amfani da Chloroquine tare da zinc, bitamin A, bitamin C, da bitamin D.
Ana gudanar da bincike mai zurfi a Jami'ar Duke da Jami'ar Oxford.
NYU Langon Medical School yana gwada aminci da ingancin hydroxychloroquine a matsayin maganin rigakafi.
Gwaje-gwajen asibitocin kasar Sin a Wuhan da Shenzhen sun yi ikirarin cewa Favipirvir yana da "cikakken tasiri".
A Shenzhen, 35 daga cikin marasa lafiya sun nuna cewa ba su da lafiya a cikin kwanaki 4 yayin da 45 suka nuna cewa ba su da lafiya a cikin kwanaki 11.
A cikin wani bincike da aka yi a Wuhan, an yi wa marasa lafiya 240 da ke fama da cutar sankarar bargo, an ba rabin su maganin favipirvir, kuma rabin su sun sha maganin imifenovir.
Hukumar Magunguna ta Italiya ta tunatar da jama'a cewa, akwai isassun bayanai da ke tallafawa maganin.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan, tare da taimakon soji, kuma za ta ba da shi ga asibitocin jami'a, inda za a yi amfani da maganin don kula da marasa lafiya na COVID-19.
A cewar South China Morning Post, Shinzo Abe ya yi tattaunawa ta yau da kullum da gwamnatin Trump kan sayan magungunan da ke iya zama marasa tasiri a cikin marasa lafiya masu tsanani, inda cutar ta riga ta ninka.
Ba zai zama da lafiya ba ga mata masu juna biyu ko kuma waɗanda suke ƙoƙarin yin ciki.
Wani bincike a kan lopinavir/ritonavir (Caletra), wanda ya hada maganin rigakafi na lopinavir da ritonavir, ya kammala da cewa "babu wani amfani da aka samu".
An tsara magunguna don hana kwayar cutar HIV ta hanyar haɗa shi da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin gano mahaɗan da ke ɗaure da furotin SARS-CoV-2 ta hanyar inganta waɗannan magungunan.
WHO ta haɗa da lopinavir/ritonavir a cikin gwajin Solidarity.
Gilad Sciences ne ya kirkiro Remdesivir don magance cutar Ebola da kuma cutar Marburg. Gilad Sciences ta gano cewa Remdesivir yana da tasirin kwayar cuta ta kwayar cuta ta kwayar cuta ta filas, pneumonia, paramyxovirus, da coronaviruses.
Wata matsala da ke tattare da maganin antiviral ita ce, ƙin kamuwa da cuta da ke tasowa daga wani canji da ke haifar da cututtuka da kuma kamuwa da cuta.
Wasu binciken farko na farko sun nuna cewa Remdesivir yana da babban juriya ga jini. Wasu gwaji na asibiti suna gudana, ciki har da gwaji biyu a asibitin Jami'ar Cleveland; ɗaya a cikin mutane masu rashin lafiya da kuma na biyu a cikin mutane masu rashin lafiya.
Gwaje-gwaje uku na asibiti na ba da bitamin C a cikin jijiyoyin marasa lafiya masu cutar COVID-19 da ke kwance a asibiti suna gudana; biyu a ƙarƙashin kulawar placebo ((China, Kanada) da ɗaya ba tare da kulawa ba ((Italiya).
Jihar New York ta fara gwajin maganin rigakafi azithromycin a ranar 24 ga Maris.
Cibiyar Kula da Lafiya da Magunguna ta Japan (NCGM) ta shirya yin gwajin asibiti na maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Ana gudanar da gwajin Phase II na Vaccine-2 mai canzawa zuwa angiotensin, wanda zai hada da marasa lafiya 200 a asibitoci a Denmark, Jamus, da Austria.
Masu bincike a Cibiyar Zuciya ta Montreal, Kanada, suna nazarin rawar da colchicine ke takawa wajen rage kumburi da rikice-rikicen huhu a cikin marasa lafiya da ke da alamun COVID-19.
Ana daukar tsofaffi 6000 masu shekaru 40 ko sama da haihuwa waɗanda aka gano suna da COVID-19 kuma ba sa buƙatar asibiti don binciken da ake kira Colcorona.
Mata masu juna biyu ko masu shayarwa da kuma mata da ba su da maganin hana haihuwa masu tasiri ba su cancanci.
Ana gwada wasu maganin rigakafi a Italiya.
Ana amfani da ƙananan nauyin ƙwayar cuta don magance marasa lafiya, wanda ke ƙarfafa cibiyoyin kiwon lafiya a Italiya don buga jagora.
An sanar da wani bincike mai yawa na marasa lafiya 300 a ranar 14 ga Afrilu a Italiya don bincika rigakafin cutar da maganin maganin maganin Enoxaparin sodium.
Tun da SARS-CoV-2 kwayar cuta ce, ana ba da hankali sosai ga amfani da maganin rigakafin cutar da aka amince da shi a cikin annobar MERS, SARS, da West Nile.
Ribavirin: An ba da shawarar ribavirin don maganin COVID-19 bisa ga Juzu'i na 7 na Jagororin China.
Yumifenovir: An ba da shawarar Yumifenovir don maganin COVID-19 bisa ga Tsarin 7 na Jagororin China.
An gano cewa wasu maganin rigakafi na iya amfani da su don sabon maganin COVID-19:
Tosilezumab ((IL-6-anti-receptor): an amince da shi daga China
Duba kuma gwaji a China da Italiya da Tocilizumab#COVID-19.
B'A COVID 19 Vaccine wani rigakafi ne na almara da aka yi da cutar coronavirus ta 2019 (COVID-19).
Ko da yake babu wani allurar rigakafi da aka kammala gwajin asibiti, ana ci gaba da yin ƙoƙari don samar da irin wannan.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba za a sa ran samun allurar rigakafin cutar SARS-CoV-2 ba har sai bayan watanni 18.
A watan Afrilu, an gudanar da binciken lafiya na Farfajiyar I kan 'yan takarar allurar rigakafi biyar.
An gano COVID-19 a watan Disamba na 2019.
Cutar da ta bulla a duniya a shekarar 2020 ta haifar da saka hannun jari da bincike mai yawa don samar da allurar rigakafi.
Kungiyoyi da dama suna amfani da wannan kwayar halitta don samar da maganin rigakafin SARS-CoV-2
Kamar yadda aka sanar a watan Afrilu, abubuwan da ke da muhimmanci na shirin CEPI na samar da allurar rigakafi sune saurin, iya samarwa, tsarawa, da kuma isar da ita a duniya.
A watan Afrilu, masana kimiyya na CEPI sun sami labarin cewa ana gudanar da bincike da ci gaba a kan dandamali daban-daban na fasaha guda 10 a farkon 2020 don samar da ingantaccen rigakafin COVID-19.
Babban manufofin dandamali a cikin Nazarin Tsaro na I sune:
Nucleic acid ((DNA da RNA) ((tsarin I masu haɓakawa da masu neman allurar rigakafi: Moderna, mRNA-1273)
Mai ɗaukar hoto (mai haɓaka na farko da ɗan takarar allurar rigakafi: Cancino Biologics, adenovirus nau'in 5 vector)
A watan Afrilu, masana kimiyya na CEPI sun sami bayanai cewa akwai masu neman allurar rigakafi 115 a cikin matakan ci gaba, 78 daga cikinsu an tabbatar da cewa suna kan aiki (milken institute ya ce 79) kuma an sanar da wasu 37 kuma ba a bayyana su sosai ba (an ɗauka cewa suna cikin shiri ko kuma ana shirin tsara su).
An fara gwada lafiyar da kuma ingancin rigakafi a cikin gwaji na Phase I-II, wanda yawanci ana yin sa ne a bazuwar, sarrafawa da wuri, da kuma wurare da yawa don ƙayyade madaidaicin, ƙimar ƙimar.
Gwaje-gwaje na Phase III yawanci suna da ƙarin mahalarta, wanda ya haɗa da ƙungiyar sarrafawa, kuma ana bincika ingancin allurar rigakafi don hana cutar, tare da lura da tasirin sakamako mai illa bayan an ba da isasshen allurai.
Daga cikin alluran rigakafi 79 da ke cikin aiki (kamar yadda aka tabbatar a farkon Afrilu 2020), 74 ba su da kimantawa a cikin ɗan adam (har yanzu ana gudanar da "binciken" na "preclinical").
A ranar 24 ga Janairu, 2020, a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana binciken yiwuwar allurar rigakafin ƙwayar cuta wanda zai iya haifar da amsawar rigakafi ta hanyar gyaran kwayar cutar ta hanyar gyaran kwayar cutar.
A ranar 24 ga Janairu, 2020, Cibiyar Alurar riga kafi ta Duniya a Jami'ar Saskatchewan a Kanada ta sanar da fara aikin kan allurar rigakafi, tare da gwajin ɗan adam a cikin 2021.
Cibiyar Kula da Cututtuka ta China ta sanar da aikin samar da allurar rigakafi don sarrafawa da rigakafin cutar a ranar 26 ga Janairu, 2020 kuma Jami'ar Hong Kong ta sanar da shi a ranar 28 ga Janairu, 2020.
A ranar 29 ga Janairu, 2020, Jansen Pharmaceutical, wanda Hannek Skytemaker ya jagoranci, ya sanar da cewa yana aiki kan haɓaka allurar rigakafi.
Janssen tana haɗin gwiwa tare da Vaxart, abokin aikinta na fasahar kere kere, don samar da maganin rigakafin bakin.
A ranar 18 ga Maris, 2020, Emergent Biosolutions ya sanar da haɗin gwiwar samar da kayayyaki tare da Vaxart don haɓaka allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, Oncogene Laboratory a Romania ta buga takarda game da tsarin samar da allurar rigakafi kamar yadda ake amfani da shi a maganin rigakafin cutar kansa.
A ranar 25 ga Maris, shugabannin cibiyar bincike sun sanar da cewa sun yanke shawarar hada allurar rigakafi kuma sun fara gwaji.
A ranar 27 ga Fabrairu, 2020, kamfanin Generex, NuGenerex Immuno-Oncology, ya sanar da cewa ya ƙaddamar da aikin rigakafi don haɓaka Li-Key peptide rigakafin COVID-19.
Suna son su samar da wani maganin rigakafi da za a iya gwadawa a cikin mutane "a cikin kwanaki 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da aikinta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Cibiyar Nazarin Likita ta Amurka da Materiel Command a Fort Detrick da Walter Reed Army Institute a Silver Spring, duka a Yammacin Maryland, sun sanar da cewa suna aiki kan allurar rigakafi.
A kusan 10 ga Maris, 2020, Emergent Biosolutions ya sanar da cewa yana aiki tare da Novavax Inc.
don samar da rigakafi.
Abokan sun sanar da cewa za su gudanar da gwajin asibiti na farko da gwajin asibiti na farko a watan Yuli na 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki a kan isolates 11 kuma zai ɗauki kusan shekara daya da rabi zuwa biyu don haɓaka allurar rigakafi, koda da sauri.
Kamfanin kimiyyar halittu na Quebec City, Quebec, MediCago, ya ba da rahoton cewa ya haɓaka kwayar cutar coronavirus, tare da samun wani ɓangare na kudade daga Cibiyar Nazarin Lafiya ta Kanada, a ranar 12 ga Maris, 2020.
Ana gudanar da bincike na gwaji a kan ɗan takarar rigakafin kuma ana shirin yin gwajin ɗan adam a watan Yuli ko Agusta 2020.
A farkon wannan makon, The Guardian ta ruwaito cewa Shugaban Majalisar Dinkin Duniya Donald Trump ya nuna shirye -shiryen bayar da "babban kuɗi don samun damar samun damar yin amfani da allurar COVID-19" ga Curevac, wanda gwamnatin Jamus ta yi tir da shi.
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da cewa ya haɗu tare da kamfanin Biontech na Jamus don haɓaka allurar rigakafin mRNA.
Ana gudanar da gwajin rigakafin mRNA-based candidate BNT162 a cikin gwaji na farko kuma ana sa ran gudanar da gwajin asibiti a watan Afrilu 2020.
A Italiya a ranar 17 ga Maris, 2020, Takes Biotech, wani kamfanin samar da maganin da ke samar da maganin, ya sanar da cewa za su sami sakamakon gwajin rigakafin a watan Afrilu na 2020, sannan kuma za a yi gwajin gwajin na ƙarshe na ɗan takarar rigakafin.
A ranar 19 ga Maris, 2020, Coalition for Epidemic Preparedness Innovations (CEPI) a Faransa ta sanar da saka hannun jari na US$4.9 ga ƙungiyar tallafin binciken rigakafin COVID-19 tare da haɗin gwiwar Cibiyar Pasteur, Themis Biosciences (Vienna, Austria) da Jami'ar Pittsburgh, wanda ya kai jimlar saka hannun jari na CEPI na US$29 don haɓaka rigakafin COVID-19.
Abokan haɗin CEPI don haɓaka allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
Jami'an kiwon lafiya na Rasha sun sanar a ranar 20 ga Maris, 2020 cewa masana kimiyya sun fara gwajin dabbobi akan takaddun rigakafi daban-daban guda shida.
Masu bincike a Kwalejin Imperial na London sun sanar a ranar 20 ga Maris, 2020 cewa suna haɓaka rigakafin RNA mai haɓaka kansa don COVID-19.
An samar da takardar rigakafin a cikin kwanaki 14 bayan an ba da umarni daga China.
Gwamnatin Kanada ta sanar da kudade na dala miliyan 275 a ƙarshen Maris don ayyukan magani 96 na COVID-19, wanda ya haɗa da kamfanoni da jami'o'i daban-daban na Kanada, kamar su Medicago da Saskatchewan Initiative.
A daidai wannan lokacin, Gwamnatin Kanada ta ba da C$192 miliyan don haɓaka allurar rigakafin COVID-19, gami da shirin kafa "Bankin Alurar rigakafin ƙasa" wanda za a iya amfani da shi idan cutar ta sake barkewa.
A ranar 2 ga Afrilu, 2020, Jami'ar Pittsburgh School of Medicine ta sanar da cewa tana yin gwaji a cikin beraye akan yiwuwar allurar rigakafin COVID-19 ta Pitkovak, tana mai cewa "An gwada ingantaccen maganin rigakafin antigen-takamaiman maganin rigakafin SARS-CoV-2 S1 subunit na allurar rigakafin MNA a cikin beraye wanda ya fara samun sakamako makonni 2 bayan allurar rigakafi".
A ranar 16 ga Afrilu, 2020, Jami'ar Waterloo School of Medicine ta Kanada ta sanar da shirin samar da wani takardar rigakafin DNA a matsayin hanyar samun maganin cutar.
Za a yi amfani da kwayar cuta don ƙirƙirar DNA wanda zai iya yin kwafi a cikin kwayar cuta ta mutum don samar da kwayar cutar da ba ta da cutarwa, wanda zai iya motsa tsarin rigakafi don samar da rigakafi ga cutar SARS-CoV-2.
A watan Maris na 2020, gwamnatin Majalisar Dinkin Duniya, masana'antu, da jami'o'i uku sun haɗa kai da albarkatun kwamfuta na Cloud Computing na Hewlett Packard Enterprise, tare da Amazon, Microsoft, da Google don samun damar IBM Supercomputers.
Wasu alluran rigakafi suna haifar da sakamako na musamman, wanda ake kira sakamako da ba a so.
Wannan yana nufin cewa yana iya samun fa'idodi fiye da maganin cutar.
A nan gaba, za a yi amfani da ma'aikatan kiwon lafiya 4,170 don yin gwajin bazuwar a Australia.
Akwai yiwuwar cewa allurar rigakafin da ake samarwa ba ta da lafiya ko inganci.
Binciken da aka yi a baya don kimanta tasirin allurar rigakafin COVID-19 a kan takamaiman dabbobi kamar ACE2-transgenic mice, sauran dabbobi masu bincike da primates ban da mutane, ya nuna buƙatar haɗin kai na duniya don tabbatar da matakan kula da lafiyar 3 da daidaitaccen tsarin tsaro don sarrafa kwayar cutar.
An gwada allurar rigakafin SARS da MERS a cikin dabbobi ban da mutane.
Har zuwa 2020, babu maganin SARS ko allurar rigakafi mai lafiya da tasiri ga mutane.
A cewar takardun bincike da aka buga a shekarar 2005 da 2006, ganowa da kuma bunkasa sabbin alluran rigakafi da magunguna don maganin SARS ya kasance babban fifiko ga gwamnatoci da hukumomin kiwon lafiya na jama'a a duk duniya.
Yayin da cutar ta MERS ta yi ƙarfi, ana tsammanin binciken da ake yi a kan SARS zai samar da samfurin da zai iya amfani da shi wajen gano maganin rigakafi da magungunan cutar MERS-CoV.
Ya zuwa Maris 2020, an kammala gwajin asibiti na farko na allurar rigakafin DNA na MERS a cikin ɗan adam, kuma ana kan aiki kan wasu alluran rigakafi guda uku, dukansu alluran rigakafin ƙwayar cuta ne, biyu adenoviral-vectored (ChAdOx1-MERS, BFRS-Gamvac), da kuma MVA-vectored (MVA-MERS-S).
A cikin wani sako da aka wallafa a shafukan sada zumunta, an bayyana cewa an san kwayar cutar COVID-19 kuma an riga an samar da maganin rigakafinta.
Takaddun shaida da aka gabatar a matsayin hujja daga wasu sakonnin kafofin watsa labarun suna nuni ne ga takaddun shaida na yau da kullun don jerin kwayoyin halitta da rigakafin wasu nau'ikan coronavirus kamar SARS coronavirus.
B'Coronavirus Disease 2019 (COVID-19) cuta ce mai yaduwa wacce ke haifar da cutar SARS-CoV-2.
Alamun da suka fi kowa shi ne zazzabi, tari, da kuma wahalar numfashi.
Wasu alamun na iya zama gajiya, rashin motsin jiki, zawo, ciwon makogwaro, rashin wari, da kuma ciwon ciki.
Lokaci na farko da za a fara nuna alamun cutar daga lokacin da aka hana shi yana da kwanaki biyar, amma zai iya zama daga kwana biyu zuwa 14.
Yawancin marasa lafiya suna da ƙananan alamun cutar, wasu kuma suna da ciwon da ke haifar da cutar sankara da kuma rashin sassan jiki da yawa.
Ya zuwa 17 ga Afrilu, 2020, an sami sama da mutane miliyan 2.24 a cikin kasashe da yankuna 210, wadanda suka mutu 153,000.
An samu sama da mutum 5,68,000 da suka warke daga cutar, kuma ana yada cutar ta hanyar hulɗa da mutane, sau da yawa ta hanyar tari, tari, ko kuma ta hanyar magana.
Idan muka numfasa, za mu iya fitar da wannan ƙwayoyin kuma su fāɗa a ƙasa ko kuma a kan ƙasa, ba za su iya kaiwa nesa ba.
Idanun mutum, hanci, da baki da kuma shafawa da gurɓataccen abu na iya cutar da mutane.
Kwayar cutar tana rayuwa har tsawon sa'o'i 72 a kan kowane irin farfajiya.
Ana iya samun cutar a cikin kwanaki uku na farko bayan bayyanar cututtuka, amma ana iya samun yaduwar cutar a cikin pre-symptomatic da post-symptomatic.
Ana ba da shawarar cewa duk wanda ake zargi da kamuwa da cutar da masu kula da su su sanya abin rufe fuska.
Ana ba da shawarwari daban-daban game da sanya abin rufe fuska daga talakawa, wasu jami'ai suna adawa da sanya abin rufe fuska, wasu suna ba da shawarar yin hakan, wasu kuma suna cewa dole ne a yi amfani da shi.
Babu takamaiman maganin rigakafi ko rigakafi na COVID-19 a halin yanzu.
Yawancin ƙasashe a duk yankuna shida na WHO suna da cututtukan gida.
Wasu lokuta marasa lafiya da suka kamu da cutar ba sa nuna alamun cutar ko kuma suna nuna alamun cutar mura kamar zazzabi, tari, gajiya da wahalar numfashi.
Alamun na gaggawa sun hada da wahalar numfashi, ciwon kirji ko damuwa, jin rikicewa, wahalar tafiya, da fuska da lebe masu launin shuɗi; ana ba da shawarar zuwa asibiti nan da nan idan an gano alamun.
Ƙananan alamun na iya zama alamun numfashi kamar su jin ƙai, hanci mai ɓacin rai, ko kuma ɓacin hanci.
Wasu marasa lafiya sun fi samun alamun cututtukan hanta kamar su amai, amai da kuma zawo.
Wasu marasa lafiya a China sun fara nuna alamun ciwon kirji da bugun zuciya.
Wasu daga cikin marasa lafiyar sun kamu da ciwon huhu, sun rasa gabobin jiki da yawa, kuma sun mutu.
Ana kiran wannan lokacin lokacin hawan.
Lokacin ɓoyewar COVID-19 yawanci kwanaki 5 zuwa 6 ne, amma a wasu lokuta zai iya zama kwanaki 2 zuwa 14.
A cikin kashi 97.5 na waɗanda suka kamu da cutar, bayyanar cututtuka ta bayyana ne a cikin kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa ba duka waɗanda suka kamu da cutar ba ne ke nuna alamun cutar.
Ba a bayyana matsayin masu dauke da cutar ba a cikin kamuwa da cutar, amma ana ganin suna da hannu wajen yaduwar cutar daga matakan farko.
Ba a san yawan mutanen da ke kamuwa da cutar ba kuma ana ci gaba da bincike, yayin da 20% na waɗanda aka tabbatar da su daga Cibiyoyin Kula da Cututtuka da Rigakafin Cutar Korea (KCDC) sun ba da rahoton cewa ba su da alamun cutar har sai an kwantar da su.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara hada marasa alamun cutar a cikin adadin masu cutar yau da kullun daga ranar 1 ga Afrilu; daga cikin mutane 166 da suka kamu da cutar a wannan ranar, 130 (78%) ba su da alamun cutar a lokacin gwajin.
Tsutsotsi da hawaye suna ɗauke da ƙwayoyin cuta masu yawa.
Magana da ƙarfi tana fitar da ƙaiƙayi fiye da magana ta al'ada.
Wani bincike da aka yi a Singapore ya nuna cewa ƙudaje suna iya kaiwa nesa na mita 4.5 (15 feet) idan suka yi tari ba tare da rufe fuska ba.
Ko da yake ba a samo wannan kwayar daga iska ba, National Academy of Sciences ta yi hasashen cewa ana iya watsa ta ta hanyar bioaerosol, kuma an sami RNA mai kyau na kwayar a cikin samfuran da aka ɗauka daga masu tara iska a cikin gidajen mutane.
Wasu hanyoyin kiwon lafiya, kamar su saka tubes da kuma sake kunna zuciya da jijiyoyin jini, suna iya fitar da ruwa daga cikin numfashi kuma ta haka ne za su iya yaduwa ta iska.
Idan ana damu da yaduwar cutar ta hanyar fitsari, an yi la'akari da cewa akwai ƙananan haɗari, kuma mutane da ke da alamun cutar sun fi kamuwa da cutar.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce, ba a san yadda cutar take yaduwa ba, amma mutum ɗaya zai iya cutar da mutane biyu ko uku, kuma zai iya rayuwa a kan rufin jiki na tsawon sa'o'i da kwanaki.
Ainihin, an gano cewa kwayar cutar ta shafe kwana ɗaya a kan takarda, ta shafe kwana uku a kan filastik da karfe (AISI 304), kuma ta shafe sa'o'i huɗu a kan takarda mai nauyin 99%.
Amma, ya dangana ne da yanayin yanayi da kuma yanayin zafi, kuma yana canjawa.
Safiya da kayan wanki suna iya taimakawa idan aka yi amfani da su yadda ya kamata; kayan wanki suna kawar da garkuwar kwayar cutar, suna kashe ta, kuma suna ware ta daga fata da sauran wurare.
Wasu hanyoyin, kamar su benzakonium chloride da chlorhexidine gluconate (wani irin maganin kashe ƙwayoyin cuta) ba su da tasiri sosai. A wani bincike da aka yi a Hong Kong, an ɗauki samfurori na sallama a cikin kwanaki biyu bayan an shigar da su asibiti.
A cikin marasa lafiya shida, biyar sun sami mafi yawan kwayoyin cutar a cikin samfurin farko, kuma a cikin marasa lafiya shida, an sami mafi yawan kwayoyin cutar a gwajin da aka yi a rana ta gaba.
Cutar cutar sankarar rai mai saurin kamuwa da cuta ta SARS-CoV-2 wani sabon kwayar cutar sankarar rai ce da aka fara warewa daga cikin mutane uku da suka kamu da cutar sankarar rai da ke da nasaba da cibiyar kula da cututtukan numfashi mai tsanani a Wuhan.
Dukkanin halayen wannan sabon kwayar SARS-CoV-2 ana iya ganin su a cikin kwayar cutar corona da ke da alaƙa da ita a yanayi.
A waje da jikin mutum, ana kashe kwayar cutar ta hanyar sabulu na gida wanda ke samar da kumfa mai kariya. SARS-CoV-2 yana da alaƙa da kwayar cutar SARS-CoV.
COVID-19 yana da tasiri sosai a cikin huhu, saboda kwayar cutar tana kaiwa ga ƙwayoyin asali ta hanyar enzyme angiotensin-converting enzyme 2 (ACE2), wanda yake da yawa a cikin wasu nau'ikan ƙwayoyin iska a cikin huhu.
Wannan kwayar cutar tana amfani da wani takamaiman glycoprotein mai farfajiya da ake kira spike don haɗa kai da ACE2 kuma ta shiga cikin ƙwayoyin asali.
Kashi 12 na marasa lafiya da aka kwantar a asibitoci a Wuhan, China, suna da ciwon zuciya mai tsanani, wanda ya zama sananne a cikin mummunan rashin lafiya.
Cutar cututtukan zuciya suna da yawa saboda halayen kumburi na jiki da lalacewar rigakafi yayin yaduwar cutar, amma kuma cututtukan zuciya na iya kasancewa tare da abubuwan karɓar ACE2 na zuciya.
Masu karɓar ACE2 suna da yawa a cikin zuciya kuma suna da hannu cikin aikin zuciya.
An sami ƙarin ƙwayoyin cuta (31%) da ƙwayoyin jini (25%) a cikin marasa lafiya masu tsanani na COVID-19, wanda wataƙila yana da alaƙa da rashin kulawa. An gano ɓarnar huhu (ɓarna mai ɓarna) a cikin autopsies na marasa lafiya da suka mutu saboda COVID-19 da kuma ƙwayoyin fata masu kumburi a cikin huhu.
Kodayake SARS-COVID-2 yana da halayen kamuwa da cuta tare da ƙwayoyin cuta na numfashi don ACE2, ana iya ganin alamun hyperinflammation a cikin marasa lafiya masu tsanani na COVID-19.
Musamman: Kwayoyin GM-CSF-T masu ƙonawa sun kasance suna da alaƙa da sanya IL-6 masu ƙonawa na monocytes da kuma cutar huhu mai tsanani a cikin waɗannan marasa lafiya na COVID-19.
An kuma gano cewa an yi wa jikin mutum gwaje-gwaje da suka nuna cewa yana da ƙwayoyin jini.
Hukumar Lafiya ta Duniya (WHO) ta wallafa wasu dokoki da suka shafi gwajin cutar.
Real-time reverse transcription polymerase chain reaction shine hanyar da aka yarda da ita.
Ana yin gwajin ne a kan abubuwan da aka samu daga cikin hanci da kuma cikin hanci, amma ana iya yin amfani da abubuwan da aka samu daga cikin hanci da kuma cikin hanci.
Sakamakon gwajin yakan kasance cikin sa'o'i kadan ko kuma kwanaki biyu.
Ana iya yin gwajin jini, amma ana bukatar a yi gwajin jini sau biyu a kowane mako, kuma sakamakon ba shi da muhimmanci nan take.
Masana kimiyyar kasar Sin sun sami damar gano kwayar cutar ta Corona da kuma buga jerin kwayoyinta, wanda ya baiwa dakunan gwaje-gwaje na duniya damar samar da gwajin polymerase chain reaction (PCR) da zai iya gano cutar.
Ya zuwa 4 ga Afrilu, 2020, ana ci gaba da gwajin rigakafin (wanda zai iya gano kamuwa da cutar a halin yanzu kuma ya gaya wa mutum ko ya riga ya kamu da cutar) amma ba a yi amfani da su sosai.
Kwarewar gwajin da aka yi a kasar Sin ta nuna cewa daidaito na kashi 60 zuwa 70 ne kawai.
FDA a Amurka ta amince da gwajin farko na kulawa don amfani a ƙarshen watan a ranar 21 ga Maris, 2020. Jagororin bincike da asibitin Zhongnan na Jami'ar Wuhan ya bayar sun ba da shawarar hanyoyin gano kamuwa da cuta bisa la'akari da halaye na sunadarai da kuma haɗarin yanayin cuta.
A farkon kamuwa da cuta, bambancin bangarorin biyu na multilobar na ƙasa-gilashin gilashi tare da rarrabawar kewayon, asymmetrical da bango ya zama ruwan dare.
Yayin da cutar ke ci gaba, za a iya samun subplantar dominance, pewing mai ban mamaki (ƙaraccen lobular septum tare da canzawa alveolar filing) da kuma ƙuƙwalwa.
Akwai wasu bayanai game da ilimin lissafi da kuma ƙananan raunuka na COVID-19.
Ga wasu muhimman bayanai game da yadda ake gane cututtuka a lokacin da aka yi wa mutum jana'iza:
Abubuwan da za a iya gani: ciwon huhu, ciwon zuciya, ƙuƙwalwar huhu, da kumburi
An lura da nau'i huɗu na cutar huhu da ke yaɗuwa:
Ƙaramin ciwon huhu: kumburi, ƙwayoyin cuta da ke ƙaruwa a cikin huhu, ƙwayoyin cuta da ba su da tushe a cikin huhu, kumburi tsakanin jiki da kuma ƙwayoyin cuta masu yawa da ke ƙaruwa a cikin huhu
Cutar huhu mai tsanani: Rashin ƙarfi na huhu da kuma zubar da jini a cikin huhu
Ciwon da ke saurin yaɗuwa yana sa mutum ya yi ciwon numfashi mai tsanani da kuma rashin iskar oxygen.
Ƙarfin da ke warkarwa: Ƙarfin da ba a iya sarrafawa a cikin huhu da kuma ciwon ciki na huhu
Jinin: Ruwa yana ƙwanƙwasawa a cikin jijiyoyin jini (ƙwaƙwalwar ƙwayar cuta ta ciki); halayen leukorethroblastic
Matakan da za a iya ɗauka don rage yiwuwar kamuwa da cutar sun haɗa da zama a gida, guje wa wuraren taruwa, wanke hannuwanku da sabulu da ruwa akai-akai kuma aƙalla na dakika 20, kiyaye tsabtace numfashi, da kuma guje wa taɓa idanu, hanci ko baki da hannayen da ba a wanke ba.
CDC ta ba da shawarar a saka tawul a gaban hanci da baki yayin da kake yin tari ko tari, idan babu tawul, a rufe hanci da kusurwar hannu.
An gaya mana mu wanke hannayenmu bayan mun yi wani irin tari ko tari.
CDC ta ba da shawarar yin amfani da sutura masu rufe fuska yayin tafiya a cikin jama'a don rage kamuwa da cutar daga mutanen da ba su da alamun cutar. Dalilin nisantar da jama'a shine rage haɗuwa da manyan mutane masu kamuwa da cutar.
A cikin batun nesa, an gaya wa mutane su kiyaye nesa da juna na aƙalla ƙafa 6.
Ba a san ko za a sami maganin rigakafin COVID-19 ba. Ko da yake ba a tsammanin za a sami allurar rigakafin ba har zuwa 2021, babban ɓangare na gudanarwar COVID-19 a halin yanzu shine daidaita yanayin cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu akai -akai da sabulu da ruwa na akalla sakan 20, musamman bayan sun je bayan gida ko kuma idan hannayensu sun lalace, kafin cin abinci da kuma bayan sun taɓa hanci, da kuma bayan sun yi tari ko tari.
CDC ta kuma ba da shawarar yin amfani da kayan aikin tsabtace hannu tare da ɗan giya, wanda ya ƙunshi aƙalla kashi 60 cikin ɗari na giya, amma kawai idan sabulu da ruwa ba su da wadatarwa. A yankunan da ba a samun kayan aikin tsabtace hannu na kasuwanci, WHO ta ba da shawarwari biyu don samar da gida.
A cikin waɗannan ƙwayoyin, maganin rigakafi yana samuwa ne daga ethanol ko isopropanol.
An yi amfani da hydrogen peroxide don hana ƙwayoyin cuta su yi girma a cikin giya, 'ba shi da amfani wajen kashe ƙwayoyin cuta a hannu.'
An haɗa glycerol a matsayin mai riƙe danshi.
Ana kula da marasa lafiya ta hanyar kulawa mai taimako, wanda ya haɗa da samar da iskar oxygen, maganin ruwa da sauran abubuwan da suka shafi sassan jikin da suka shafi.
CDC ta ba da shawarar cewa duk wanda ya yi zargin cewa yana da kwayar cutar ya sa takunkumin fuska.
An riga an yi amfani da maganin oxygen don magance matsalar rashin numfashi, amma har yanzu ana ganin amfanin da yake samu.
An ba da shawarar tsabtace jiki da rayuwa mai kyau da abinci don haɓaka rigakafi.
WHO da Hukumar Lafiya ta China sun ba da shawarwari game da kula da marasa lafiya da ke cikin asibiti da ke fama da COVID-19.
Masana asibiti da likitocin huhu a Amurka sun tattara shawarwarin magani daga hukumomi daban-daban a cikin tushen buɗe ido guda ɗaya, IBCC.
Babu takamaiman magani don COVID-19 kamar yadda aka ƙaddara a watan Afrilu, 2020.
Wasu likitoci suna ba da shawarar yin amfani da paracetamol maimakon ibuprofen da farko saboda alamun.
Ya kamata a yi taka tsantsan don rage haɗarin yaduwar kwayar cutar, musamman yayin aiwatar da hanyoyin samar da ruwan sha a cikin iska, kamar su tube a jiki ko iska ta hannu.
CDC ta ba da shawarar cewa ma'aikatan kiwon lafiya da ke kula da marasa lafiya da ke fama da COVID-19 su kiyaye su a cikin ɗakunan keɓewar kamuwa da cutar ta iska (AIIR) tare da kiyayewa, kula da hulɗa da kuma hana yaduwar iska.
Kayan rigakafi da aka ba da shawarar don shiri: PPE tufafi, na'urar numfashi ko abin rufe fuska, kariya ga idanu da safofin hannu na likita. Idan akwai, ya kamata a fi son na'urar numfashi maimakon na'urar rufe fuska.
An amince da masu numfashi na N95 don amfani da masana'antu, amma FDA ta amince da amfani da abin rufe fuska a ƙarƙashin izinin Amfani da Gaggawa (EUA).
An tsara su don kare ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin.
Idan ba a samun abin rufe fuska, ana iya amfani da abin rufe fuska ko abin rufe fuska na gida a matsayin ƙarshen magani, kamar yadda CDC ta ba da shawarar.
Yawancin marasa lafiya da ke da COVID-19 ba su da tsanani har su buƙaci yin amfani da iska ko kuma wasu hanyoyin, amma kashi kaɗan ne kawai na waɗanda suke da shi.
Ana ci gaba da nazarin irin nau'ikan hanyoyin numfashi na likita da ake samu ga marasa lafiya saboda matsalar matsalar numfashi ta COVID-19. Ana iya guje wa shigar da bututu ta hanyar hanci mai gudana ko kuma ta hanyar karfin iska mai kyau.
Har yanzu ba a san ko ko ɗaya daga cikin waɗannan yana da amfani ga marasa lafiya masu ciwo mai tsanani ba.
Wasu likitoci suna son maganin iska mai ƙarfi idan akwai, saboda yana iyakance yaduwar ƙwayoyin cuta a cikin iska fiye da na bututun mai. Matsayin rashin lafiya yana da yawa a cikin tsofaffi.
Ko da a cikin ƙasashe masu tasowa, rashin isasshen gadaje a asibiti a kowane mutum na iya iyakance ikon kula da lafiyar jama'a wajen magance matsalar asibiti idan aka yi saurin karuwar masu fama da cutar COVID-19.
Wani bincike da aka yi a kasar Sin ya nuna cewa kashi 5 cikin 100 na marasa lafiya da aka kwantar a ICU, kashi 2.3 cikin 100 na bukatar samun iska mai iska, kuma kashi 1.4 cikin 100 sun mutu.
Kimanin kashi 30 cikin dari na marasa lafiya da ke cikin asibiti na COVID-19 a China sun ƙare a cikin sashen ICU.
Matsalar numfashi mai tsanani (ARDS) a cikin marasa lafiya na COVID-19 yana sanya iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska
Ana buƙatar masu amfani da iska masu ƙarfin matsi da kuma PEEP mai ƙarfi don rage haɗarin raunin huhu da pneumothorax yayin da suke ba da ƙarin iskar oxygen.
Tsoffin na'urorin numfashi na iya rashin PEEP mai ƙarfi.
Bincike kan yiwuwar magani ya fara a watan Janairu, 2020, kuma an gwada magungunan rigakafi da yawa tun daga lokacin.
Remdesivir ne ya fi nuna cewa zai yi nasara.
Ko da yake zai ɗauki har zuwa 2021 don haɓaka sabbin magunguna, yawancin magungunan da aka gwada sun sami izini don sauran amfani ko kuma suna cikin ƙarin gwaji.
Ana iya gwada maganin rigakafi a kan marasa lafiya masu tsanani.
Masu ba da gudummawa da Hukumar Lafiya ta Duniya ta ba da shawarar su shiga cikin gwaji don nazarin tasirin da amincin waɗannan hanyoyin magani. FDA ta ba da izinin ba da izinin maganin convalescent plasma a matsayin magani na gwaji a cikin marasa lafiya waɗanda ke da haɗarin rayuwa.
Ba su shiga gwajin sunadarai ba don tabbatar da cewa maganin yana da tasiri kuma mai lafiya.
A watan Fabrairun 2020, kasar Sin ta kaddamar da wani manhajar wayar salula don magance cutar.
Ana tambayar masu amfani su saka sunansu da lambar shaidarsu.
Aikace-aikacen na iya nuna 'kusa da juna' daga bayanan da aka lura, kuma yana iya fahimtar yiwuwar kamuwa da cuta.
Kowane mai amfani zai iya bincika matsayin wasu masu amfani uku.
Idan aka gano cewa akwai yiwuwar haɗari, wannan app ɗin yana ba da shawarar keɓe kai, kuma yana ba da sanarwar ga jami'an kiwon lafiya na gida. Big Data Analytics na bayanan wayar salula, fasahar ganewar fuska, bin diddigin wayar salula da kuma fasaha ta wucin gadi duk ana amfani da su ne a Koriya ta Kudu, Taiwan da Singapore don lura da marasa lafiya da kuma mutanen da suka shiga cikin hulɗa da su.
A watan Maris na 2020, gwamnatin Isra'ila ta ba da umarnin jami'an tsaro su bincika bayanan wayar hannu na mutanen da ke da yiwuwar kamuwa da cutar.
An dauki matakai don sanya keɓewa da kuma kare waɗanda ke iya kasancewa tare da waɗanda ke da cutar.
A watan Maris na 2020, Deutsche Telecom ta ba da bayanan wuraren tarho ga cibiyar Robert Koch ta gwamnatin Tarayyar Jamus, don amfani da su wajen bincike da kuma hana yaduwar cutar.
Rasha ta kafa fasahar gane fuska don gano mutanen da suka karya keɓewa.
Kwamishinan kiwon lafiya na yankin Italiya, Julio Galleria, ya ce yana samun bayanai ta wayar salula.
Gwamnatin Jamus ta gudanar da wannan taron na tsawon sa'o'i 48 tare da masu ruwa da tsaki sama da 42,000 a karshen mako.
Shugaban kasar Estonia Kirsty Karlulaid ya yi kira ga duniya da ta dauki matakan da suka dace wajen dakile yaduwar cutar.
Mutane na iya jin tsoro game da keɓewa, hana su tafiya, sakamakon jinya, ko kuma tsoron kamuwa da cuta.
BBC ta yi ƙaulin kalaman Rory O'Connor cewa "ƙaruwar warewar jama'a, kaɗaici, rashin lafiya, matsi, da kuma koma bayan tattalin arziki su ne manyan abubuwan da ke kawo barazana ga lafiyar mutane da kuma lafiyarsu".
Waɗannan cututtuka na iya nuna alamun rashin lafiya ko kuma rashin alamun cutar, wanda ya yi daidai da cututtukan numfashi kamar su sanyi da tari.
Sau da yawa, marasa lafiya sukan warke cikin makonni biyu, amma masu ciwo mai tsanani suna iya ɗaukar makonni uku zuwa shida.
Bisa ga bayanan wasu irin wannan kwayar cutar kamar SARS, MERS, ana iya cewa mata masu juna biyu da suka kamu da cutar COVID-19 suna iya zama cikin haɗari, amma babu bayanai game da COVID-19 a wannan batun. COVID-19 na iya shafar huhu a cikin wasu mutane, wanda ke haifar da cutar huhu.
COVID-19 na iya haifar da ciwon ciwon numfashi mai tsanani (ARDS) a cikin mutanen da ke fama da cutar, wanda zai iya haifar da rashin aikin numfashi, rashin karfin jini ko rashin aiki da yawa, da sauransu.
Matsaloli da ke tattare da COVID-19 sun haɗa da sepsis, ƙwayoyin jini da rashin ƙarfi, da kuma lalacewar zuciya, koda da hanta, da sauransu.
Kashi 6 cikin 100 na waɗanda aka kwantar da su a asibiti saboda COVID-19 sun sami rikicewar ƙwayoyin jini, ƙaruwa a cikin prothrombin, kuma kashi 4% na waɗannan rukunin sun sami rikicewar aikin koda.
Kusan kashi 20-30% na mutanen da ke da COVID-19 suna da ƙwayoyin hanta masu ƙarfi.
Wannan rahoton ya ce tsakanin bayyanar cututtuka da mutuwa, kwanaki 10 ne, daga cikinsu, kwana 5 ne ake bukatar a kwantar da mutum a asibiti.
Duk da haka, akwai kwanaki bakwai tsakanin lokacin da aka kwantar da marasa lafiya a sashen kulawa mai tsanani da lokacin da suka mutu.
Nazarin farko ya nuna cewa matsakaicin lokacin da cutar ta fara nuna alamun cutar zuwa mutuwa ya kasance kwanaki 14.
Wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin (NHC) ta yi ya nuna cewa, mace ta mutu a kashi 2.8 cikin 100 na maza, yayin da mace ta mutu a kashi 1.7 cikin 100.
Binciken ilimin lissafi na bayan-mutuwa na ƙwayar huhu ya nuna lalacewar alveolar da ke yaduwa tare da fibromycoxide na salula a cikin huhu biyu.
An gano wasu canje-canje a cikin ƙwayar cuta ta hanyar kwayar cutar.
An yi amfani da hoton huhu don nuna cewa yana da alaƙa da ciwon numfashi mai tsanani (ARDS).
Kashi 11.8 na mutuwar da Hukumar Lafiya ta Kasa ta China ta ruwaito sun nuna cewa akwai hawan troponin ko kuma rashin aiki na zuciya.
Rahoton Maris na Amurka ya nuna cewa kashi 89% na mutanen da aka kwantar da su a asibiti suna da wasu gunaguni. Samun damar samun albarkatun kiwon lafiya da yanayin zamantakewar al'umma na yankin ma suna shafar mutuwar.
Rashin nisa na yanki yana sa a yi hasashen yawan mutuwar a wannan yanayin, amma kuma matsaloli na tsarin suna sa a yi hakan.
Rage yawan masu kamuwa da cutar zai iya haifar da karin adadin mutuwa.
Duk da haka, gaskiyar cewa waɗannan mutuwar sun kasance sakamakon haɗuwa da lokuta na baya na iya nufin cewa ƙididdigar mutuwar yanzu ba ta da kyau.
Masu shan sigari sun fi masu shan sigari sau 1.4 na fuskantar bayyanar cututtukan COVID-19 da kuma kusan sau 2.4 na buƙatar kulawa mai tsanani ko yiwuwar mutuwa.
Jami'an asibiti a Hong Kong sun gano cewa wasu mutane da suka warke daga cutar sun rasa damar yin amfani da huhu da kashi 20 zuwa 30 cikin dari, kuma binciken da aka yi a kan huhu ya nuna cewa gabobin jikin sun lalace.
Wannan yana iya haifar da ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon.
Har zuwa Maris 2020, ba a san ko mutanen da suka warke daga cutar sun sami gagarumar rigakafi na dogon lokaci daga kamuwa da cutar ba.
Dangane da yanayin sauran ƙwayoyin cuta, ana iya ganin rigakafi, amma akwai wasu lokuta da aka sami tabbataccen gwajin COVID-19 a cikin 'yan kwanaki masu zuwa.
An yi imanin cewa a cikin irin waɗannan lokuta, ana iya samun ƙarin kamuwa da cuta maimakon sake kamuwa da cuta.
An yi imanin cewa kwayar cutar ta samo asali ne daga dabba kuma ana yaduwa ta hanyar kamuwa da cuta.
Ba a san ainihin asalin cutar ba, amma a watan Disamba na 2019, an yi hasashen cewa an kamu da ita ne ta hanyar kamuwa da cutar daga mutum zuwa mutum.
Nazarin 41 na tabbatar da cutar COVID-19 da aka buga a cikin Janairu a cikin Lancet ya nuna cewa 1 ga Disamba, 2019 shine farkon lokacin bayyanar cututtuka.
A cikin sanarwar da WHO ta fitar, an ba da kwanan wata farkon bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Ana amfani da hanyoyi dabam dabam wajen ƙidaya yawan mutuwar mutane.
Waɗannan lambobin sun bambanta daga yanki zuwa yanki da kuma lokaci zuwa lokaci, kuma suna da tasiri ta hanyar yawan gwaje -gwaje, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokacin da cutar ta fara, da kuma halaye na alƙaluma kamar shekaru, jinsi, da lafiyar gaba ɗaya.
A cikin ƙarshen 2019, WHO ta ba da lambar gaggawa ta ICD-10 U07.1 ga mutuwar da aka tabbatar da lab daga SARS-CoV-2 kamuwa da cuta, da lambar cuta U07.1 ga mutuwar COVID-19 da ba a tabbatar da su ba ta hanyar asibiti ko ta hanyar cututtukan cututtukan SARS-CoV-2.
Rahoton Jami'ar Johns Hopkins ya nuna cewa yawan mutanen da suka kamu da cutar a duniya ya kai kashi 6.9 cikin dari.
Sauran matakan sun hada da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano, wadanda suka mutu daga wata cuta, da kuma yawan mutuwar cuta (IFR), wanda ke nuna yawan mutanen da suka kamu (wanda aka gano da wanda ba a gano ba), wadanda suka mutu daga wata cuta.
Waɗannan ƙididdigar ba su da wani lokaci kuma suna dogara ne akan takamaiman yawan mutanen da suka kamu da cutar ta hanyar yanayin cutar.
Ba dukan mutane da suka kamu da cutar ba ne suke samar da rigakafi, kuma kasancewar rigakafin zai iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A tsakiyar annobar a Italiya, wani karamin gari mai suna Castiglione d'Adda, mutane 4600,80 (1.7%) sun mutu.
A Gangelt, cutar ta samo asali ne daga bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin
Bugu da ƙari, tsarin kiwon lafiya na Jamus ba shi da nauyi sosai.
A Netherlands, kusan kashi 3 cikin 100 na mutane suna da rigakafin cutar, kamar yadda aka samu daga mai ba da jini.
An tabbatar da mutuwar mutane 69 (kashi 0.004 na yawan jama'a) daga COVID-19.
Sakamakon cutar da kuma yawan mace-macen da ke mutuwa sun bambanta ga mata da maza.
Bincike da aka yi a China da Italiya ya nuna cewa maza suna da yawan mutuwa.
Maza masu shekaru hamsin ne suka fi fuskantar wannan cuta, kuma bambancin mace da namiji a cikin mutuwar ya ragu sosai a shekarun 1990s.
A kasar Sin, mace ta mutu a kashi 2.8 cikin 100 na maza da kuma kashi 1.7 cikin 100 na mata.
Ba a san ainihin dalilin da ya sa ake da bambancin jinsi ba, amma ana iya ganin cewa suna da nasaba da kwayoyin hali da kuma ɗabi'a.
Rashin daidaiton rigakafi bisa jinsi, ƙarancin shan sigari a cikin mata, da kuma ci gaba da yanayin rashin lafiya kamar hawan jini a cikin maza a cikin shekaru fiye da mata, duk suna iya zama dalilai na yawan mutuwar maza.
A Turai, 57% na waɗanda suka kamu da cutar maza ne kuma 72% na waɗanda suka mutu daga COVID-19 maza ne.
Har zuwa watan Afrilu 2020, gwamnatin Amurka ba ta samun bayanan jinsi a cikin mutanen da ke dauke da COVID-19.
Binciken ya nuna cewa cututtuka kamar Ebola, HIV, mura, da kuma SARS suna shafan maza da mata a hanyoyi dabam dabam.
Yawancin ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya mata ne, kuma suna cikin hadarin kamuwa da cutar.
WHO ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan cutar zai zama "COVID-19".
Shugaban WHO, Tendros Edhanom Ghebreyesus ya bayyana cewa CO na nufin Corona, VI na nufin Virus, D na nufin Cutar, kuma 19 shine shekarar da cutar ta fara bulla a Lakshmi: 31 ga Disamba, 2019.
An ba da wannan sunan ne don kaucewa yin nuni ga takamaiman wuri na ƙasa (kamar China), nau'in dabba, ko rukuni na mutane, wanda ya bi shawarar da aka ba da ta duniya, kuma an yi niyyar hana kowa ya zama mai lalatarwa. An ba da sunan cutar da ke haifar da COVID-19 mai suna Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).
A cikin sadarwa ta jama'a, WHO tana amfani da "COVID-19 Virus" da "Virus da ke da alhakin COVID-19".
An fi kiran wannan cuta da kwayar cutar "coronavirus".
A lokacin da cutar ta bulla a Wuhan, China, an fi kiran wannan cuta da cutar "coronavirus" da kuma "Wuhan coronavirus".
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCoV da 2019-nCoV Acute Respiratory Diseases a matsayin sunaye na wucin gadi don cutar da cutar, bisa ga jagorar 2015 game da amfani da wuri a cikin sunayen cututtuka da ƙwayoyin cuta.
An ba da sunayen hukuma na COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda ƙarancin ƙarfin da aka ƙayyade a cikin daidaitattun jerin, wasu masana'antun dijital suna buga kayan aikin kiwon lafiya azaman nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan.
Alal misali, a asibiti a Italiya, lokacin da ake bukatar bawul din iska da gaggawa kuma mai samarwa bai iya samar da shi ba a kan lokaci, wani kamfani na gida ya sake tsarawa kuma ya buga bawul 100 a dare.
Bayan barkewar COVID-19, an kafa da kuma yada bayanai marasa kyau da kuma karkatarwa game da asalin cutar, da yadda ake kamuwa da ita, da hanyoyin da za a bi da ita, da sauransu, kuma an yi ta yada su a yanar gizo cikin hanzari.
An gano cewa ɗan adam yana iya yada wannan kwayar cutar zuwa wasu dabbobi.
Wannan binciken bai sami tabbacin cewa ana iya kwafin kwayar cutar a aladu, ducks da kaji ba.
Babu wani magani ko rigakafi da aka amince da shi don maganin wannan cuta.
Ana ci gaba da bincike na duniya kan allurar rigakafi da maganin COVID-19 ta hanyar gwamnati.
A watan Maris, WHO ta ƙaddamar da "Gwaji na Solidarity" don kimanta tasirin maganin maganin ƙwayoyin cuta huɗu da suka fi tasiri.
Duk da cewa babu allurar rigakafi a halin yanzu, hukumomi daban-daban suna aiki sosai don samar da 'yan takarar rigakafi.
Ana amfani da binciken da aka yi a baya akan SARS-CoV-2, saboda SARS-CoV da SARS-CoV-2 suna amfani da igiyar ACE2 don shiga cikin ƙwayoyin ɗan adam.
An gano dabarun allurar rigakafi guda uku.
Na farko, masu bincike suna da burin samar da cikakkiyar allurar rigakafin cutar.
Manufar amfani da irin wannan kwayar cutar, ko dai mai kashewa ko kuma mai mutuwa, shine samar da sabon kamuwa da cutar tare da COVID-19 a cikin martani na gaggawa na jikin mutum.
Wata dabarar ita ce allurar rigakafi, wadda take nufin samar da rigakafi da zai sa tsarin garkuwar jikinmu ya zama mai saukin kamuwa da wani nau'in kwayar cutar.
A cikin yanayin SARS-CoV-2, irin wannan binciken ya mai da hankali kan furotin S-spike wanda ke taimakawa kwayar cutar ta rarrabe ACE2 enzyme neuronal fibers.
Dabara ta uku ita ce rigakafin nucleic acid (DNA ko RNA vaccine, wani sabon fasaha na samar da rigakafi).
Kowane ɗayan waɗannan dabarun na iya buƙatar gwajin gwaji don aminci da tasiri. A Seattle, a ranar 16 ga Maris, 2020, an fara gwajin asibiti na rigakafi tare da masu sa kai huɗu.
Wannan allurar rigakafi tana dauke da kwayar halitta mai lafiya, wanda aka kirkira daga kwayar cutar da ke haifar da cutar. An ba da shawarar yin amfani da rigakafin rigakafi a matsayin wata matsala ga samar da allurar rigakafin SARS-CoV-2, amma wannan yana da rikici.
A cikin rahoton da aka bayar a watan Afrilu na 2020, an gudanar da gwaje-gwaje sama da 300.
Ana kimanta gwaji bakwai daga magungunan da aka riga aka amince da su don cutar zazzabin cizon sauro, gami da bincike huɗu akan hydroxychloroquine ko chloroquine.
Yawancin binciken da ake yi a kasar Sin sun hada da magungunan rigakafin cutar da ke amfani da magungunan cutar, rahotanni da aka gabatar a karshen watan Afrilu sun nuna cewa akwai gwaji tara a kan matakin na uku na Remedicivir a kasashe da dama.
A cikin rahoton Afrilu 2020, akwai nazarin motsi na ci gaban asibiti don allurar rigakafin COVID-19 da kuma masu neman magani. An kimanta magungunan rigakafin cutar COVID-19 da yawa, gami da Remedicivir, Chloroquine da Hydroxychloroquine, Lopinavir/Tonavir, da Lopinavir/Ranavir tare da Interferon Beta.
Rahoton na Maris 2020, ya nuna cewa akwai shaidar wucin gadi game da tasirin Remedicivir.
An ga ci gaba a cikin marasa lafiya da aka yi wa magani ta hanyar Remedicivir.
Ana gudanar da gwajin asibiti na Phase-III a Amurka, China da Italiya. Chloroquine, wanda aka yi amfani da shi a baya don cutar zazzabin cizon sauro, an yi nazari a cikin China a watan Fabrairun 2020, wanda ya ba da sakamakon farko.
Amma, wannan bincike yana bukatar bita na jama'a.
Jami'an kiwon lafiya na Koriya da China sun ba da shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Kwayoyin cuta ta Wuhan ta ba da shawarar yin amfani da gram ɗaya a rana, inda ta lura cewa ninki biyu na cutar yana da haɗari sosai kuma yana iya haifar da mutuwa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa na hydroxychloroquine da chloroquine bisa ga ƙudurin likitocin da ke kula da marasa lafiya da COVID-19. Har ila yau, jagorar na 7 na kasar Sin ya haɗa da Interferon, Raibavirin ko Yumifenovir don amfani da su a kan CORONA-19.
Bayanai na farko sun nuna cewa ana buƙatar ƙarin maganin rabayvirin don hana SARS-CoV-2 a cikin gwaji.
An ba da shawarar Nitasoxanoid don ƙarin gwaji bayan nuna ƙarancin ƙarancin SARS-CoV-2. Nazarin ya nuna cewa ana buƙatar farkon fashewar furotin mai ƙarfi ta hanyar transmembrane protease serine 2 (TMPRSS2) don shigar da SARS-CoV-2 ta hanyar hulɗa tare da ACE-2 na'urar.
Nazarin chloroquine da hydroxychloroquine tare da azithromycin ko ba tare da shi ba yana da manyan matsaloli waɗanda suka hana ƙungiyar likitanci ɗaukar waɗannan jiyya ba tare da ƙarin bincike ba. Oseltamivir bai hana SARS-CoV-2 a cikin gwaji ba kuma ba a sami wani matsayi a cikin maganin COVID-19 da aka sani ba.
Cytokine Storm na iya zama mai rikitarwa a cikin matakan gaba na COVID-19.
Bayan wani ɗan ƙaramin bincike, Hukumar Lafiya ta ƙasar Sin ta haɗa tossilizumab cikin jagororin magani.
A Italiya, ana gudanar da gwajin gwaji na mataki na biyu ba tare da daidaito ba, bayan an sami sakamako mai kyau a cikin mutanen da ke da mummunan cuta.
Idan aka hada maganin jini da gwajin jini don gano cutar cytokine, hakan na nufin cewa za a iya hana ci gaban da aka yi la'akari da shi a matsayin sanadin mutuwa a cikin wasu mutane da ke kamuwa da cutar.
A cikin 2017, FDA ta amince da wani mai adawa da neurotransmitter na Interleukin-6 bisa ga binciken farko da aka yi don maganin cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Har zuwa yau, babu wani gwaji na bazuwar, wanda aka sarrafa cewa tosilezumab magani ne mai tasiri ga CRS.
Ana ci gaba da bincike don samar da rigakafin rigakafin da aka tsarkake da kuma mayar da hankali ga mutanen da suka warke daga COVID-19 a cikin mutanen da ke buƙatarsa a matsayin hanyar da ba ta dace ba ta yin allurar rigakafi.
An yi amfani da wannan dabarar a SARS, amma ba ta da wani sakamako mai kyau.
Hanyar da ake tsammani ta hanyar aikin kashe ƙwayar cuta ta hanyar maganin rigakafin da ba a yi aiki ba a kan SARS-CoV-2.
Duk da haka, wasu hanyoyi, kamar su ƙwayoyin cuta masu ƙwayoyin cuta da kuma/ ko ƙwayoyin cuta, za su iya yiwuwa.
Ana ci gaba da haɓaka wasu nau'ikan maganin antibody marasa aiki, misali, amfani da ƙwayoyin cuta na monoclonal.
Za a iya ƙara samar da sinadarin da ke saurin yaduwa, wanda ya ƙunshi sunadarai na jini na marasa lafiya da suka warke da kuma ƙwayoyin cuta da ke da alaƙa da wannan kwayar cutar.
Cutar Coronavirus, wani rukuni na cututtukan da ke da alaƙa da juna
Li Wenliang, wani likita a asibitin Wuhan, ya kamu da cutar COVID-19 bayan ya kara wayar da kan jama'a game da yaduwar cutar, kuma ya mutu.
